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FUNCTION OF HISTONE CROTONYLATION

Benjamin R. Sabari, Ph.D.
The Rockefeller University 2016

Histone lysine acetylation (Kac) plays a critical role in gene regulation by
affecting the accessibility of the DNA wrapped around histones and by
recruiting effector complexes. Three major classes of proteins are associated with
Kac, namely “writers,” enzymes that covalently modify specific lysine residues,
“readers,” protein domains that specifically bind modified residues, and
“erasers,” enzymes that catalyze the removal of the modification. While histone
acetylation is well characterized within this paradigm, little is known about the
regulation and function of an expanding list of histone lysine acylations. Lysine
propionylation, butyrylation, and crotonylation were all discovered by
proteomics-based approaches as I started in the Allis Lab. With reports
suggesting that lysine crotonylation (Kcr) was the most functionally distinct from
Kac I embarked to purify and identify the writers, readers, and erasers and
thereby characterize the regulation and function of histone Kcr.
To identify writers of Kcr I purified a histone crotonyltransferase (HCT)
activity from nuclear extract by fractionation, which resulted in the purification
of p300, a well-studied transcriptional co-activator and histone acetyltransferase
(HAT). Together with colleagues in the Roeder lab, we established that p300’s

HCT activity directly stimulates transcription to a greater degree than p300’s
HAT activity. This work is discussed in Chapter 2.
I developed several genetic and chemical approaches to manipulate the
cellular concentrations of acetyl-CoA and crotonyl-CoA and established that
acyl-CoA metabolism determines the state of differential histone acylation (Kac
versus Kcr) thereby coupling the metabolic state to gene regulation. This work is
discussed in Chapter 3.
With these methods, I next studied the impact of Kcr in the macrophage
inflammatory response, a classic model of signal-dependent gene activation.
Through bioinformatics analysis of RNA-seq and ChIP-seq of macrophages in
various conditions, I established that increased histone Kcr leads to enhanced
expression of p300-regulated genes. This work is discussed in Chapter 4.
These data suggested that there was a reader for Kcr with positive
regulatory activity. In collaboration with colleagues in the Li lab, we identified
the YEATS domain as a novel Kcr reader. Through a series of structural,
biophysical, bioinformatic, and genetic studies we showed that AF9 and the
YEATS-Kcr interaction is responsible for the enhanced expression of increased
Kcr. This work is discussed in Chapter 5. As discussed in Chapter 6, I have also
identified and characterized several decrotonylase (eraser) activities.
The regulation of histone crotonylation or the functional consequence of a
histone being acetylated versus crotonylated (differential acylation) has
remained unclear since the discovery of the modification was reported. In my
thesis work, I have demonstrated that the differential acylation state of histones
is an integration of environmental and metabolic information, which serves a
functional role in the regulation of gene expression.

For my first teachers, my parents
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CHAPTER 1: GENERAL INTRODUCTION

The physiological form of eukaryotic nuclear DNA is chromatin, a nucleic acidprotein complex. In its simplest form, chromatin is composed of repeating
nucleosomal units, each containing an octamer of histone proteins (two copies
each of the core histones H3, H4, H2A, and H2B) and 147 base pairs (bp) of DNA
(Kornberg, 1977). The nucleosome (Luger et al., 1997) is the first order of
compaction mediated by histones required to fit the immense quantity of
genomic DNA into the relatively small nuclear volume while maintaining
appropriate access (Figures 1.1A and 1.1B). A wealth of discoveries over the past
two decades has transformed the long-standing view of histones from being
passive static scaffolds to dynamic modulators of virtually all DNA-templated
events, such as replication, genomic maintenance, and transcription. Much of this
progress in understanding the active role of histones has been due to the study of
the regulation and function of histone post-translation modifications (PTMs).
Histone proteins are subject to a wide variety of PTMs of both chemical
type and site that, alone or in combination, are characteristic of functional
chromatin states. The combinatorial potential of histone PTMs is often referred to
as the “histone code,” a language written on the histone proteins distinct from
the genetic code written within the DNA double helix. The identification and
characterization of histone-modifying enzymes as the products of genes
previously associated with transcriptional and epigenetic regulators led to the
proposal that the information encoded in the patterns of histone PTMs represents
a form of epigenetic regulation of gene expression and cellular memory
(Jenuwein and Allis, 2001; Strahl and Allis, 2000).
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Figure 1.1: Structural and Functional Organization of the Eukaryotic
Genome by Histones and Histone PTMs.
(A) Illustration of genomic compaction. Adapted from (Felsenfeld and
Groudine, 2003). (B) Structure of the nucleosome. Adapted from (Luger et
al., 1997). (C) Electron Micrograph of a guinea pig plasma cell. Electron
dense heterochromatin is marked with an H and electron poor euchromatin
is marked with an E. Adapted from Columbia University Histology Manual.
(D) Designation of nine distinct chromatin states of the Drosophila
melanogaster genome as defined by ChIP-seq for histone PTMs and other
chromatin factors. Adapted from (Kharchenko et al., 2011).
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Two distinct chromatin states can be defined visually as heterochromatin
and

euchromatin.

Under

electron

microscopy

heterochromatin

appears

condensed while euchromatin appears open (Figure 1.1C), these chromatin states
are functionally distinct as heterochromatin is generally transcriptionally silent
while euchromatin transcriptionally active. Particular histone PTMs associate
with and determine these functional chromatin states (Felsenfeld and Groudine,
2003). With advances in high-throughput sequencing, genome-wide maps of
histone PTMs and other transcriptional machinery have been generated by
chromatin immunoprecipitation followed by sequencing (ChIP-seq) (Zhou et al.,
2010). These data have allowed for a finer characterization of the functional
organization of the eukaryotic genome (Figure 1.1D) (Kharchenko et al., 2011).
From two states discernable by visual density with electron microscopy the field
recently described nine or up to fifteen distinct chromatin states derived in large
part from bioinformatics analysis of ChIP-Seq data of distinct subgroupings of
histone PTMs genome-wide (Ernst et al., 2011).
With the application of high-sensitivity mass spectrometry to the
identification of histone PTMs the current catalogue of observed histone PTMs is
immense and growing (Figure 1.2) (Huang et al., 2014). Taking into account data
on all four core histone proteins (H3, H4, H2A, and H2B) and the linker histone
H1, roughly 500 unique histone modifications have been detected comprising 23
different types of chemical modification.

The direct function or the regulatory

mechanisms for a majority of these modifications remains unknown. Three major
classes of proteins are involved in the regulation and function of histone PTMs
and they are colloquially termed “writers,” enzymes that catalyze the covalent

3

Figure 1.2: The Current “Snapshot” of Histone Modifications.
Histone proteins are decorated by a variety of post-translational
modifications (PTMs), which are critical to the dynamic modulation of
chromatin structure and function, contributing to the cellular gene
expression program. Histone PTMs can influence chromatin either directly,
by changing the physical characteristic of the histone protein (e.g. lysine
acetylation negates the residue's positive charge), or indirectly, by
recruitment

of

modification-

and

site-specific

effector

proteins

("readers"). The function of a given histone PTMs is therefore mediated by
both the physical properties of the modification (i.e. size and charge) and
the location of the modified residue within the quaternary structure of the
nucleosome. Recent studies, many powered by high-sensitivity mass
spectrometry, have expanded our understanding of the extent to which
histone proteins are modified. These studies have not only expanded the
sites of well-studied modification, but have also revealed several new
types of histone PTMs with a large diversity of structure, charge, and site
of modification. Presented here is a compilation of data for histone PTMs
observed from studies on human, mouse, or rat. Red boxes highlight the
chemical structures of acetyl-lysine and crotonyl-lysine, the subject of this
thesis. This figure is adapted from the Cell SnapShot (Huang, Sabari, et al.
2014).

4

5

modification of specific histone residues, “readers,” effector protein domains that
bind histones in a modification specific manner, and “erasers,” enzymes that
remove the modification. The combined activities of these three protein classes
establish functional chromatin landscapes. Characterization and identification of
the writers, readers, and erasers for any given modification is the first step to
establishing the function of the modification. For example, the identification of a
histone acetyltransferase (HAT) as a known transcriptional co-activator and a
histone deacetylase (HDAC) as a transcriptional co-repressor prompted a
breakthrough in the understanding of histone acetylation and its role in
transcriptional regulation (Brownell et al., 1996; Taunton et al., 1996). This was
followed soon thereafter by the identification of the bromodomain, a protein
domain found in many transcriptional regulators with unknown function, as a
reader of acetyl-lysine (Dhalluin et al., 1999). Together with a wave of
subsequent research, these studies established a model for the function of histone
acetylation in gene regulation, discussed in the next section (Figure 1.3).
My thesis work has focused on characterizing the regulation and function
of one of these recently described and under-studied histone PTMs, histone
lysine crotonylation (Kcr). To this end I have identified writers, readers, and
erasers of histone crotonylation, demonstrated that acyl-CoA metabolism
regulates the abundance of the modification, and characterized its role in gene
expression. Lysine crotonylation is chemically similar to lysine acetylation in its
linkage to the ε amine of lysine, yet it is distinct in its extended and rigid
hydrocarbon chain (Figure 1.2, see red boxes). The majority of my thesis work
will be comparing the regulation and function of histone crotonylation to that of
the more established histone acetylation. In this chapter, I will review the
6

literature on histone acetylation and its role in transcription, focus on the role of
p300/CBP, provide background on the metabolic regulation of histone
acetylation, and conclude with an introduction to histone crotonylation.

A Brief History of Histone Acetylation
In 1871 Friedrich Miescher published his work on extracts derived from purified
nuclei of white blood cells that contained both acid and basic substances, what
we would today consider DNA and histones, respectively. Meischer went on to
study the nuclein of salmon sperm and prepare high purity preparation of its
acidic component making him the first to isolate DNA (van Holde, 1989). In 1884
Albrecht Kossel purified the basic component of nuclein from goose erythrocytes
by extraction with hydrochloric acid and termed the acid-soluble protein histon
(Doenecke and Karlson, 1984; Kossel, 1884). This simple purification of histones
by acid extraction is still a commonly used lab practice and is used throughout
this thesis.
Through the early 20 century, histones were considered a homogenous
th

group of proteins until Stedman and Stedman identified multiple forms of
histone proteins in their analysis of histones extracted from various tissues and
species (Stedman, 1950). This heterogeneity of histone proteins led to the
proposal that distinct phenotypes could result from the type of histone(s)
associated with DNA (Stedman and Stedman, 1951). Although the Stedmans’
claims were later dismissed, their hypothesis presented histones as more than
mere scaffolds for DNA and inspired further research into the sequence and

7
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Figure 1.3: Reversible Histone Acetylation in Transcription.
Ordered recruitment of transcription factors (DNA-binding activators) recruit
p300 and other co-activators allowing for histone modifications and remodeling,
which facilitates the recruitment and stabilization of the transcription apparatus
(Txn) through protein-DNA (activator-DNA), protein-protein (activator-coactivator), and protein-PTM (reader-histone) interactions allowing for the
effective activation of transcription. This process is reversible by the recruitment
of HDAC co-repressor complexes, which will deacetylate histones and nonhistone substrates.
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structure of the histone proteins (van Holde, 1989). In the 1960’s nucleosomal
histones were shown to be generally repressive to RNA synthesis (Huang and
Bonner, 1962). Around the same time chemical analysis of the composition of
histone proteins identified acetyl-lysine (Phillips, 1963) and methyl-lysine
(Murray, 1964) as constituents of histones. At The Rockefeller Institute, Vincent
Allfrey and colleagues performed a series of critical experiments that established
a new paradigm for the active role of histones in gene regulation. They first
demonstrated that intact nuclei readily took up and incorporated labeled acetate
(acetate-2-C ) into histone proteins, even in the presence of translation inhibitors.
14

These experiments established that histone acetylation was post-translational.
Allfrey and colleagues next reproduced the studies showing that histones
inhibited RNA synthesis, but demonstrated that chemically acetylated histones
were inert (Allfrey et al., 1964). These observations led Allfrey to the following
statement:
Specific (and presumably reversible) changes in histone structure …
may permit DNA to serve as a template in the RNA polymerase
reaction. This raises the possibility that relatively minor modifications
of histone structure, taking place on the intact protein molecule, offer
a means of switching-on or -off RNA synthesis at different loci along
the chromosome. (Allfrey et al., 1964)
Allfrey’s prescient conclusions were not widely accepted for another thirty years,
yet in that time many studies built upon this early hypothesis.
In the mid-1970’s Riggs and colleagues showed that a previously reported
butyrate-induced differentiation of Friend Leukemia cells into globin-secreting
cells (Leder and Leder, 1975) was accompanied by an increase in histone
acetylation (Riggs et al., 1977; 1978). Soon after, Davie and Allfrey demonstrated
that butyrate was an inhibitor of histone deacetylase activity (Boffa et al., 1978;
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Candido et al., 1978). These studies provided early evidence that the highly
dynamic

regulation

of

histone

acetylation

was

involved

in

cellular

differentiation. Furthermore, these studies illustrated the potential for small
molecule intervention at the level of chromatin and provided an experimental
tool to perturb histone acetylation by addition of butyrate to cells in culture.
These observations also introduced the potential for histone modifications and
their physiological output to be modulated by naturally occurring metabolites, in
this case the short-chain fatty acid butyrate, a premise I raise in my thesis work.
The late 1980’s to early 1990’s provided a string of studies that further
illustrated the importance of histone acetylation in regulation of gene expression.
A number of groups utilizing the power of genetics in S. cerevisiae demonstrated
that mutating the four highly conserved lysine residues on the histone H4 tail to
either arginine or alanine resulted in growth defects, replication timing defects,
abnormal silencing of telomeric chromatin, and defects in repression and
activation of the mating type locus (Johnson et al., 1990; Megee et al., 1990; Park
and Szostak, 1990). These four lysine residues were known to be acetylated to
varying degrees in vivo yet, aside from substituting lysine for the acetyl-lysine
mimic glutamine, these studies could not make direct claims on the role of
histone acetylation per se.
Development of acetyl-histone-specific antibodies further established the
connection

between

histone

acetylation

and

gene

activity.

By

immunofluorescence, the transcriptionally silent micronucleus of Tetrahymena
thermophila

was

shown

to

be

hypo-acetylated

as

compared

to

the

transcriptionally active macronucleus (Lin et al., 1989), the hyper-active
Drosophila melanogaster X-chromosome was shown to be hyper-acetylated (Turner
10

et al., 1992), and the mammalian inactive X-chromosome was shown to be hypoacetylated (Jeppesen and Turner, 1993). By chromatin immunoprecipitation
(ChIP), actively transcribed regions of the genome were shown to be hyperacetylated (Hebbes et al., 1988), while silenced regions were shown to be hypoacetylated (Braunstein et al., 1993). Furthermore, histone acetylation was shown
to be generally coincident with DNaseI hypersensitivity (Hebbes et al., 1994), a
classic characteristic of actively transcribed chromatin (Weintraub and Groudine,
1976).
In 1996 two studies established a direct link between the regulation of
histone acetylation and gene regulation by purification and characterization of a
histone acetyltransferase (HAT) and histone deacetylase (HDAC). Many
unsuccessful attempts had been made by various groups to purify HAT and
HDAC activities from extract and the success of these groups relied on the
utilization of unique and novel techniques. Allis and colleagues used extracts
from the macronuclei of the protozoan Tetrahymena thermophila, a source known
to have enriched HAT activity (Vavra et al., 1982). Utilizing an elegant in-gel
assay, they identified a 55 kDa protein from Tetrahymena macronuclear extracts
with HAT activity (Brownell and Allis, 1995). Once the protein was sequenced
and its gene cloned it was identified as a homolog of the yeast transcriptional coactivator Gcn5 (Brownell et al., 1996).

Soon after, Schreiber and colleagues

utilized a potent HDAC inhibitor, trapoxin, as an affinity matrix for the
purification of HDAC activity that they identified as a homolog of the yeast
transcriptional co-repressor Rpd3 (Taunton et al., 1996). Taken together, these
studies provided a direct link between gene regulation and the regulation of
histone acetylation, prompting a new wave of research focused on the writers
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and erasers of histone acetylation. With sequence homology searches to the
mapped active sites of Gcn5 and Rpd3, dozens of new enzymes were identified
and characterized, generally reinforcing the original discovery that HATs and
HDACs are positive and negative transcriptional regulators, respectively. In a
later section I will explore the HATs p300/CBP, as they are the most relevant to
my thesis work. HDACs will be discussed later in Chapter 6.
The long-held mechanism for histone acetylation’s positive role in
transcription was considered to be due to the charge negation that occurs to the
lysine residue upon acetylation, thus disrupting electrostatic interactions
between the histone tails and the phosphate backbone of DNA leading to a looser
configuration and increased accessibility to DNA-binding activators (cismechanisms). By observations with electron microscopy Woodcock and
colleagues demonstrated that hyper-acetylated chromatin isolated from butyratetreated cells did not form the compacted 30nm fiber observed in untreated cells
(Annunziato et al., 1988).

Wolffe and colleagues further demonstrated that

histone acetylation facilitates transcription factor binding to nucleosomal DNA
(Lee et al., 1993). These in vitro studies were corroborated by the previously
mentioned ChIP studies by Crane-Robinson and colleagues showing that histone
acetylation is found at sites of DNaseI hypersensitivity (Hebbes et al., 1994).
A distinct trans-mechanism for histone acetylation function was proposed
by Zhou and colleagues when they demonstrated that the bromodomain of
P/CAF, a human homolog of Gcn5, bound acetylated histone peptides (Dhalluin
et al., 1999). Several of the newly discovered HATs contained a conserved
protein domain called the bromodomain also present in a number of
transcriptional regulators, such as Brm/Brg, Swi/Snf, and TAF1 (Haynes et al.,
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1992; Jeanmougin et al., 1997). While its function remained unclear, the
bromodomain was proposed to function as an interaction domain with
chromatin, potentially facilitating recruitment and localization. Zhou and
colleagues proposed that histone acetylation could generate docking platforms
for effector proteins in a similar way previously observed for SH2-domains and
tyrosine phosphorylation. Multiple reader domains have now been identified for
the major classes of histone PTMs, including acetylation, methylation, and
phosphorylation exhibiting exquisite site and modification type sensitivity and
are now considered a major mechanism of histone PTM function (Patel and
Wang, 2013). By 2000 a concise model for the regulation and function of histone
acetylation was established (Figure 1.3).
In the early 2000’s genome-wide profiles of histone acetylation were
generated by ChIP followed by microarray analysis (ChIP-on-chip), which
showed that acetylation marked active regions of the yeast and fly genome
(Kurdistani et al., 2004; Schübeler et al., 2004). Higher resolution array data
revealed that histone acetylation marked the promoters and distal regulatory
elements of active genes (Pokholok et al., 2005; Roh et al., 2005). Following the
increased output and efficiency of high-throughput sequencing ChIP-seq became
the dominant technique for mapping histone modifications at high-resolution.
ChIP-seq of histone acetylation has led to the high-confidence mapping of
enhancers in a number of cell types (Creyghton et al., 2010; Heintzman et al.,
2009; Rada-Iglesias et al., 2011) and has led to the discovery of novel classes of
regulatory elements involved in the regulation of key developmental genes
(Parker et al., 2013; Whyte et al., 2013) and aberrant activation of oncogenic
transcription factors (Lovén et al., 2013; Mansour et al., 2014).
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As foreshadowed by studies with butyrate and other synthetic HDAC
inhibitors, the chemical inhibition of writers, readers and erasers of histone PTMs
in the treatment of cancer is a topic of major interest and promise (Cai et al., 2015;
Dawson and Kouzarides, 2012). The HDAC inhibitor, vorinostat, was clinically
approved in 2006 for the treatment of T cell lymphoma. Since then, other HDAC
inhibitors have been approved or are in clinical trial for the treatment of various
malignancies (Falkenberg and Johnstone, 2014). Following impressive preclinical
data (Delmore et al., 2011; Filippakopoulos et al., 2011) small molecule inhibitors
of the bromodomain proteins, particularly inhibitors of the BET family, are
currently in clinical trial for treatment of NUT midline carcinoma and various
hematological malignancies (Filippakopoulos and Knapp, 2014). Furthermore,
recurrent mutations in the writers, readers, and erasers of histone acetylation and
other histone PTM have been found in a number of patient derived tumors (Plass
et al., 2013), establishing chromatin regulators as a major class of drug targets in
the treatment of cancer.

The Transcriptional Co-Activator p300/CBP
Before being characterized as a HAT, p300 was identified as a binding partner of
the adenovirus oncogene E1A and was shown to be required for the activity of
certain enhancer elements (Eckner et al., 1994). Independently, CBP was
identified as a cyclic-AMP and phosphorylation dependent binding partner of
the transcription factor CREB with a role in transcriptional activity (Chrivia et al.,
1993). Once both factors were cloned and sequenced it became clear that p300
and CBP were highly related proteins with shared sequence and function (Arany
et al., 1994). Given their role as transcriptional co-activators and integrators of
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signal-dependent transcriptional activity (Chakravarti et al., 1996; Kamei et al.,
1996), knockout of either CBP or p300, even heterozygous null of either gene, led
to embryonic lethality in mice (Yao et al., 1998). In 1996, stoked by the
identification of GCN5 as a HAT, two independent groups reported that
CBP/p300 have intrinsic HAT activities, further highlighting the direct link
between histone acetylation and transcriptional activation (Bannister and
Kouzarides, 1996; Ogryzko et al., 1996). p300/CBP were shown to interact with a
wide range of transcriptional activators (Shikama et al., 1997) and their HAT
activities were also shown to be involved in activation of enhancer elements.
Notably, studies utilizing the beta-interferon enhancer demonstrated a critical
role for the recruitment of p300/CBP via specific interactions with the p65
subunit of NF-κb and ordered histone acetylation followed by chromatin
remodeling and promoter unmasking (Agalioti et al., 2000; Merika et al., 1998).
These cell-based assays could not directly establish the role of p300’s histone
acetylation per se in the activation of transcription as most of the observations
were based on correlative and associative observations. Furthermore, it was
reported that p300 also acetylated non-histone factors, such as p53, with
functional consequences, calling into question whether histone tails were the
direct functional targets of acetylation (Gu and Roeder, 1997).
Direct testing came with the development of cell-free transcription assays
utilizing a DNA template chromatinized with recombinant histones and purified
factors, allowing for elegant and precise experimentation. In studies utilizing the
synthetic activator Gal4-VP16, maximal RNA synthesis was shown to require the
activator, p300, and acetyl-CoA (Kundu et al., 2000). Furthermore, by using
recombinant histones with lysine to arginine mutations, the transcription
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reaction was shown to be dependent on the acetylation of specific lysine residues
on the histone tails (An et al., 2002), directly demonstrating that p300-catalyzed
histone acetylation was critical for transcriptional activation.
The current model presents an ordered recruitment of transcription
factors (DNA-binding activators) that in turn recruit p300 and other co-activators
allowing for histone modifications and remodeling, which facilitate the
recruitment and stabilization of the transcription apparatus through proteinDNA (activator-DNA), protein-protein (activator-co-activator), and protein-PTM
(reader-histone) interactions (Figure 1.3).

More recently, Gerschbach and

colleagues demonstrated that targeting the minimal HAT domain of p300 to
specific genomic loci activated the expression of target genes in a HATdependent manner (Hilton et al., 2015). Intriguingly, the activation mediated by
p300 was more substantial than the activation induced by targeting a potent
synthetic activator domain (VP64), suggesting that histone acetylation may be
sufficient to nucleate the assembly of the transcriptional apparatus and activation
of transcription.

Metabolic Regulation of Histone Acetylation
Histone PTMs, including histone acetylation, are part of a complex regulatory
process that establishes gene expression programs during development and
disease. Strikingly, almost all histone-modifying enzymes require metabolites as
essential co-factors, suggesting a link between these two pathways. The histone
methyl-transferases require S-adenosyl-methionine (SAM), a product of onecarbon metabolism. The histone demethylases require either alpha-ketoglutarate,
an intermediary product in the citric acid cycle, or flavin adenine dinucleotide
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(FAD), a redox cofactor. The sirtuin class of deacetylases requires nicotine
adenine dinucleotide (NAD ), a redox cofactor. And most relevant to my studies,
+

the histone acetyltransferases require acetyl-CoA, a central metabolite in the
citric acid cycle, fatty acid metabolism, and cholesterol biosynthesis.
The regulation of enzymatic activity by the concentration of its cofactors
requires that the Km of the enzyme be in range of the natural fluctuations of the
cofactor within the cell. For example, phosphorylation catalyzed by protein
kinases is not thought to be regulated by the cellular concentration of ATP, as
this concentration is tightly regulated and well above the typical Km for a given
kinase (Kaelin and McKnight, 2013). On the other hand, a series of landmark
studies have established that levels of acetyl-CoA are within the range to
influence histone acetylation (Fan et al., 2015; Su et al., 2016). The nuclear
concentration of acetyl-CoA in cells grown in culture is estimated at 2-13$M (Lee
et al., 2014) placing it below the Km of several mammalian HATs, such as p300.
These accurate measurements of subcellular acetyl-CoA are fairly new and most
of the literature has used levels of histone acetylation as proxy measurement of
acetyl-CoA concentrations.
Several studies in S. cerevisiae have illustrated the role of nuclear-localized
synthesis of acetyl-CoA in the regulation of histone acetylation and thereby gene
expression. Boeke and colleagues demonstrated that the acetyl-CoA used for
histone acetylation was generated locally in the nucleus by Acetyl-CoA
Synthetase (Acs2). This enzyme charges acetate to free CoA in an ATPdependent reaction. They demonstrated that Acs2 was predominantly nuclearlocalized and that knockout of Acs2 led to a reduction in global histone
acetylation and a downregulation of ~70% of all genes assayed by microarray
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(Takahashi et al., 2006). This work linked a metabolic enzyme to the regulation of
gene expression, but it was unclear whether acetyl-CoA concentrations
fluctuated in a regulated manner that could be exploited by gene regulatory
networks.
Yeast grown in the nutrient-limiting environment of a chemostat
spontaneously enter a synchronized cycle where they go through robust
oscillations in metabolism and gene expression (Tu et al., 2005). Tu and
colleagues showed that during these cycles the levels of acetyl-CoA fluctuate
rhythmically, increasing and peaking as the cell enters the growth phase. These
acetyl-CoA peaks were coincident with peaks in global histone acetylation and in
the local acetylation at promoters of critical growth-related genes, which they
found to be dependent on Gcn5 (Cai et al., 2011). They concluded that these 6fold shifts in the concentration of acetyl-CoA and the concomitant histone
acetylation represented a metabolic signal to the cell to induce cell growth and
proliferation. These studies in yeast demonstrated that concentrations of acetylCoA can regulate histone acetylation and that the natural fluctuations of acetylCoA are sufficient to control this process.
While single cell eukaryotes rely of acetate as the major source of acetylCoA, metazoans use glucose as their main carbon source and have minimal
exposure to extracellular acetate. While mammalian cells have a homolog of Acs2
(ACSS2) they have evolved a novel pathway for generation of cytosolic and
nuclear acetyl-CoA by conversion of glucose-derived citrate to acetyl-CoA. This
reaction is catalyzed by ATP-Citrate Lyase (ACL), as enzyme Wellen and
colleagues established as the dominant source of acetyl-CoA used for histone
acetylation (Wellen et al., 2009). Wellen and colleagues demonstrated that
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glucose availability affected histone acetylation in an ACL-dependent manner
and that knockdown of ACL reduced global histone acetylation. Furthermore,
they established that ACL, and not ACSS2, is required for dynamic histone
acetylation in response to growth factor signaling and adipocyte differentiation.
These studies demonstrated that nutrient availability regulates histone
acetylation and thereby regulates gene expression programs involved in
differentiation and environment sensing (Wellen et al., 2009).
As demonstrated by Wellen and colleagues, for mammalian cells grown in
culture, the concentration of acetyl-CoA in the nucleus and thereby histone
acetylation is tied to the metabolic state of the cell through glucose (Evertts et al.,
2013; Wellen et al., 2009) (Figure 1.4). Glucose is converted into pyruvate through
the process of glycolysis. Pyruvate is transported into the mitochondria where it
is converted to acetyl-CoA in an irreversible reaction by the pyruvate
dehydrogenase (PDH) complex. The acetyl-CoA generated by PDH in the
mitochondria has no active transport out of the mitochondria, is too large for
passive diffusion across the mitochondrial double membrane, and is therefore
effectively trapped and ready to fuel the tricarboxylic acid (TCA) cycle. The first
step of the TCA cycle is the condensation of acetyl-CoA and oxaloacetate by
citrate synthase to yield citrate and free CoA-SH. Citrate can be transported out
of the mitochondria through the tricarboxylate transport system. ACL can then
convert citrate into acetyl-CoA, in a reversal of the citrate synthase reaction. This
ACL-derived acetyl-CoA can then be used for fatty acid synthesis (via AcetylCoA

Carboxylase,

ACC1),

cholesterol

synthesis

(via

acetyl-CoA

acetyltransferase, ACAT), or as the high-energy donor of acetyl to histone lysine
acetylation (via p300 and other HATs) (Figure 1.4). A recent study found that
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Figure 1.4: Cytosolic and Nuclear Metabolism of Acetyl-CoA.
Simplified schematic of pathways involved in acetyl-CoA (AcCoA)
synthesis and catabolism in the mammalian cyto/nuclear compartment.
For mammalian cells in culture, the main source of cyto/nuclear acetylCoA is through TCA-cycle generated citrate that is converted to acetylCoA by ACL. The majority of these carbons originate as glucose, but the
degradation of fatty acids and amino acids can also contribute (not drawn).
Stress-induced PDH translocation out of the mitochondria can bypass the
TCA cycle by converting cyto/nuclear pyruvate directly into acetyl-CoA.
Acetyl-CoA can also be generated from acetate by ACSS2. Three major
pathways utilize cyto/nuclear acetyl-CoA: cholesterol biosynthesis, fatty
acid synthesis, and protein acetylation. The enzymes that initiate each
pathway are indicated: Acetyl-CoA Acetyltransferase (ACAT), Histone
Acetyltransferase (HAT), and Acetyl-CoA Carboxylase (ACC).
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under stress the PDH complex could translocate into the nucleus where it would
generate acetyl-CoA used for histone acetylation directly from pyruvate,
bypassing the mitochondria (Sutendra et al., 2014). As in yeast, acetyl-CoA can
also be generated by the cyto/nuclear localized acetyl-CoA synthetase (ACSS2)
by charging acetate with free CoA-SH in an ATP-driven reaction. The ACL
reaction is favored during energy rich states (Wellen et al., 2009) whereas the
ACSS2 reaction is necessary under hypoxic conditions (Comerford et al., 2014).
These two pathways are not mutually exclusive and can complement each
other. For example, under conditions of depleted ACL, addition of excess acetate
can rescue the levels of histone acetylation in an ACSS2-dependent manner
(Wellen et al., 2009). These data suggest that both enzymes feed into the same
pool of acetyl-CoA, but that under different growth conditions the dominance of
either enzyme changes. My thesis work implicates ACSS2 in the generation of
crotonyl-CoA used for histone crotonylation, even in normal growth conditions,
suggesting that ACSS2 might have secondary roles in regulating acyl-CoA
metabolism

under

high

glucose

conditions.

Furthermore,

aberrant

phosphorylation of ACL by constitutively active AKT allows for the continuous
production of acetyl-CoA even under nutrient limiting states (Lee et al., 2014),
which could explain the epigenomic reprogramming observed in tumors with
oncogenic Kras and Akt.

Histone Crotonylation
With high-sensitivity mass spectrometry several groups have profiled the histone
acetylation landscape (Choudhary et al., 2009; Kim et al., 2006) demonstrating
the general importance of protein acetylation on non-histone substrates.
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Thousands of acetylation sites on hundreds of proteins have now been identified,
making lysine acetylation a globally important PTM with function outside the
nucleus (Choudhary et al., 2014; Verdin and Ott, 2014). Another outcome of these
proteomic studies has been the discovery of a range of novel modifications. The
major novel class of histone modifications described has been lysine acylations,
similar in ε-amine linkage to lysine acetylation yet distinct in the hydrocarbon
chain attached (Figure 1.5). Dr. Yingming Zhao, himself a graduate of The
Rockefeller University, and his colleagues at The University of Chicago have
been at the forefront of identifying these novel histone acylations and have so far
identified propionylation, butyrylation (Chen et al., 2007), 2-hydroxyisobutyrylation (Dai et al., 2014), succinylation, malonylation (Xie et al., 2012), and
crotonylation (Tan et al., 2011) (Figure 1.5A).
The identification of histone lysine crotonylation came out of a systematic
approach to identify novel histone PTMs by tandem mass spectrometry
(MS/MS) (Tan et al., 2011). The covalent modification of histone protein leads to
a characteristic mass shift that can be identified by MS/MS and parsed by
computational methods. In their analysis, Zhao and colleagues identified
peptides with a mass shift of +68 Da, which did not correspond to any known
histone PTM. Through a series of deductions they determined that the additional
68 Da was likely due to the modification of lysine residues by crotonyl (trans-2butenyl). By comparing peptides extracted from histones with peptides
synthesized to include crotonyl-lysine (Kcr), they demonstrated that the two had
the same mass spectra and co-eluted off an HPLC column, suggesting that the
+68 Da shift they observed was most likely due to crotonyl-lysine.
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Figure 1.5: Diversity of Histone Lysine Acylation.
(A) Chemical structures of all currently identified histone lysine
acylations. (B) Three-dimensional representation of crotonyl-lysine and
acetyl-lysine. Note that while acetyl-lysine is free to rotate, crotonyllysine has a rigid planar orientation (represented by light blue plane) due
to the presence of C-C %-bond. Figure 1.5B is adapted from (Tan et al.,
2011).
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The Zhao group next generated and validated a pan-Kcr antibody, which
stained histones extracted from human, mouse, worm, fly, and yeast cells.
Furthermore, this immunoblot signal was competed away by a library of Kcr
peptides, but not by a library of acetyl-lysine (Kac) peptides, demonstrating that
Kcr was a conserved histone modification. Using the pan-Kcr antibody Zhao and
coworkers performed ChIP-seq in IMR90, a well-characterized human fibroblast
line. Kcr was enriched at promoters and putative enhancer elements of active
genes generally coincident with Kac. Like Kac, levels of Kcr generally correlated
with gene expression.
To explore the role of Kcr in a biological setting Zhao and colleagues
characterized the modification in the highly dynamic spermatogenesis process.
They performed ChIP-seq for Kcr in pre-meiotic spermatocytes (Spc) and in postmeiotic round spermatid (RS) and observed a similar patterning of Kcr as in
IMR90, marking promoters and enhancers. When they compared levels of Kcr in
Spc and RS they observed that the set of genes that had increased Kcr signal
through meiosis tended to be highly expressed testis genes, suggesting that Kcr
marked testis-specific genes. Furthermore, about a third of these genes resided
on the X chromosome, an enrichment not observed with ChIP-seq with pan-Kac.
During the transition between Spc and RS, the X-chromosome is known to
undergo meiotic sex chromosome inactivation (MSCI), which leads to
heterochromatin formation over the sex chromosomes, yet some genes “escape”
silencing. Zhao and colleagues’ data suggested that Kcr marked these “escapee”
genes. This prompted them to perform immunohistochemistry on tissue
enriched for RS, which exhibit MSCI, with pan-Kcr and markers for
heterochromatin. This analysis demonstrated that Kcr signal marked small
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sections of the heterochromatic X-chromosome. This localization was not
observed with Kac staining. They conclude that Kcr may play an important role
in epigenetically marking sex chromosomes in the post-meiotic stages of
spermatogenesis (Tan et al., 2011). Several manuscripts have been published
since the original discovery of histone Kcr in 2011, I will introduce them and
discuss their findings within the relevant chapters of my thesis.
The manuscript describing the discovery of Kcr (Tan et al., 2011) was
published just as I had joined the Allis lab for my graduate work. I was intrigued
by the unique properties reported for Kcr in spermatogenesis and was also
excited by the potential for discovery inherent in the novelty of the subject. I was
motivated to characterize this novel histone PTM within the paradigm set forth
by the studies conducted with histone acetylation. In my Thesis Research
Proposal, written at the start of my graduate work, I proposed to study the
regulation

and

function

of

histone

crotonylation

by

identifying

and

characterizing the writers (Chapter 2), readers (Chapter 5), and erasers (Chapter
6) of the newly discovered histone PTM. Through these originally proposed
experiments I uncovered an unexpected role for acyl-CoA metabolism in the
regulation of histone Kcr and its impact of gene activation (Chapters 3 and 4).
Portions of Chapters 2-4 have been published as:
Sabari, et al. (2015). Intracellular Crotonyl-CoA Stimulates Transcription
through p300-Catalyzed Histone Crotonylation. Molecular Cell 58, 203–
215.
Portions of Chapter 5 are currently under review as:
Li, Sabari, Panchenko, et al. (2016). Molecular Coupling of Histone
Crotonylation and Active Transcription by AF9 YEATS Domain.
Molecular Cell (in review)
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CHAPTER 2: PURIFICATION OF A HISTONE CROTONYLTRANSFERASE
ACTIVITY AND CHARACTERIZATION OF ITS ROLE IN
TRANSCRIPTION

INTRODUCTION
Histones are subject to a vast range of post-translational modifications with
specific genomic localizations and well-documented functional roles in the
regulation of transcription and other DNA-templated processes. Critical to our
understanding of how histone modifications are regulated has been the
identification and characterization of enzyme systems that catalyze the covalent
modification of specific target residues. Histone lysine acetylation has been
particularly well characterized within this paradigm, with the purification and
identification of histone acetyltransferases prompting a breakthrough in our
understanding of targeted lysine-acetylation’s direct role in gene regulation
(Brownell et al., 1996). Despite this progress, little is known about the cellular
regulation and functional relevance of a rapidly-expanding group of chemically
related modifications known as histone acylations, of which acetylation is a wellstudied member.
Histone lysine propionylation, butyrylation, malonylation, succinylation,
2-hydroxyisobutyrylation, and crotonylation have all been identified by tandem
mass spectrometry (MS/MS) proteomic analysis over the past several years
(Chen et al., 2007; Dai et al., 2014; Tan et al., 2011; Xie et al., 2012) (Figure 1.5).
These discoveries have increased the potential complexity of histone lysine
modifications and have prompted interest in the functional consequence of
differential acylation, both on histone proteins and non-histone proteins.
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Previous ChIP-seq analyses with “pan” acyl-specific antibodies have mapped
histone crotonylation and histone 2-hydroxyisobutyrylation to regulatory
elements of actively transcribed regions of the genome, generally coincident with
the localization of histone acetylation (Dai et al., 2014; Tan et al., 2011). These
studies demonstrate that histones flanking active regulatory elements are
modified by a number of chemically distinct acylations, suggesting a role for
these modifications in transcriptional regulation. Yet, the enzymes responsible
for catalyzing crotonylation of histone lysine residues have not been
characterized.

Here

I

report

the

partial

purification

of

a

histone

crotonyltransferase (HCT) activity from HeLa S3 nuclear extract by column
fractionation. I show that the well-studied transcriptional co-activator and
histone acetyltransferase (HAT) p300 also possesses histone crotonyltransferase
(HCT) activity. In collaboration with Dr. Zhanyun Tang of the Roeder lab, we
demonstrate that p300-catalyzed histone crotonylation directly stimulates
transcription and does so to a greater degree than p300-catalyzed histone
acetylation.

RESULTS
HAT and HCT Activities Co-Purify with p300 from HeLa S3 Nuclear Extract
To identify enzyme(s) capable of catalyzing histone crotonylation, I sought to
purify a histone crotonyltransferase (HCT) activity from HeLa S3 nuclear
extracts. I employed an HCT assay that mirrors previously described histone
acetyltransferase (HAT) assays (Mizzen et al., 1999), except that crotonyl-CoA,
rather than acetyl-CoA was used as the high-energy acyl-donor, and
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Figure 2.1: Purification of an HCT Activity.
(A) HCT purification scheme. (B-C) HCT activity co-elutes with HAT
activity. HCT and HAT activities were assayed by panKCr or panKAc
immunoblot, respectively, at each round of fractionation and peak HCT
activity was followed. The immublot readouts for HCT (B) and HAT
activity (C) of the final Mono S fractions are shown here. S3 indicates
crude unfractionated extract, L indicates the load/Mono S input, and FT
indicates the column flow through. Equal volumes of each fraction were
used in these assays. For MS/MS analysis of fractions with peak HCT
activity (fractions 4, 5, and 6) see Figure 2.2.

28

29

immunoblotting of reaction products with a pan-crotonyl-lysine antibody
(panKCr) was used as a measure of HCT activity. In parallel, HAT activity was
determined by substituting acetyl-CoA in the reactions and immunoblotting
reaction products with a pan-acetyl-lysine antibody (panKAc). Utilizing these
assays, HCT activity was detected in crude HeLa S3 nuclear extracts and
partially purified by the fractionation scheme outlined in Figure 2.1A. Briefly, a
soluble nuclear extract was prepared from HeLa S3 cells grown in suspension
(see Methods for details), which was subject to a 60% (NH ) SO cut, followed by a
4

2

4

three step column fractionation over a linear gradient of KCl (0.15M-1M). HCT
assays were performed on collected fractions and those presenting HCT activity
were pooled and subject to the next round of fractionation. Unexpectedly, HAT
activity co-purified with HCT activity through multiple purification steps,
including the final step in the partial purification scheme (Figures 2.1B and
2.1C). Co-elution of these two activities, albeit with subtle differences toward H3
and H4, suggested either that distinct HAT and HCT activities co-eluted
throughout this purification or, unexpectedly, that a “HAT” might be responsible
for the observed HCT activity.
To identify proteins that were enriched during the purification of the HCT
activity, I worked with Dr. Henrik Molina, the director of The Rockefeller
University Proteomics Facility. Dr. Molina subjected peak Mono S fractions 4-6,
and the crude nuclear extract (fraction “S3”) to MS/MS analysis (see Methods for
details). Our analysis focused on identifying proteins that had been significantly
enriched over the course of the purification scheme. Seven previously described
HATs were identified with high confidence in the crude nuclear extract, p300,
CBP, MOF, TIP60, GCN5, HBO1, and HAT1. Interestingly, five of these HATs
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Figure 2.2: Proteomics Analysis of Partially Purified HCT Activity.
(A) Box and whisker plot representation of Intensity Based Absolute
Quantification (iBAQ) values for all proteins identified in the crude nuclear
extract, and in the three Mono S fractions with peak HCT activity (fractions
4, 5, and 6). Calculated iBAQ values for all observed HATs (p300, CBP,
MOF, TIP60, GCN5, HBO1, HAT1) are plotted onto the box plots. All
shown HATs were confidently matched with between 7 and 46 unique
peptides. (B) Enrichments of iBAQ values for Fraction 5 over crude nuclear
extract for all observed proteins are plotted as log values. The observed
2

HATs are highlighted in red. (C) Heatmap representation of the relative
iBAQ value enrichment or depletion over crude nuclear extract of the
seven observed HATs in Mono S fractions 4, 5, and 6. (D) Immunoblot for
p300 in indicated fractions. S3 indicates crude unfractionated extract, L
indicates the load/Mono S input, and FT indicates the column flow
through. Equal volumes of each fraction were assayed.
The data and analysis presented in Figures 2.2A-2.2C were generated by
Dr. Henrik Molina.
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were enriched over crude nuclear extract in all three peak-fractions, while HBO1
and HAT1 were depleted. HAT1 went from being the most abundant HAT in
crude extract to being below the detection limit in all three peak-fractions. Of all
the HATs present in the final fractions, the transcriptional coactivator p300 was
the most enriched (Figure 2.2A). Based on Intensity Based Absolute Quantitation
(iBAQ) values (Schwanhäusser et al., 2011), p300 went from being among the
10% least abundant of all detectible proteins in the crude extract to being among
the 20% most abundant of all detectible proteins in the Mono S fraction 5.
Utilizing iBAQ values, Dr. Molina assigned an enrichment value for each protein
identified in the peak HCT fraction (fraction 5) defined as iBAQ(fraction 5) over
iBAQ(crude input). By plotting this enrichment value for all detected proteins,
we observed that p300 is among the most enriched proteins and the most
enriched HAT in fraction 5 (Figure 2.2B). Furthermore, p300 is the most enriched
HAT in all three peak-HCT fractions (Figure 2.2C). In support of the MS/MS
data, immunoblot of the Mono S fractions for p300 showed that the protein is
markedly enriched from nuclear extracts through the purification of HCT
activity (compare S3 to Mono S fraction 5 in Figure 2.2D). These data highlight
p300 as a strong candidate for the enzyme responsible for HCT activity observed
in my partially purified nuclear extract.

p300 has HCT Activity In Vitro and In Cells
To directly test whether p300, or any of the other HATs enriched by our HCT
purification, have intrinsic HCT activity, I purified recombinant p300, GCN5,
TIP60, and MOF, and assayed their capacity to crotonylate and/or acetylate
recombinant histone octamers by our previously described HCT and HAT
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Figure 2.3: p300 Has Intrinsic HCT activity.
HATs identified as being enriched during the HCT purification (p300,
GCN5, TIP60, and MOF) were purified as recombinant proteins and used as
enzyme source in HCT and HAT activity assays. (A) HCT activity assay
with purified recombinant p300, GCN5, and TIP60. (B) HAT activity assay
with same proteins as in (A). (C) HCT activity assay with purified
recombinant MOF. (D) HAT activity assay with purified recombinant MOF.
All reactions were performed with recombinant histone octamers as
substrate. Reaction products were immunoblotted with the indicated
antibodies.
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assays. While all of these recombinant enzymes exhibited their wellcharacterized HAT activities, only p300 showed measurable HCT activity (Figure
2.3). Taken together, these data suggest that p300 is most likely the responsible
enzyme for the observed HCT activity derived from the purified nuclear extract.
To determine the principal sites of p300-catalyzed crotonylation and
acetylation, I worked with Dr. He Huang in Dr. Yingming Zhao’s Lab at the
University of Chicago, experts in the proteomics of histone acylations. Using
semi-quantitative MS/MS analysis of in vitro reaction products by spectral
counting (Carvalho et al., 2008), they found that H3K18 is the dominant site of
both p300 crotonylation and acetylation, under our reaction conditions (data not
shown). To confirm activity on H3K18, I made use of available site-specific
antibodies against H3K18Cr or H3K18Ac to probe p300-driven HCT and HAT
reaction products. Each antibody reacted with its intended target and failed to
cross-react with the unintended target, lending support to both our MS/MS data
and the acetyl vs. crotonyl specificities of the antibodies (Figure 2.4A). To
confirm the site-specificity of these antibodies, recombinant H3 with a H3K18R
mutation was used as a substrate in p300-driven HAT and HCT assays. Signals
from both H3K18Cr and H3K18Ac antibodies were attenuated on the p300modified H3K18R mutant as compared to the wild type H3, further confirming
the antibody site-specificities (Figures 2.4B and 2.4C).
I next sought to determine whether p300 regulates H3K18Cr in cells.
Knockdown of p300 or its paralog CBP by siRNA reduced the global levels of
H3K18Cr, H3K18Ac, and H3K27Ac and double knockdown of p300 and CBP
reduced the signals even further, as measured by immunoblot of acid-extracted
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Figure 2.4: p300 Catalyzes H3K18cr.
(A) p300-mediated HCT and HAT reactions were performed with the
indicated reaction conditions. Reaction products were probed with the
indicated site-specific antibodies. (B-C) Recombinant H3 with lysine 18
mutated to arginine (K18R) was used, in parallel with wild-type H3 (wt), as
substrates in p300-driven HCT (B) or HAT (C) reactions. Products were
immunoblotted with the indicated antibodies. (D) HeLa S3 cells were
transfected with control or p300- and/or CBP-specific siRNA. 72 hours posttransfection,

whole

cell

lysates

and

histones

were

prepared

and

immunoblotted with the indicated antibodies. Immunoblots of acid extracts
are shown above the black line, while immunoblots of whole cell lysates are
shown below the black line. (E) Overexpression of p300 in HEK 293T cells
increases global levels of H3K18Cr and H3K18Ac. 293T cells were transfected
with p300 cDNA. 48 hours post-transfection histones were prepared and
immunoblotted with the indicated antibodies.
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histones (Figure 2.4D). In addition, overexpression of full-length p300 by
transient transfection increased both H3K18Cr and H3K18Ac signals (Figure
2.4E). Taken together these data support the conclusion that p300 (and its
paralog CBP) catalyze both H3K18Cr and H3K18Ac in vitro and in cells.

p300-Catalyzed Histone Crotonylation Stimulates Transcription in a Cell-Free
System
To directly test whether p300-catalyzed histone crotonylation plays a role in
transcriptional regulation, I worked with Dr. Zhanyun Tang. We took advantage
of a cell-free transcription assay wherein the presence of either acetyl-CoA or
crotonyl-CoA could be experimentally controlled. p300’s HAT activity has long
been implicated in activator-dependent stimulation of transcription from
chromatinized templates in a reaction where maximal RNA synthesis is
dependent upon p300 and acetyl-CoA (An et al., 2002). More recently, this assay
has been modified to include natural activators, such as p53, and has been
exploited to further our mechanistic understanding of transcriptional regulation
in the context of chromatin (An et al., 2004; Tang et al., 2013).
Similar experiments were conducted using a p53-dependent transcription
assay, but with acetyl-CoA replaced by crotonyl-CoA (see schematic in Figure
2.5A). To ensure the integrity of these assays, I validated the purities of the
acetyl-CoA and crotonyl-CoA by HPLC analysis, which showed that both
cofactors were pure and showed no traces of cross-contamination (Figure 2.5B).
Using the H3K18Cr and H3K18Ac antibodies, Dr. Tang confirmed crotonylation
of the recombinant chromatin substrate by p300 and its p53-dependence in this
system (Figure 2.5C). Dr. Tang next performed the transcription assay and
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Figure 2.5: Histone Crotonylation Stimulates Transcription.
(A) Schematic of the transcription template (top) and the transcription
reaction order of addition (bottom). (B) Acetyl-CoA or crotonyl-CoA were
injected onto a C18 column and eluted over an acetonitrile gradient as
previously described (King and Reiss, 1985). CoA molecules were detected
by UV absorbance at 254 nm. (C) p300 HAT and HCT reactions using
recombinant chromatin with the indicated additions were analyzed by
immunoblot. (D) Transcription assays were performed under the indicated
conditions. RNA products were visualized by autoradiography. (E)
Densitometry of autoradiographs comparing acetyl-CoA and crotonylCoA containing transcription reactions. Data represent mean fold change
from three independent experiments ± standard deviation, p-value =
0.0013. (F) In vitro transcription assays using chromatin reconstituted with
recombinant wild-type H3 or with lysine residues 9, 14, 18, 23, 27, 36, and
56 mutated to arginine (K-to-R). RNA products were visualized by
autoradiography.
The data presented in Figures 2.5C-2.5F was generated by Dr. Zhanyun
Tang.
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observed that p300-catalyzed crotonylation stimulated transcription in this
system to a greater extent than did p300-catalyzed acetylation (Figure 2.5D).
Under identical assay conditions, crotonyl-CoA containing reactions produced,
on average, 1.66-fold greater transcript than did acetyl-CoA containing reactions,
as measured by densitometry of autoradiograms from three independent
experiments (Figure 2.5E).
To confirm that p300’s crotonyltransferase activity stimulates transcription
by crotonylation of histone proteins and not of auxiliary factors from the added
nuclear extract, Dr. Tang reconstituted recombinant chromatin with either wildtype histone H3 or histone H3 with lysine residues 9, 14, 18, 23, 27, 36, and 56
mutated to arginine (K-to-R). For both acetylation and crotonylation, p300-driven
RNA production was substantially inhibited when chromatin containing histone
H3 K-to-R mutations was used as a template (Figure 2.5F), demonstrating that
the acetylation or crotonylation of the mutated histone lysine residues is
necessary for the production of transcript in this cell-free system. The modest, yet
reproducible and statistically significant, difference between histone acetylation
and histone crotonylation in the stimulation of transcription provided an early
hint that p300-catalyzed histone acetylation and crotonylation are functionally
distinct.

DISCUSSION
Here I present data on the purification and characterization of p300 as a histone
crotonyltransferase. In collaboration with the Roeder Lab, we demonstrate that
p300-catalyzed histone crotonylation directly stimulates transcription. While
previous sequencing based studies have shown that histone crotonylation
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associates with transcriptionally active regions of the genome (Tan et al., 2011),
the studies presented here demonstrate the direct role of histone crotonylation in
transcription. Through cell-free experimentation in a controlled environment we
were able to make these observations, which would have been difficult in the
complex milieu of the cell. For example, early in the investigation of histone
crotonylation, I observed that the pan-Kcr antibody exhibited an undefined
cross-reactivity with histone acetylation that confounded many early results
using this reagent (data not shown). These early observations led to cautious use
of this antibody only in cases where it was clear that histone crotonylation was
being detected, as in HAT and HCT activity assays where the only source of
acetyl or crotonyl is from the added acyl-CoAs. The focus on p300 and the p300catalyzed H3K18cr led to the adoption of the H3K18cr antibody, which I was
able to carefully test and deem acyl-specific (Figure 2.4A, and unpublished
results). These observations were critical for the next stage of experimentation,
which dealt with the cellular regulation and function of p300-catalyzed histone
crotonylation.
The HCT activity of p300 is unique among HATs assayed. p300, along
with its paralog CBP, occupies a distinct class of HAT proteins based on primary
sequence (Lee and Workman, 2007; Roth et al., 2001). Members of the other two
major HAT families GNAT (GCN5) and MYST (TIP60 and MOF) exhibited their
well-documented HAT activities but did not display HCT activity under the
same reaction conditions. Interestingly, p300’s HAT domain is structurally
unique and utilizes a distinct catalytic method for acetyl transfer (Liu et al., 2008).
While it is clear that p300 performs its HAT reaction through a distinct structure
and catalytic mechanism, it remains unresolved what specifically allows p300 to
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perform the HCT reaction while other HATs cannot. The p300 gene is mutated in
a number of developmental disorders and cancers (Gayther et al., 2000;
Pasqualucci et al., 2011; Roelfsema et al., 2005), mostly resulting in heterozygous
truncation or inactivation. It remains unknown whether a particular mutation
could alter p300’s preference for acetyl-CoA or crotonyl-CoA, thereby altering its
HAT and HCT activities. Another potential for the regulation of p300’s HAT
versus HCT activity would be conformational change due to signal-induced
PTMs. While p300’s HAT and co-activator activities are regulated by PTM of
various type (auto-acetylation, phosphorylation, and arginine methylation) at
various sites (Karanam et al., 2006; Lee et al., 2005; Yang et al., 2001), the effect of
these modifications on HCT activity is unknown.
Given that p300 catalyzes both acetylation and crotonylation and barring
the identification of a mutant or modified form that only catalyzes one or the
other, initial functional characterization of p300’s HCT activity was limited to
cell-free systems where the presence or absence of acetyl-CoA or crotonyl-CoA
could be controlled. The cell-free chromatinized-template transcription assay
championed by the Roeder lab (An et al., 2002; 2004; Tang et al., 2013) was an
obvious choice. By utilizing this recombinant chromatin template transcription
assay, we show that p300-catalyzed histone crotonylation directly stimulated
transcription to a greater degree than p300-catalyzed histone acetylation. Our
study focused largely on H3K18 because of its identification as the dominant site
of p300-driven crotonylation in our in vitro assays, the clear regulation of its
global levels in mammalian cells by p300/CBP, and the availability of acylspecific antibodies for this modification. It is currently unknown if one site or a
minimal subset of these sites is responsible for the transcriptional stimulation
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observed in our cell-free system. Since the multi-site H3 K-to-R mutations ablate
this transcriptional response, I conclude that histone crotonylation per se is
required for this response; but exactly how that response is mediated and how it
may differ mechanistically from the stimulation associated with acetylation
remains unclear. While the assays described here utilize purified DNA, histones,
activator, and p300, a nuclear extract is added as a source of general
transcriptional machinery. Therefore, the precise mechanism by which histone
crotonylation is distinct from histone acetylation is not resolved by these
experiments. A fully purified system, as detailed in (Guermah et al., 2006) would
be necessary for a direct comparison of transcriptional activation observed in
crotonyl-CoA containing reactions and acetyl-CoA containing reactions.
Lysine crotonylation, like other acylations, including acetylation, will
neutralize the positive charge of the ε-amino group of lysine, yet the “functional
groups” of the various acylations are chemically distinct (Figure 1.5). For most
acylations, as is the case for histone crotonylation, the difference from acetylation
is in increased bulk and rigidity, but for malonylation and succinylation, the
modification adds net negative charge to an existing positively charged lysine. It
is currently unknown whether there are specific “readers” for crotonyl-lysine or
the other histone acylations that take advantage of this increased bulk, rigidity,
and/or negative charge, which would add functionality to these modifications
through trans-effects. The surprising discoveries that methyl-lysine “readers”
can distinguish mono-, di-, and tri-methylated lysines, a comparably small
chemical difference compared to the diversity of acylations, provides precedent
for such discrimination (Taverna et al., 2007). Identification and characterization
of binding modules that selectively prefer crotonyl-lysine, or other acylations,
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will be critical to our understanding of the mechanism by which differential
histone acylation exerts function. Chapter 5 discusses collaborative work with
Dr. Haitao Li (Tsinghua University; Beijing, China) on the characterization of the
YEATS domain as a crotonyl-lysine reader.
In addition to the potential recruitment of reader or effector proteins, the
cis-effects of various acylations on nucleosome or chromatin structure remains
unexplored. Histone acetylation has been shown to directly influence both internucleosomal structure (Robinson et al., 2008; Shogren-Knaak et al., 2006) and
intra-nucleosomal structure (Tropberger et al., 2013) by charge neutralization. It
is of interest to understand how the additional bulkiness, rigidity, or charge of
the various acylations will directly affect nucleosomal or oligonucleosomal
structures.
The studies presented in Chapter 2 establish that p300-catalyzes both
histone acetylation and crotonylation and demonstrate a role for histone
crotonylation in stimulating the transcription reaction. The observations of
p300’s dual activity immediately suggested that the levels of histone
crotonylation would be determined by the concentration of crotonyl-CoA and
acetyl-CoA, the subject of Chapter 3.
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CHAPTER 3: THE RELATIVE CONCENTRATIONS OF CROTONYL-COA
AND ACETYL-COA REGULATE GLOBAL HISTONE CROTONYLATION

INTRODUCTION
As described in Chapter 2, I identified that p300, a previously described HAT
and transcriptional co-activator, also has HCT activity, yet it remained unclear
how histone crotonylation could be regulated differently than histone
acetylation.

Given

that

the

various

histone

acylations

(acetylation,

propionylation, butyrylation, crotonylation, etc.) are derived from their
respective charged acyl-CoAs (acetyl-CoA, propionyl-CoA, butyryl-CoA,
crotonyl-CoA, etc.), which populate various arms of intermediary metabolism, it
has been proposed that differential histone acylation could be regulated by the
cellular concentration of these metabolites and thereby act as a potential
“integrator” of a cell’s metabolic state (Lin et al., 2012). However, this hypothesis
has not been directly tested. With the identification of p300’s dual activity, a
simple hypothesis could be proposed: while maintaining p300 (enzyme) and
histone (substrate) concentrations, the relative concentrations of either coreactant (acetyl-CoA or crotonyl-CoA) would determine the rate of either
reaction (acetylation or crotonylation), thereby regulating the amounts of either
product (acetyl-lysine or crotonyl-lysine). In this model the relative metabolite
concentration would determine the state of differential acylation (either acetyl or
crotonyl). A number of studies have linked mammalian cellular metabolism to
the regulation of histone acetylation (see Chapter 1). An early landmark paper
demonstrated that in mammalian cells the enzyme ATP-Citrate Lyase (ACL) was
responsible for generating acetyl-CoA used for histone acetylation (Wellen et al.,
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2009). Importantly, this study illustrated that the cyto/nuclear concentration of
acetyl-CoA could affect histone acetylation and gene expression, providing a
precedent for metabolite driven control of transcription mediated through
histone modifications.
Here I demonstrate that as a result of p300’s dual enzymatic activities, the
level of histone crotonylation in the cell is sensitive to the relative cellular
concentrations of crotonyl-CoA and acetyl-CoA. I demonstrate that treatment of
cells with the neutralized salt of the short chain fatty acid crotonic acid, sodium
crotonate (from here on referred to as crotonate), can be used to increase cellular
concentrations of crotonyl-CoA. This increase in crotonyl-CoA leads to increased
levels of histone crotonylation, which can be “tuned” by treating cells with
different concentrations of crotonate. I implicate the cytoplasmic/nuclear
metabolic enzyme acyl-CoA synthetase (ACSS2 or AceCS1) in the synthesis of
crotonyl-CoA from crotonate in mammalian cells. Furthermore, by depletion of
enzymes that produce acetyl-CoA levels of histone crotonylation increase,
further demonstrating the balance between acetyl-CoA and crotonyl-CoA for
p300’s catalytic activity. These data support the conclusion that differential
acylation of histones is regulated metabolically, by the relative concentrations of
acyl-CoAs.

RESULTS
Crotonyl-CoA and Acetyl-CoA Compete for p300’s Acyltransferase Activity
I next sought to gain insights into how differential acylation is regulated in
mammalian cells. Given that p300 can catalyze both histone acetylation and
crotonylation, I hypothesized that a differentially modified substrate would be
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Figure 3.1: The Relative Concentrations of Acetyl-CoA and Crotonyl-CoA
Determine the Reaction Products.
In vitro p300 HAT/HCT reactions were performed with indicated
concentrations of crotonyl-CoA and acetyl-CoA. Reaction products were
immunoblotted with the indicated antibodies.
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the direct result of the cellular concentrations of either acetyl-CoA or crotonylCoA that would, in turn, be regulated by extracellular and intracellular sources
of these cofactors. To provide a preliminary test of this hypothesis, p300 reactions
were performed in which acetyl-CoA and crotonyl-CoA were mixed in varying
ratios. Indeed, altering the relative concentrations of these two acyl-CoAs
dictated how much of each modification was present in the final reaction product
(Figure 3.1). I conclude that crotonyl-CoA can compete with acetyl-CoA for
p300’s activity toward its substrate and, consequentially, the relative
concentrations of crotonyl-CoA to acetyl-CoA will determine the enzyme’s
reaction products. While H3K18 is not the exclusive site of either p300-catalyzed
acetylation or crotonylation, the levels of H3K18Cr and H3K18Ac can be used as
a surrogate for p300’s differential activity in vitro and in cell-based assays.

LC-MS Measurements of Crotonyl-CoA and Acetyl-CoA
To investigate the relative cellular concentrations of acetyl-CoA and crotonylCoA, I worked with Dr. Justin Cross, Director of Memorial Sloan Kettering’s
Cancer Metabolism Center, and his colleague Dr. Vladimir Yong-Gonzalez to
establish a targeted LC-MS approach that would allow us to extract CoA species
from whole cells in culture and measure the abundance of acetyl-CoA and
crotonyl-CoA. We assayed HeLa S3 cells growing in full media under
exponential growth conditions and observed a small yet measurable pool of
crotonyl-CoA, which was approximately 1000x less abundant than acetyl-CoA
(Figures 3.2A and 3.2B, first column). The pool of crotonyl-CoA was small in
comparison to acetyl-CoA, the most abundant CoA-species measured and the
product of several major biosynthetic pathways in multiple organelles. The low
49

basal abundance of crotonyl-CoA places it well below the Km of p300 (Meier,
2013), which should allow any fluctuation in its concentration to affect
downstream crotonyltransferase reactions.
To test this prediction, I experimentally increased the concentration of
crotonyl-CoA in HeLa S3 cells by adding crotonate to the culture media, and
observed a dose-dependent increase in both the cellular concentration of
crotonyl-CoA and the global levels of H3K18Cr (Figures 3.2A-3.2C). The
relatively low abundance of cellular crotonyl-CoA allowed for this dramatic fold
change in its availability. In contrast, addition of acetate to cells did not
dramatically increase the abundance of cellular acetyl-CoA and had little to no
effect on global levels of H3K18Ac (Figures 3.2B and 3.2C). Here again, I utilized
the site-specific and acyl-specific antibodies (H3K18Ac and H3K18Cr) as a
tenable surrogate measure for the differential acylation state of histone residues
modified by p300/CBP in the cell. Moreover, the increase in histone
crotonylation was not specific to H3K18. A dose-dependent signal increase was
also observed with the pan-crotonyl-lysine antibody, not only in H3, but also in
the other core histones, upon crotonate addition (Figure 3.2C). I also observed a
similar dose-dependent increase in global histone crotonylation in HEK293T
cells, mouse embryonic stem cells, and RAW 264.7 cells, a mouse macrophage
cell line, demonstrating that this is not a HeLa S3-specific phenomenon (Figures
3.2D-3.2E). These data demonstrate that histone crotonylation is sensitive to
fluctuations in crotonyl-CoA concentrations and that crotonate treatment is a
general experimental method to specifically increase levels of histone
crotonylation.
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Figure 3.2: Manipulation of Intracellular Crotonyl-CoA Concentration by
Treatment of Cells with Sodium Crotonate.
(A-B) LC-MS analysis of cellular crotonyl-CoA (A) and acetyl-CoA (B) levels
extracted from HeLa S3 cells cultured with the indicated concentration of
sodium crotonate (pH 7.4) or sodium acetate (pH 7.4) added to full media for 12
hours. The data represent mean peak area ± standard deviation of four
independent experiments. Summary of p-value is as follows: ns (p>0.05), ****
(p≤0.0001). (C-F) Histones were acid extracted from HeLa S3 cells (C), mouse
embryonic stem cells (mESC) (D), RAW 264.7 cells (E), and HEK293T cells (F)
treated as in (B) and immunoblotted by the indicated antibodies.

51

Sodium Crotonate Does Not Have HDAC Inhibitor Activity
Given the chemical similarity between crotonate and butyrate, a compound with
known histone deacetylase (HDAC) activity (Boffa et al., 1978; Candido et al.,
1978), I next sought to ensure that the increase in histone crotonylation was not
due to the inhibition of an unknown crotonyl-specific HDAC activity. To rule out
this possibility I carried out a fluorometric-based HDAC assay with HeLa S3
nuclear extracts as a general source of HDAC activity in the presence of
increasing concentrations of crotonate, acetate, or butyrate. While butyrate
showed the expected inhibition of HDAC activity, crotonate and acetate showed
minimal inhibition (Figure 3.3).

Figure 3.3: Crotonate is Not an HDAC Inhibitor.
Increasing concentration of either acetate, butyrate, or crotonate (0,
0.5mM, 1mM, or 5mM) were added to a Fluorometric HDAC assay kit
(Active Motif) where fluorescence intensity is an indirect measure of
HDAC activity. Butyrate is a known HDAC inhibitor, while Acetate is not
considered an HDAC inhibitor. HeLaS3 nuclear extract was used as a
general source of HDAC activity.
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ACSS2 is Responsible for Synthesizing Crotonyl-CoA from Crotonate
To further demonstrate that addition of crotonate is increasing histone
crotonylation through the direct production of crotonyl-CoA and not through an
indirect mechanism, I asked whether knockdown of the Acyl-CoA Synthetase,
ACSS2, would attenuate the increase in histone crotonylation. ACSS2 is known
to charge acetate with free CoA-SH to form acetyl-CoA in mammalian cells, is
known to localize to the cytosol and the nucleus (Wellen et al., 2009), and has
been shown to charge longer chain SCFAs in vitro (Frenkel and Kitchens, 1977),
making it an excellent candidate for the conversion of crotonate to crotonyl-CoA.
Supporting this notion, knockdown of ACSS2 prior to addition of crotonate to
HeLa S3 cells reduced the amount of crotonyl-CoA produced and the levels of
H3K18Cr (Figures 3.4A and 3.4B, compare columns/lanes 2 and 4). Intriguingly,
I also observed that ACSS2 knockdown reduced the global levels of H3K18Cr in
untreated cells (Figure 3.4B, compare lanes 1 and 3). This suggests that basal
concentrations of crotonyl-CoA used for histone crotonylation are synthesized
from endogenous sources of crotonate. To further support this observation and
to rule out potential complications due to siRNA off-target effects, I tested four
separate ACSS2-specific RNAs that all showed a global reduction in H3K18Cr
(Figure 3.4C). These data suggest that ACSS2 is responsible, at least in part, for
the production of crotonyl-CoA to be used for histone crotonylation.

53

Figure 3.4: Knockdown of ACSS2 Reduces Cellular Levels of H3K18cr.
(A) HeLa S3 cells were transfected with control or ACSS2-specific siRNA
(pool of 5). 12 hours prior to harvest 10 mM crotonate was added to the
media as indicated. 72 hours post-transfection cells were harvested and
subject to LC-MS analysis. The data represent mean peak area ± standard
deviation of four independent experiments. *, t-test derived p-value < 0.05.
(B) Same as (A), except 72 hours post-transfection, histones and whole cell
lysates were prepared, and immunoblotted with the indicated antibodies.
Immunoblots of acid extracts are shown above the black line, while
immunoblots of whole cell lysates are shown bellow the black line. (C) HeLa
S3 cells were transfected with control or specific siRNAs to ACSS2. ACSS2
#1-3 are unique single RNAs, and ACSS2 #4 is the pool of 5 used in (A-B).
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Impairing Acetyl-CoA Synthesis Leads to Higher Levels of Histone
Crotonylation
I next asked whether impairing acetyl-CoA production would have an effect on
histone crotonylation. My in vitro reactions would predict that lowering the
concentration of acetyl-CoA will lead to an increase in H3K18Cr by reducing the
competition for p300/CBP (Figure 3.1). A growing literature has shown that the
cytoplasmic and nuclear enzyme ATP-Citrate Lyase (ACL) is responsible for
producing acetyl-CoA used for histone acetylation in mammalian cells (Lee et al.,
2014; Wellen et al., 2009). Knockdowns of ACL by three unique siRNAs resulted
in the expected reduction in global levels of H3K18Ac and, as predicted by my in
vitro experiments, an increase in global levels of H3K18Cr (Figure 3.5A).
Furthermore, the increase in H3K18Cr can be reversed by the addition of acetate,
which has previously been shown to restore histone acetylation levels in the
absence of ACL (Figure 3.5B) (Wellen et al., 2009).
Recently, the pyruvate dehydrogenase (PDH) complex, which synthesizes
acetyl-CoA for the TCA cycle in the mitochondria, has been shown to translocate
to the nucleus where it can synthesize acetyl-CoA used for histone acetylation
(Sutendra et al., 2014). Upon knockdown of PDHE1α, a critical subunit of the
PDH complex, I observed both the previously reported reduction in H3K18Ac
and the predicted increase in H3K18Cr (Figure 3.5C). Given the relatively low
steady-state levels of crotonyl-CoA to acetyl-CoA in the cell and the decrease in
acetyl-CoA observed with ACL knockdown, we do not suggest that crotonylCoA is completely replacing acetyl-CoA, but rather that the crotonyl-CoA that is
present has less competition for p300 and is therefore more often used for p300catalyzed histone acylation.
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Figure 3.5: Reducing Acetyl-CoA Leads to an Increase in Histone
Crotonylation.
(A) HeLa S3 cells were transfected with non-target, or one of three unique
ACL siRNAs, as indicated. 72hrs post-transfection histone extracts and whole
cell lysates were prepared and immunoblotted with the indicated antibodies.
Immunoblots of acid extracts are shown above the black line, while
immunoblots of whole cell lysates are shown bellow the black line. Asterisks
designate non-specific band in anti-ACL blots. (B) HeLa S3 cells were
transfected with either non-target or ACL-specific siRNA (#1) using the same
protocol as in (A), except 14 hours prior to harvest 10 mM acetate was added
to the media as indicated. Analysis and labeling are as in (A). (C) HeLa S3 cells
were transfected with non-target, PDHE1α, or ACL (#1) specific siRNA, as in
(A-B). Analysis and labeling are as in (A-B).
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DISCUSSION
Regulation of histone PTMs by metabolite availability has been proposed as a
mechanism for linking chromatin state to metabolism (Donohoe and Bultman,
2012; Gut and Verdin, 2013; Kaelin and McKnight, 2013; Katada et al., 2012; Lu
and Thompson, 2012; Meier, 2013). The basic premise is that many chromatinmodifying enzymes utilize products of intermediary metabolism as cofactors
essential for their activities.

Fluctuations in these metabolites could directly

transduce a transcriptional response through the modification of chromatin state
either by activating or inhibiting various chromatin-modifying enzymes. This
study introduces a new dimension to this paradigm in that fluctuations in both
acetyl-CoA and crotonyl-CoA are shown to affect levels of histone acylation.
Here I show that crotonyl-CoA can compete with acetyl-CoA for p300’s acyltransferase activity, allowing the relative concentrations of either CoA to
determine the reaction products. I implicate the cytoplasmic and nuclear
localized metabolic enzyme ACSS2 as a source of intracellular crotonyl-CoA
used for histone crotonylation. Together these data demonstrate the sensitivity of
histone crotonylation to acyl-CoA metabolism and provide a toolkit for
perturbing histone crotonylation in the cell.
I propose that fluctuations in acyl-CoA metabolism and the ratios of these
various metabolites will be “translated” by chromatin, through mechanisms
described here and through mechanisms yet to be uncovered (Figure 3.6).
Although I have focused on H3K18, I anticipate that these observations will hold
for other enzyme-driven crotonylations, and acylations that share enzymemachineries. The ability to quantitatively measure the cellular concentrations of a
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Figure 3.6: Metabolic Regulation of Histone Crotonylation
Schematic diagram of the pathways involved in the enzymatic and
metabolic regulation of histone crotonylation and histone acetylation
(differential acylation). The differential acylation state of chromatin is
regulated by the relative concentrations of acetyl-CoA and crotonyl-CoA,
which are synthesized through distinct metabolic pathways, diagramed
here. Branches of the diagram that are still unknown are marked by
question marks. The PDH (pyruvate dehydrogenase), ACSS2 (Acyl-CoA
synthetase), and ACL (ATP Citrate Lyase) reactions occur in both the
cytosol and nuclear compartments. We favor the model that DNAsequence-specific transcription factors (TF) recruit p300/CBP to specific
genomic loci where they will “translate” the nuclear/cytosolic acyl-CoA
levels by differentially acylating histones.
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variety of acyl-CoAs opens up the potential for a new avenue of research.
Comparative profiling of acyl-CoAs from a variety of biological materials will be
a valuable resource and will allow correlations to be drawn between basal
concentrations and function and/or physiological state. For example, ChIP-seq
data from developing spermatagonia show an interesting relationship between
histone crotonylation and active gene expression programs in the development
of male germ cells (Montellier et al., 2013; 2011; Tan et al., 2011). It remains to be
tested whether a unique metabolic program underlies these observations or
whether similar mechanisms are in play during other developmental or disease
pathways. Additionally, it has been long observed that the transformation of
cells to a cancerous state requires a rewiring of metabolic pathways (Pavlova and
Thompson, 2016; Warburg et al., 1927). Global and local changes in histone
acetylation have been observed in a variety of tumors and cancer models
(Horwitz et al., 2008; Seligson et al., 2009; 2005). It remains of interest to bridge
these two observations and understand whether changes in acyl-CoA
metabolism and thereby downstream histone acylations play a significant role in
cancer or other aspects of human biology and disease.
These data also suggest that both intra-cellular and extra-cellular
concentrations of short chain fatty acids (SCFA), like crotonate, will influence
chromatin state through the activity of ACSS2. Fluctuations in the concentration
of a variety of SCFAs have been linked to metabolic disorders and diseases. For
example, the concentration of 3-hydroxy-butyrate can rise to as high as 25mM in
peripheral blood and has been implicated in chromatin regulation (Shimazu et
al., 2013). Additionally, differences in the concentrations and makeup of SCFAs
from environmental sources have been implicated in a variety of physiological
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and disease states ranging from gut microbiota dysbiosis leading to obesity,
colitis, and cancer predisposition to the regulation of immune cell development
(Lee and Hase, 2014; Tan et al., 2014a). Whether these observed fluctuations in
SCFA lead to an increase in their corresponding histone acylation, as we have
shown here with crotonate and histone crotonylation, remains untested.
Furthermore, it is still unclear how crotonate or crotonic acid, are generated in
mammalian cells. Finally, recent reports have highlighted the critical role of
ACSS2 in tumor growth (Comerford et al., 2014; Mashimo et al., 2014), yet the
role of differential histone acylation in this context was unexplored.
The studies in Chapter 3 establish the metabolic regulation of histone
crotonylation and develop tools to specifically perturb histone crotonylation in
the cell. With these tools I was now able to ask how increasing or decreasing
crotonyl-CoA affects p300-regulated gene activation, the subject of Chapter 4.
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CHAPTER 4: EXPERIMENTAL MANIPULATION OF [CROTONYL-COA]
AFFECTS ACTIVATION AND EXPRESSION OF P300 TRAGET GENES IN
LPS-INDUCED INFLAMMATORY RESPONSE

INTRODUCTION
Having shown that p300-catalyzed histone crotonylation directly stimulates
transcription in a cell-free system (chapter 2) and the metabolic regulation of
histone crotonylation in cells (chapter 3), I next sought to investigate whether
p300-catalyzed histone crotonylation is involved in the process of gene activation
in a cellular context. The LPS-induced inflammatory response in macrophages is
a classic model of signal-dependent gene activation, where the role of chromatin
and chromatin modifying enzymes are well documented (Smale et al., 2014).
The innate immune system protects an organism from pathogens and other
environmental insults through a wide range of mechanisms. While many
proteins involved in innate immunity are constitutively expressed other are
induced only when needed. This induction is controlled by a series of pattern
recognition receptors that specifically recognize pathogen-associated molecular
patterns. The presence of receptors on the host cell surface allows the host cell to
recognize and respond to specific pathogen-associated signals by activation of
signaling cascades generally leading to a specific transcriptional response
(Janeway and Medzhitov, 2002; Takeuchi and Akira, 2010).
Lipopolysaccharide (LPS), found on the outer membrane of Gram-negative
bacteria, stimulates multiple signaling cascades by engagement with the host
receptor, TLR4. While there are transcription-independent responses to TLR4
activation, most of the response is mediated through a signal-dependent
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transcriptional cascade (Medzhitov and Horng, 2009; Smale, 2012), which I will
refer to as the inflammatory response. The rapid and robust activation of
inflammatory response genes provides a model for gene activation where the
temporal control of transcription is dependent on the addition of LPS to cells in
culture allowing manipulations to crotonyl-CoA concentrations to be made prior
to gene activation. Furthermore, the inflammatory response induces the
transcription of hundreds of genes through distinct mechanisms dependent on
various factors. For example, some genes are primed and their chromatin fully
modified before LPS stimulation, while other genes must go through chromatin
modification and remodeling before the gene is expressed (Bhatt et al., 2012;
Ramirez-Carrozzi et al., 2009). This provides genes that can be experimentally
perturbed at the level of chromatin regulation and a series of genes that can act
as internal controls that are LPS-responsive but insensitive to chromatin
perturbations, as their chromatin is already primed.
The wealth of previously published data profiling the transcriptomic and
epigenomic aspects of the inflammatory response also made it an attractive
model. Most important to my studies on p300-catalyzed histone crotonylation
was a published ChIP-seq data set for p300 ± LPS (Ghisletti et al., 2010). This
p300 ChIP-seq data set provided critical information on which LPS-induced
genes are regulated by p300, as demonstrated by ChIP signal at promoter
proximal or distal regulatory elements. From these ChIP-seq data I could also
determine which p300-regulated genes had p300 localized prior to LPS (primed)
and which ones had signal-dependent recruitment of p300. In this chapter, I refer
to the former group of genes as “pre-activated” and the latter group of genes as
“de novo-activated,” and define these categories based on the p300 ChIP-seq
62

data. This classification is important because while the genes that are “preactivated,” meaning they already have p300 bound at their associated regulatory
elements, will not be dependent on p300 recruitment and subsequent histone
acetylation and/or crotonylation for gene activation, the “de novo-activated”
genes will be dependent on this process. This feature of “de novo-activated”
genes provides a means to ask whether having more or less p300-catalyzed
histone crotonylation affects expression, which can be accomplished through
manipulations to crotonyl-CoA concentrations described in Chapter 3.
Here, I show that increasing or decreasing the cellular concentration of
crotonyl-CoA prior to LPS-stimulation causes local changes in histone
crotonylation, specifically at the histones flanking regulatory elements that show
the greatest increase in p300 localization during the inflammatory response (i.e.
“de novo-activated” genes). This increase or decrease in crotonyl-CoA
concentration also leads to enhanced or diminished levels, respectively, in
expression of those specific activated genes.

RESULTS
H3K18Cr is Associated with Active Chromatin and Correlates with p300
Localization
To investigate the role of differential acylation in transcriptional activation
within a cellular context, I turned to the LPS-induced inflammatory response in
the macrophage cell line RAW 264.7. The macrophage LPS response involves a
well-characterized transcriptional program that requires p300 recruitment to
many sites of downstream gene activation to facilitate histone acetylation and
chromatin remodeling that are critical for the inflammatory response (Ghisletti et
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al., 2010; Ramirez-Carrozzi et al., 2009). I performed RNA-seq and ChIP-seq for
H3K18Ac and H3K18Cr on cells pre- and post-LPS stimulation (120’). I also made
use of published p300 ChIP-seq from macrophages under similar stimulation
conditions (Ghisletti et al., 2010).
I first assessed the ChIP-seq data for H3K18Ac and H3K18Cr under
unstimulated conditions and observed that both histone modifications map to
promoter-proximal and –distal regulatory elements associated with active genes
(Figure 4.1). By mapping the average profile of both H3K18Ac and H318cr ± 2kb
of the transcription start site (TSS) for four equal groups of genes ranked by
expression levels (as determined by RNA-seq), both modifications showed a
correlation with gene activity; the group of highest expressed genes exhibited the
highest levels of H3K18Ac and H3K18Cr and vice versa (Figures 4.1A and 4.1B).
Both modifications exhibited the common histone acetylation profile, two peaks
flanking a putatively nucleosome depleted regulatory element where p300 is
recruited. Levels of H3K18Ac and H3K18Cr followed a significant linear
correlation (Figure 4.1C) and were enriched at peaks of p300 across the genome
(Figure 4.1D), as predicted by my findings that both modifications are catalyzed
by p300. The trends observed by average profiles of H3K18Ac and H3K18Cr
reads were also clearly observed at individual genes (Figures 4.1E and 4.1F),
where peaks of H3K18Ac and H3K18Cr flanked promoter-proximal and –distal
regulatory elements, marked by p300. These data point to a role for p300catalyzed crotonylation in general transcriptional activation and reaffirm the
notion that active regulatory elements are modified by a number of histone
acylations.
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Figure 4.1: H3K18Cr, H3K18Ac, and p300 Co-Localize Genome-Wide.
(A-B) All genes with FPKM >1 were split into 4 equal groups based on their
expression levels calculated from RNA-seq of unstimulated RAW 264.7 cells.
The average profile of H3K18Ac (A) and H3K18Cr (B) ChIP-seq data from
unstimulated RAW 264.7 cells are plotted for each group at TSS ± 2kb. (C)
Correlation between H3K18Ac and H3K18Cr ChIP-seq read counts within all
H3K18Cr peaks (17,747). Plotted as normalized read counts (read counts per
million mapped reads). (D) Average profile of H3K18Ac, H3K18Cr, and input
ChIP-seq data from unstimulated RAW 264.7 around all annotated p300 peaks
from unstimulated macrophages. (E-F) Genome browser representation of
normalized ChIP-seq reads for p300, H3K18Ac, H3K18Cr, and input from
unstimulated macrophages at a “housekeeping” gene (Actb) (E) and a lineage
specific constitutively expressed (“pre-activated”) gene (Ccl3) (F). Normalized
to total mapped reads. The y-axis maximum is given at the far left of each
track. Arrow below refseq gene track indicates directionality of transcription.
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H3K18Cr and H3K18Ac are Induced at “De Novo-Activated” Regulatory
Elements Upon LPS Stimulation
Stimulation of macrophages by LPS initiates a well-characterized, rapid, and
robust transcription program (Bhatt et al., 2012; Ramirez-Carrozzi et al., 2009).
For my interests in investigating differential acylation by p300, I focused on two
unique classes of LPS-induced genes: I) those showing increased p300
recruitment upon LPS stimulation (fold (reads) > 4), which I will term “de novoactivated”, and II) those showing pre-localized levels of p300 (prior to LPS
stimulation) that are not significantly changed upon stimulation (-1.3 < fold
(reads) < 1.3), which I will term “pre-activated.” The ChIP-seq traces for p300,
H3K18Ac, H3K18Cr, and RNA-seq of genes from both classes ± LPS stimulation
(120’) demonstrate how the chromatin landscape at these two different classes of
genes responds to LPS stimulation (Figure 4.2). While “de novo-activated” genes
(Figures 4.2A and 4.2B) showed an induction in both modifications upon LPS
stimulation, “pre-activated” genes (Figures 4.2C and 4.2D) had peaks of both
H3K18Ac and H3K18Cr prior to LPS stimulation. These trends were also
observed by average profiles of H3K18Ac and H3K18Cr centered on the TSS of
all “pre-activated” and all “de novo-activated” genes (Figures 4.2E-4.2H).

Increasing Crotonyl-CoA Concentrations by Crotonate Addition Increases
H3K18Cr at “De Novo-Activated” Genes and Enhances Gene Expression
To test whether altering the levels of histone crotonylation would affect
gene activation, I asked whether increasing or decreasing the concentration of
crotonyl-CoA in RAW 264.7 cells prior to LPS stimulation would alter the
differential acylation state at the regulatory elements of “de novo-activated”
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Figure 4.2: Two Classes of LPS-Stimulated Genes, as Defined by p300
Localization.
(A-D) Genome browser representation of RNA-seq reads and ChIP-seq
reads for p300, H3K18Ac, and H3K18Cr from unstimulated (UT) and 120’
LPS-stimulated (LPS) macrophages at two “de novo-activated” genes (Il6
and Ifit1) (A and B) and two “pre-activated” genes (Ccl3 and Nlrp3) (C and
D). Normalized to total mapped reads. The y-axis maximum is given at the
far left of each track. Arrow indicates directionality of transcription. (E-H)
The average profile of H3K18Cr (E and F) and H3K18Ac (G and H) ChIPseq data plotted at the TSS ± 2kb of either all “de novo-activated” genes (E
and G) or all “pre-activated” genes (G and H) with or without LPS
stimulation.
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genes. I focused on the “de novo-activated” genes because the above data
suggest that for these genes the p300-catalyzed acylation of histones was a ratelimiting step in the transcription reaction.

I hypothesized that “de novo-

activated” genes would be more responsive to changes in the concentrations of
crotonyl-CoA than the “pre-activated” genes, which are both acetylated and
crotonylated prior to LPS stimulation.
RAW 264.7 cells were first treated with varying concentrations of sodium
crotonate followed by LPS stimulation. The crotonate pretreatment increased the
concentration of crotonyl-CoA within the cell in a dose-dependent manner
without impacting the concentration of acetyl-CoA, as measured by LC-MS
(Figure 4.3). After 2 hours of LPS stimulation, I performed ChIP for H3K18Cr

Figure 4.3: LC-MS Measurements of Crotonyl-CoA and Acetyl-CoA in
RAW264.7 Cells. LC-MS measurements of crotonyl-CoA (left) and acetyl-CoA
(right) from RAW 264.7 cells pretreated with the indicated concentration of
sodium crotonate, pH 7.4, for 12 hours. The data represent mean peak area ±
standard deviation of four independent experiments. Summary of unpaired ttest p-value: ns (p>0.05) and **** (p≤0.0001). These experiments were
conducted by Drs. Justin Cross and Vladimir Yong-Gonzalez.
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Figure 4.4: Crotonate Treatment Correlates With Increased H3K18Cr, Decreased
H3K18Ac and Increased Gene Expression.
(A) qPCR analysis of H3K18Cr ChIP products from RAW 264.7 cells pre-treated
with the indicated concentration of sodium crotonate (pH 7.4) (mM) for 6 hours
prior to a 2-hour LPS stimulation. Primers were designed for TSS-proximal ChIPseq peaks of H3K18Ac and H3K18Cr. ChIP-qPCR results for four “de novoactivated” genes (Il6, Gbp2, Ifit1, and Rsad2) and one “pre-activated” gene (Ccl3)
are shown. Data are represented as mean of % input ± standard deviation of
technical replicates. Summary of p-value is as follows: ns (p>0.05), ** (p≤0.01), ***
(p≤0.001), **** (p≤0.0001). (B) Experiment and analysis are same as (A), except
ChIP was performed with H3K18Ac antibody. (C) RT-qPCR analysis of LPSstimulated (120’) RAW 264.7 cells pre-treated with the indicated concentration of
sodium crotonate (pH 7.4) (mM). Relative expression is normalized to Gapdh. RTqPCR data for the same set of genes as in (A-B). Data are represented as the mean
fold-change in relative expression due to crotonate addition from three
independent experiments ± standard deviation.
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and H3K18Ac. In support of our hypothesis, I observed a dose-dependent
increase in H3K18Cr at the promoters of four “de novo-activated” genes (Il6,
Gbp2, Ifit1, and Rsad2) and no significant change in H3K18Cr at a “pre-activated”
(pre-acylated) gene (Ccl3) (Figure 4.4A). Furthermore, I observed an associated
dose-dependent decrease in H3K18Ac at the promoters of the “de novoactivated” genes tested and no significant change in H3K18Ac at the “preactivated” gene (Figure 4.4B).
With the ability to fine tune the amount of H3K18Cr present on the promoters of
“de novo-activated” genes, I next measured mRNA by RT-qPCR from cells
treated with varying concentrations of sodium crotonate prior to a 2 hour LPS
stimulation. Gene expression of the “de novo-activated” genes was increased in a
dose-dependent manner, while the “pre-activated” gene was only minimally
affected (Figure 4.4C). Additional tested genes (“de novo-activated:” Cmpk2,
Cxcl10, Ifnb, and Ccl5, and “pre-activated:” Pim1) followed the same trend
(Figure 4.5). These data provide evidence correlating the abundance of H3K18Cr
at the proximal regulatory elements of a gene to its expression, supporting the
notion that the balance between histone crotonylation and histone acetylation
(i.e. differential acylation) plays a functional role in gene expression.
To explore the scope of LPS-induced genes that are further induced due to
crotonate pre-treatment, I next performed RNA-seq on LPS stimulated (120’)
cells with and without pre-treatment of crotonate (10mM). Consistent with the
RT-qPCR data of select genes, “de novo-activated” genes were on average
further stimulated by crotonate pre-treatment with a mean fold increase of 2.4
over LPS-induction, whereas “pre-activated” genes were on average unaffected
with a mean fold change of 1.0 (Figure 4.6A). I next asked whether all crotonate72

Figure 4.5: De Novo-Activated Genes Are Further Stimulated By Crotonate
Pre-Treatment. RT-qPCR analysis of LPS-stimulated (120’) RAW 264.7 cells
pre-treated with the indicated concentration of sodium crotonate (pH 7.4)
(mM) for the indicated genes. Relative expression is normalized to Gapdh.
Data are represented as the mean fold-change in relative expression due to
crotonate addition from three independent experiments ± standard deviation.
responsive genes (>2-fold increase over LPS stimulation) also show a greater
than average recruitment of p300 upon LPS stimulation. To do this, I compared
the fold-change of p300 reads (± 2kb from TSS) of a list of all genes whose
expression was induced >2-fold (“All LPS-induced”, n=850) to a subset of that
list of genes that were further induced >2-fold over LPS-stimulation due to
crotonate pre-treatment (“Further induced by crotonate”, n=48). Notably, I
observed a significantly greater than average fold-change in p300 recruitment to
crotonate-responsive genes (Figure 4.6B). I also observed a statistically
significant positive correlation between the fold-change in p300-localization
upon LPS and the fold-change in mRNA abundance due to crotonate treatment
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Figure 4.6: RNA-seq Analysis of Crotonate Pre-Treatment.
(A) The fold changes in FPKM over LPS-stimulation due to crotonate pretreatment, as measured by RNA-seq, are represented as a box and whisker
plot (10 - 90 percentile) for both “pre-activated” and “de novo-activated”
th

th

genes. ****, p-value < 0.0001. (B) Box and whisker plot representation (10 th

90 percentile) of the fold change in p300 read counts, due to LPS
th

stimulation, ± 2kb from the TSS of two sets of genes, (1) all LPS induced
genes (fold change (FPKM) ≥2 upon LPS stimulation, n=850) and (2) a
subset of (1) whose expression was further induced ≥2-fold due to pretreatment with crotonate (n=48). ****, p-value < 0.0001. (C) Scatter plot
representation of all LPS-stimulated genes with annotated p300 peaks ±
500bp from TSS (n=262), plotting fold change in p300 read counts due to
LPS by fold change in expression (FPKM) over LPS-induction due to
crotonate pre-treatment; both are plotted as log values. Four “de novo2

activated” gene (Il6, Gbp2, Ifit1, and Rsad2) and one “pre-activated” gene
(Ccl3) are highlighted in yellow.
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(Figure

4.6C),

further

establishing

the

link

between

p300-mediated

transcriptional activation and differential histone acylation.

Increasing Cellular Concentrations of Crotonyl-CoA Prior to LPS Stimulation
Enhances Cytokine and Chemokine Secretion Upon LPS Stimulation
To test whether the effects observed in gene expression led to changes in the
functional arm of the inflammatory response, I measured how pre-treating cells
with crotonate affected cytokine and chemokine secretion upon LPS stimulation.
I first performed an LPS time-course with or without crotonate treatment
(10mM), collected supernatants 0, 3, 6, and 16 hours post LPS-stimulation, and
observed a greater concentration of secreted Il6 in cells pre-treated with
crotonate at every time point post-LPS-stimulation, as measured by a standard
ELISA (Figure 4.7A). I next employed a multiplex bead-based immunoassay (see
Methods for detail) to more broadly analyze the effect of crotonate treatment on
cytokine and chemokine secretion. I collected supernatant from cells pre-treated
with increasing concentrations of sodium crotonate followed by a 16hr LPS
stimulation and measured the concentrations of a variety of LPS-induced
chemokines and cytokines (Il6, Cxcl10, Cxcl1, Ccl5, and Ccl3). In agreement with
the standard ELISA assay, I observed a dose-dependent increase in Il6 secretion
due to crotonate addition (Figure 4.7B). I also observed a dose-dependent
increase in Cxcl10, Cxcl1, and Ccl5 secretion, all of which are products of “de
novo activated” genes (Figure 4.7B). Furthermore, Ccl3, a secreted factors
expressed from a “pre-activated” gene, did not show a significant change in
protein secretion due to addition of crotonate (Figure 4.7C).
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Figure 4.7: Increased Cellular Crotonyl-CoA Concentration Prior to LPS
Stimulation Leads to Enhanced Cytokine and Chemokine secretion Upon LPS
Stimulation.
(A) RAW 264.7 cells were treated with either 10mM Acetate or 10mM Crotonate,
or left untreated for 6 hours prior to LPS stimulation. Supernatants were
collected at 0, 3hr, 6hr, or 16hr after LPS stimulation and the concentration of Il6
was measure by standard ELISA. Data are presented as mean of technical
replicates ± standard deviation. (B-C) Chemokine and cytokine protein
abundance in supernatants from LPS-stimulated (16hr) RAW 264.7 cells pretreated with the indicated concentration of sodium crotonate. Data for four “de
novo-activated” chemo/cytokines (Il6, Cxcl10, Cxcl1, and Ccl5) (B) and one
“pre-activated” chemokine (Ccl3) (C) are represented here as the mean of two
independent experiments ± standard deviation. Summary of p-value is as
follows: ns (p>0.05), ** (p≤0.01), *** (p≤0.001), **** (p≤0.0001).
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Knockdown of Acss2 Reduces H3K18Cr at the Promoters of “De Novoactivated” Genes and Attenuates Gene Expression
To test whether decreasing crotonyl-CoA available for histone crotonylation
prior to LPS-stimulation would have a negative effect on “de novo-activated”
genes, I performed siRNA knockdown of Acss2 in RAW 264.7 cells prior to a 120’
LPS stimulation. I confirmed knockdown of Acss2 both at the RNA level by RTqPCR (Figure 4.8A) and at the protein level by immunoblot (Figure 4.8B). I next
performed ChIP for H3K18Cr in LPS-stimulated (120’) cells that had been
transfected with either non-target or Acss2-specific siRNA. As expected, I
observed significant decreases in H3K18Cr due to Acss2 knockdown in five “de
novo-activated” genes (Il6, Gbp2, Ifit1, Rsad2, and Ccl5) and no significant change
in the “pre-activated” gene (Ccl3) (Figure 4.8C). I next performed RT-qPCR
under the same experimental conditions with three independent replicates and
observed a reduction in mRNA abundance for the five “de novo-activated”
genes tested (Il6, Gbp2, Ifit1, Rsad2, and Ccl5) and no change for the “preactivated” gene (Ccl3) (Figure 4.8D). Furthermore, under similar experimental
conditions I observed a reduction in the LPS-induced secretion of Il6 and Ccl5,
but no significant change in Ccl3 secretion, upon knockdown of Acss2 (Figure
4.8E). These data support the notion that the cellular concentrations of crotonylCoA regulates the levels of histone crotonylation, which in turn impacts the rate
of gene activation.
Based on these findings, I conclude that differential histone acylation
(crotonylation vs. acetylation) at specific lysine residues (H3K18, in this study,
and likely other histone sites) is regulated metabolically by a previously
unappreciated balance in cellular levels of crotonyl-CoA and acetyl-CoA. I favor
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Figure 4.8: Knockdown of Acss2 Prior to LPS Stimulation Leads to a
Decreased Induction of H3K18Cr at, and Decreased Stimulation of, “De
Novo-Activated” Inflammatory Genes Upon LPS Stimulation.
(A-B) RAW 264.7 cells were transfected with control or Acss2-specific siRNAs,
72 hours post-transfection cells were harvested for either RT-qPCR analysis
(A) or immunoblot analysis (B) to assess knockdown efficiency. For (A) data is
presented as mean fold change due to ACSS2 knockdown of technical
replicates ± standard deviation. (C) qPCR analysis of H3K18Cr ChIP products
from LPS-stimulated (120’) RAW 264.7 cells that had been transfected with
either control siRNA or siRNAs specific for Acss2 72 hours prior to
stimulation. ChIP-qPCR results for five “de novo-activated” genes (Il6, Gbp2,
Ifit1, Rsad2, and Ccl5) and one “pre-activated” gene (Ccl3) are shown here.
Data are represented as mean of % input of technical replicates ± standard
deviation. (D) RT-qPCR analysis of LPS-stimulated (120’) RAW 264.7 cells
previously transfected with either control or Acss2-specific RNAs, as in (C).
Relative expression is normalized to Gapdh. RT-qPCR data are shown for the
same set of genes as in (C). Data are represented as the mean fold-change in
relative expression due to Acss2 knockdown from three independent
experiments ± standard deviation. (E) Chemokine and cytokine protein
abundance in supernatants from LPS-stimulated (16hr) RAW 264.7 cells
transfected with the indicated RNAs, as in (C). Data for two “de novoactivated” chemo/cytokines (Il6 and Ccl5) and one “pre-activated” chemokine
(Ccl3) are represented here as the mean of two independent experiments ±
standard deviation. Summary of p-value is as follows: ns (p>0.05), ** (p≤0.01),
*** (p≤0.001), **** (p≤0.0001).
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the view that the concentrations of crotonyl-CoA and acetyl-CoA (and likely
other short-chain acylations) are “translated” by the co-activators p300 and CBP
into the differential acylation states of local chromatin influencing transcriptional
activation by mechanisms that remain unclear. These findings lend support to
emerging studies linking metabolism to the alteration of chromatin landscapes
and thereby the regulation of gene expression.

DISCUSSION
Regulation of histone modifications, and thereby regulation of chromatin
structure, by metabolite availability has been proposed as a potential mechanism
for gene regulation under the premise that many chromatin-modifying enzymes
utilize products of intermediary metabolism as cofactors essential for their
activities (Gut and Verdin, 2013; Kaelin and McKnight, 2013; Meier, 2013). Our
study introduces a new dimension to this paradigm in that fluctuations in both
acetyl-CoA and crotonyl-CoA are shown to affect global and local chromatin
landscapes leading to distinct functional outputs. While our study clearly
establishes that the concentration of crotonyl-CoA influences transcriptional
activation through its effects on differential acylation, it remains unclear whether
the physiological concentrations of crotonyl-CoA are as dynamic as they are in
our cell culture experiments where crotonate addition to media was used to
experimentally alter the cellular concentration of crotonyl-CoA.
The data presented here illustrate that the intra-and inter-cellular
metabolic state of the cell can directly influence the local chromatin landscape by
causing fluctuations in metabolite/cofactor concentrations required for histone
crotonylation and acetylation. I put forward a proof-of-concept for the
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Figure 4.9: Metabolic Regulation of Transcription Through Differential
Acylation.
A schematic of how acyl-CoA metabolism can impact transcription is
presented here. The concentration of acyl-CoAs in the nucleus
determines the state of differential acylation at p300-targetted genes,
which in turn impacts transcriptional potential. The illustration was
designed by Dr. Alexey Soshnev.
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functional connection between acyl-CoA metabolism and transcriptional
activation, operating through the differential acylation of histones (Figure 4.9).
Future work as to the physiological range of acyl-CoA concentrations in a variety
of cell-types, environments, and stress conditions will be critical to understand
specifically how and for what biological process nature exploits this hitherto
unexplored mechanism of gene regulation.
These data corroborate the cell-free transcription assays presented in Chapter
2 and demonstrate that the amount of histone crotonylation at a given regulatory
elements correlates with transcription. While the direct mechanism by which
histone crotonylation stimulates transcription is not resolved by these studies, a
cell-based model of crotonylation-dependent transcription is established. This
cell-based model is utilized in Chapter 5 to demonstrate the relevance of the AF9
YEATS domain interaction with crotonyl-lysine in the context of gene expression.
As discussed in Chapter 2 and the General Introduction, there are two main
mechanisms by which histone PTMs function, namely in cis (e.g. biophysical
modulation of the chromatin fiber) or in trans (e.g. recruitment or repulsion of
“readers”). Current work in the lab led by Dr. Tanya Panchenko is exploring the
role of histone crotonylation on chromatin fiber compaction, yet this work is too
preliminary to discuss here. In collaboration with Dr. Haitao Li, major inroads
have been made into the trans effects of histone crotonylation with the
identification and characterization of the YEATS domain as a “reader” module
for crotonyl-lysine, the subject of Chapter 5.

82

CHAPTER 5: MOLECULAR COUPLING OF HISTONE CROTONYLATION
AND ACTIVE TRANSCRIPTION BY AF9 YEATS DOMAIN

INTRODUCTION
While I have demonstrated that histone crotonylation at the promoters of genes
stimulates transcription (Chapter 4), the underlying mechanism(s) responsible
for bringing this about remained unclear. As discussed in the general
introduction (Chapter 1), there are two major mechanisms by which histone
modifications exert their function: through biophysical modulation of the
chromatin fiber or through the recruitment or occlusion of effector modules,
often termed “readers.” For example, histone acetylation negates the positive
charge of the modified lysine residue leading to the destabilization of both internucleosomal and intra-nucleosomal interactions. Histone acetylation also acts as
a platform for the binding of reader modules, most famously bromodomains,
which tend to be associated with protein and complexes involved in
transcriptional regulation (Filippakopoulos et al., 2012). In principle, histone
crotonylation could be working through both mechanisms in a similar fashion to
histone acetylation, yet little is known about the biophysical consequences of
histone crotonylation and a reader of crotonyl-lysine has not been identified.
Furthermore, studies have demonstrated that bromodomain proteins bind with
lower affinity to acyl chains more complex than acetyl and show minimal to no
binding to crotonyl-lysine (Flynn et al., 2015; Vollmuth and Geyer, 2010). In this
chapter I describe the identification and characterization of the YEATS domain as
a reader of histone crotonylation.
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The YEATS domain was identified as a conserved protein domain in
proteins associated with transcriptional regulation (pfam accession: PF03366)
and named as an acronym of the founding proteins from yeast and human (Yaf9,
ENL, AF9, Taf14, and Sas5) (Le Masson et al., 2003). While only four human
proteins contain a YEATS domain (AF9, ENL, GAS41, and YEATS2), they are all
members of chromatin-modifying complexes associated with transcriptional
activation (Schulze et al., 2009) (Figure 5.1A). GAS41 and YEATS2 are subunits
within two multi-subunit HAT complexes, NuA4 and ATAC, respectively
(Doyon et al., 2004; Suganuma et al., 2008). AF9 and ENL are paralogs and
interchangeably inhabit two distinct nuclear complexes, the super elongation
complex, thought to regulate RNAPII elongation, and the DOT1L complex,
responsible for catalyzing methylation at H3K79, a modification associated with
active transcription (Lin et al., 2010; Yokoyama et al., 2010) (Figure 5.1B). Human
YEATS domain proteins are also implicated in cancer. GAS41 is amplified in
both glioma and astrocytoma (Fischer et al., 1997; 1996) and recurrently mutated
in serous endometrial tumors (Le Gallo et al., 2012). AF9 and ENL are the most
recurrent translocation partners of MLL in MLL-rearranged leukemias, a
pediatric acute leukemia with poor prognosis and poor response to conventional
therapies (Krivtsov and Armstrong, 2007). The majority of this chapter will focus
on the YEATS domain of AF9.
The studies described in this chapter were conducted in close
collaboration with Dr. Haitao Li and his group at Tsinghua University in Beijing
and with Dr. Tanya Panchenko, a colleague in the Allis lab. Dr. Haitao Li’s group
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Figure

5.1:

YEATS

Domain

Proteins

are

Associated

with

Transcriptional Regulation.
(A) Protein domain representation of the four human YEATS domain
proteins. The coiled-coil domain (CC) in the c-terminus of AF9 and
ENL is their interaction domain with both AFF4 and DOT1L. Not
drawn to scale.

Adapted from (Schulze et al., 2009). (B) Complex

subunit composition for the two AF9 and ENL containing complexes.
Red asterisk designates MLL fusion partner and yellow star indicates
proteins with small-molecule inhibitors currently in clinical trial. The
illustration in Figure 5.1B was designed by Dr. Tanya Panchenko.

85

(from here on referred to as the Li group) has expertise in the structural biology
of epigenetic factors, with a focus on reader domains. As such, the Li group
conducted all the structural and biophysical experimentation and analysis. I
performed the functional studies in close collaboration with Dr. Tanya
Panchenko.

This work has recently been submitted for publication and is

currently under review at Molecular Cell.
Recognition of histone post-translational modifications (PTMs) by histonebinding effectors constitutes a major mechanism for epigenetic regulation
(Jenuwein and Allis, 2001). A wide-range of so-called “reader” modules has been
characterized for type- and site-specific readout of histone PTMs (Musselman et
al., 2012; Patel and Wang, 2013; Taverna et al., 2007). Following the groundbreaking discovery of bromodomain (BrD) as an acetyl-lysine “reading” module
(Dhalluin et al., 1999; Sanchez and Zhou, 2009), therapeutic applications of smallmolecule inhibitors that block BrD:ligand interactions are currently in clinical
trials and show promise for the treatment of various cancers (Filippakopoulos
and Knapp, 2014) .With the application of mass spectrometry-based proteomics,
novel histone PTMs have been documented, including various types of nonacetyl

histone

lysine

acylations,

such

as

propionylation,

butyrylation,

crotonylation, and succinylation among others (Huang et al., 2014; 2015).
Alternations in cellular metabolism that, in turn, lead to shifts in the steady-state
balance of non-acetyl histone acylations may function in coordinating particular
transcription programs that govern cell growth and development. However, the
downstream readout of histone acylations such as crotonyl-lysine is poorly
understood in comparison to a wealth of knowledge on histone acetylation.
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Like histone acetylation, histone lysine crotonylation has been detected
from yeast to human and is primarily associated with active transcription (Tan et
al., 2011). As well, crotonylation occurs on the ε-amino group of lysine, but
distinguishes itself from acetylation by its planar orientation and four-carbon
length. Histone crotonyl-lysine (Kcr) but not acetyl-lysine (Kac) was found to
preferentially mark “escapee genes” during post-meiotic sex inactivation in
mouse testis, providing an early indication for a unique role of histone
crotonylation distinct from histone acetylation (Montellier et al., 2013; Tan et al.,
2011). Similarities between histone acetylation and crotonylation also exist
blurring distinctions. For example, Kcr and Kac sites overlap in histones and are
catalyzed by p300/CBP, a well-known histone acetyltransferase (HAT). Like
histone acetylation, p300/CBP-mediated crotonylation directly stimulates
transcription in vitro and in vivo albeit to varying degrees (Sabari et al., 2015).
Moreover, Sirtuin family members (e.g. SIRT1-3), well-studied histone
deacetylases (HDACs), remove Kcr in a site-specific manner (Bao et al., 2014;
Feldman et al., 2013). A subset of bromodomains, such as BRD9 and TAF1, can
tolerate Kcr but with compromised affinity as compared to that of Kac
recognition (Flynn et al., 2015). Given these contrasting findings, a clear
distinction between histone acetylation and histone crotonylation is lacking and
structural and functional consequences between the two are poorly understood.
Previously, the Li group has reported that YEATS domains constitute a
novel family of histone acetylation readers (Li et al., 2014). Here, through a
combination of structural, biochemical/biophysical binding, and cell-based
transcription activation studies, we define the evolutionarily conserved YEATS
domain as a family of Kcr-favorable readers that directly link histone
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crotonylation to active transcription. Crystal structural studies of AF9 YEATS
bound to H3K9cr and H3K18cr peptides revealed an extended aromatic
sandwiching cage for crotonyl-specific readout. By contrast, structure analysis of
BRD3 bromodomain bound to H3K18ac peptide revealed that the bulkier and
more rigid Kcr would be occluded due to steric clash. By experimentally
perturbing histone crotonylation levels, we show that AF9 co-localizes with
H3K18cr and positively regulates gene expression in a YEATS-dependent
manner. Furthermore, we show a previously unappreciated role of AF9 in the
rapid gene activation in the context of the immune response. Collectively, our
work describes a new epigenetic mechanism to regulate gene activity through
the establishment and readout of histone crotonylation, highlighting a functional
significance of non-acetyl histone acylations.

RESULTS
The YEATS Domain Has Histone Crotonyl-lysine Binding Activity
Recently the Li group characterized the YEATS domain as a novel Kac reader
module (Li et al., 2014). Based on their structural studies of AF9 YEATS bound to
H3K9ac, they defined a serine-lined aromatic sandwiching cage for specific
readout of Kac. The long Kac side chain is sandwiched by bulky aromatic
residues with the flat acetyl group snugly clamped, well-oriented in position.
Interestingly, although the Kac-binding channel is long and flat, it contains a
clear opening at the end where the acetyl group protrudes (Figure 5.2A, pink
arrow). Based on this observation, we hypothesized that this opening might
permit the recognitions of bulkier and longer acyl-chain hydrocarbon lengths.
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Figure 5.2: Identification of AF9 YEATS Domain as a Histone CrotonylLysine Reader.
(A) Cut-away view of AF9 YEATS in complex with H3K9ac peptide. AF9
YEATS is represented as green surface and histone peptide is shown as yellow
stick. Pink arrow denotes the wide opening of Kac-reader pocket. (B) Chemical
structures of known histone lysine acylations. Abbreviations and numbers
correspond to data shown in (C). (C) Isothermal titration calorimetry (ITC)
fitting curves of wild type AF9 YEATS titrated by a series of H3

1-15

peptides

containing K9 acylations shown in (B). (D) ITC fitting curves comparing Kcr
and Kac binding preference at sites H3K18 (left) and H3K27 (right). (E) ITC
titration and fitting curves of H3K9ac or H3K9cr bound by YEATS domains
from human ENL, and yeast Yaf9 and Taf14. The data and analysis presented in
Figure 5.2 were generated by the Li group.
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To test this hypothesis, the Li group synthesized a series of acylated
histone

H3 K9
1-15

peptides

including

formylation

(fo),

acetylation

(ac),

propionylation (pr), butyrylation (bu), crotonylation (cr), succinylation (su) and
2-hydroxyisobutyrylation (hib) (Figure 5.2B), and performed isothermal titration
calorimetry (ITC) using purified AF9 YEATS domain. Calorimetric titrations
revealed that AF9 YEATS binds to lysine acylations in an order of K9cr (2.1 $M) >
K9pr (2.7 $M) > K9bu (3.7 $M) > K9ac (5.0 $M) > K9fo (120 $M) > K9su (500
$M) > K9hib (N.D.) (K values shown in parenthesis, Figure 5.2C). Remarkably,
D

the linear extension of the hydrocarbon chain beyond Kac resulted in 2.4-, 1.9-,
1.4-fold binding enhancement for Kcr-, Kpr- and Kbu-modified peptides,
respectively. By contrast, shortened (Kfo), acidified (Ksu) or branched (Khib) K9
acylations caused a significantly reduced or complete loss of binding. These
quantitative binding studies confirm that AF9 YEATS favors a subset of bulkier
acyl-lysines with the strongest preference for the planar, four-carbon
crotonylation (Figure 5.2C).
Based on previous observations made with Kac peptides (Li et al., 2014),
the Li group next tested the binding preference of AF9 YEATS for two other sites
on the H3 tail, H3K18, and H3K27. For both sites AF9 YEATS bound with higher
affinity to Kcr than to Kac (Figure 5.2D), suggesting that crotonylation can
generally enhance the AF9 YEATS-H3 interaction as compared to acetylation,
regardless of the site of modification.
Crotonylation has been identified in budding yeast as well as human (Tan
et al., 2011). In order to test if Kcr preference is conserved in YEATS across
species, the Li group expressed and purified recombinant YEATS domains of
human ENL and of yeast Yaf9 and Taf14. Calorimetric titrations using H3 K9cr
1-15
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vs H3 K9ac peptides revealed 2.5- to 4.5-fold binding enhancement for Kcr than
1-15

Kac (Figure 5.2E). Collectively, these results suggest that favorable Kcr readout is
a common function of YEATS conserved from yeast to mammals.

Structural Basis for Crotonyl-Lysine Recognition by AF9 YEATS
To explore the molecular basis underlying Kcr readout by AF9 YEATS, the Li
group first determined the co-crystal structure of AF9 YEATS bound to H3 K9cr
1-15

peptide at 2.7 Å resolution. In the complex structure, AF9 YEATS uses the same
Kac-binding aromatic sandwich cage for Kcr recognition; and the crotonyl group
takes on a trans-conformation with the extended hydrocarbon chain snugly
stacking against F59 aromatic ring (Figure 5.3A). Comparison of Kcr-bound and
Kac-bound AF9 YEATS binding pocket revealed nearly identical overall pocket
arrangements except for slight conformational adjustments of aromatic residues
Y78 and F28 (Figure 5.3B, left panel). The crotonylamide group is characteristic
of a planar feature due to %-electron conjugation (Figure 5.3B, right panel).
Besides the relayed hydrogen bonding interactions conserved in both Kac and
Kcr amide recognition, preferential binding to Kcr is notably contributed by %aromatic interactions of the planar crotonylamide group with F59, Y78 aromatic
rings, as evidenced by interplanar distances between 3.4-3.8 Å (Figure 5.3B, right
panel). Moreover, additional hydrophobic contacts introduced by hydrocarbon
chain extension further stabilize Kcr-AF9 recognition. Even though a 15 amino
acid long H3

1-15

peptide was used for crystallization, only H3 T3-S10 could be

modeled around a surface formed by loops connecting the core β-strands of AF9
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Figure 5.3: Molecular Basis for H3K9cr and H3K18cr Readout by AF9 YEATS
Domain.
(A) Crystal structure of AF9 YEATS domain shows the insertion of the H3K9
containing crotonyl-lysine (left) and acetyl-lysine (right) into its aromatic
sandwich cage. K9ac and K9cr are depicted as space-filling spheres with the two
additional hydrocarbon atoms of the crotonyl group highlighted green. (B) Left,
detailed interaction map of the K9cr readout by AF9 YEATS shows a rotation of
Y78 and F28 when compared to K9ac (pink arrows). For comparison, K9cr-bound
structure (green, with key residues highlighted in light pink) was superimposed
with K9ac-bound structure (white). Hydrogen bonds are shown as dashes. K9cr
peptide is covered by 2Fo-Fc omit map (blue meshes) contoured at 2.5 σ. A
sharpening B-factor of 75 was applied to obtain the most informative maps. Right,
details of %-aromatic stacking between planar H3K9 crotonylamide and F59
phenyl ring with distances denoted in magenta. (C) Overall structure of H3K9cr
bound to AF9 YEATS. AF9 YEATS is depicted as green ribbons with key residues
highlighted in pink. Histone H3 peptide is shown as yellow sticks. (D)
Superimposition of H3K9cr- and H3K18cr-bound complexes. H3K9cr complex is
colored white as a reference and H3K18cr peptide is shown as yellow sticks.
Structure-based sequence alignment between H3K9cr and H3K18cr is shown
below. (E) Mutagenesis and ITC titration assays using mutant and wild type AF9
YEATS with H3K9cr (left) or H3K18cr (right) peptides. (F) Sequence conservation
analysis of YEATS reader pocket residues from yeast to human. The data and
analysis presented in Figure 5.3 were generated by the Li group.
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YEATS (Figure 5.3C). Importantly, K9cr is stapled into a pocket formed by L1, L4
and L6 loops of AF9, and the K9cr-flanking H3 residues are recognized by
extensive polar or hydrophobic contacts including a signature “H3R8-AF9D103”
hydrogen bonding pair (Figures 5.3C), demonstrating the critical importance of
the -1R on the histone peptide.
AF9 YEATS binds to H3K18cr with an affinity of 5.7 $M. Therefore, we
next determined the co-crystal structure of histone AF9 YEATS bound to H3
25

1-

K18cr peptide at 2.8 Å resolution. In the complex structure, H3 K14-L20 was

modeled with K18cr anchored and was recognized essentially in the same mode
as described above for K9cr (Figures 5.3D). H3K18cr peptide binds to AF9
YEATS in the same orientation as H3K9cr such that residue H3R17 at -1 position
interacts with acidic residue D103, recapitulating the importance of an “R-Kcr”
signature motif for AF9 YEATS recognition (Li et al., 2014). Structural alignment
of H3K18cr- and H3K9cr-bound AF9 complexes revealed that H3 segment “P16R17-K18cr” overlapped well with “A7-R8-K9cr”, while H3 K14-A15 and Q19-L20
displayed large discrepancy (Figure 5.3D). Nevertheless, crotonylation brings
H3K18cr binding by AF9 YEATS to single digit micromolar order - an affinity
fairly strong compared to other known histone mark-reader pairs (Patel and
Wang, 2013).

Mutagenesis and Binding Studies
We next performed mutagenesis and ITC titration studies to verify the
importance of key Kcr binding residues. As summarized in Figure 5.3E, alanine
mutation of pocket residues F28, H56, S58, F59, G77, and Y78 resulted in 5- to
192-fold binding reduction for H3K9cr and 5- to 102-fold binding reduction for
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H3K18cr peptides, respectively. Strikingly, F59A led to the most dramatic
binding loss, highlighting its critical role in lysine crotonylation-specific readout
by providing aromatic stacking interactions.. D103 plays an important role in “-1”
arginine recognition within the “R-Kcr” motif. In support, AF9 D103A mutation
caused 36- and 10-fold binding loss for H3K9cr and H3K18cr peptides.
Consistently, histone H3 R8A mutation caused a binding loss of 31-fold for
H3K9cr readout (Figure 5.3E, left panel), further validating the contribution of
“H3R8-D103” hydrogen bonding pair. Sequence alignment reveals that all the
pocket residues from L4 and L6 loops tested above are highly conserved among
YEATS domains (Figure 5.3F), consistent with the conserved Kcr reader activity
observed for YEATS from yeast to human.

YEATS Domain Is a Crotonyl-Lysine Reader in the Cellular Context
To confirm the AF9 YEATS-Kcr interaction in a cellular context, Dr. Tanya
Panchenko performed immunoprecipitation (IP) of AF9 to determine whether
crotonylated nucleosomes would co-IP. Using HeLa cell lines expressing FLAGtagged constructs of AF9 or AF9 with the F59A point mutant shown to ablate
YEATS-Kcr binding (Figure 5.3E), Dr. Panchenko generated mono-nucleosome
containing nuclear extracts by MNase digestion and performed FLAG-IPs in this
context. Immunoblot analysis of IP material revealed that while ELL2 and AFF4
(complex component members with mapped interaction domains in the Cterminus of AF9) were insensitive to the F59A mutation, both H3K9cr and
H3K18cr nucleosomes only co-IP with the wild-type AF9 (Figure 5.4A). These
data demonstrate that AF9 binds nucleosomes marked by H3K9cr and H3K18cr
and that this interaction is YEATS-dependent.
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Dr. Panchenko next performed nucleosome pulldowns with pre-modified
nucleosomes generated via amber suppression. Recombinant pre-modified
H3K9ac, H3K9cr, H3K18ac, and H3K18cr histones were generated by amber
suppression, as previously described (Gattner et al., 2013; Kim et al., 2012). The
modification statuses of these pre-modified histones were validated by MS/MS
analysis, which showed the expected modification at >90% purity (Figure 5.4B).
These pre-modified H3 histones, in conjunction with unmodified recombinant
core histones, were assembled into nucleosomes by standard salt dialysis (Dyer
et al., 2004) with a biotinylated 601 DNA template, allowing the nucleosomes to
be

immobilized

by

streptavidin.

The

immobilized

nucleosomes

either

unmodified, acetylated, or crotonylated (at either H3K9 or H3K18) were then
incubated in HeLa nuclear extract and interacting proteins were affinity purified.
Immunoblot analysis of pulldown material, focusing on the YEATS domain
proteins AF9 and ENL, revealed that while the acylated nucleosomes at either
site pulled down more AF9 and ENL than unmodified nucleosomes or control
pulldowns, nucleosomes bearing H3K9cr and H3K18cr purified more AF9 and
ENL from extract than nucleosomes bearing H3K9ac or H3K18ac (Figure 5.4C).
These data corroborate the biophysical data that the YEATS domain of AF9 has a
stronger preference for Kcr than Kac.

Bromodomains Do Not Exhibit YEATS-Like Preference for Crotonyl-lysine
Bromodomains constitute a major family of histone acetylation readers
(Filippakopoulos et al., 2012). To explore whether bromodomains have crotonyllysine reader activity, the Li group expressed a variety of bromodomains and
compared their binding affinity to Kac- and Kcr-containing peptides. Based on
96

Figure 5.4: The YEATS Domain Prefers Kcr to Kac Marked Nucleosomes.
(A) AF9 co-immuno-precipitates nucleosomes marked by H3K9cr and
H3K18cr in a YEATS-dependent manner. MNase nuclear extracts were
derived from HeLa cells expressing either a wildtype FLAG-tagged AF9
construct (FLAG-AF9-WT) or a F59A mutant FLAG-tagged AF9 (FLAG-AF9F59A). Immunoblot analysis with the indicated antibodies was performed on
the IP eluate of WT and F59A AF9 constructs. (B) MS/MS analysis of
recombinant histones pre-modified via amber suppression demonstrates the
purity of the expected product. (C) Immunoblot analysis for AF9 and ENL of
indicated pulldowns. Site-specific pre-acetylated or pre-crotonylated H3containing nucleosomes were used as bait in pulldown assays. Direct Blue
staining of the membrane documents comparable input material. The
streptavidin monomer co-migrates with histone H4 at this resolution. The data
and analysis presented in Figure 5.3 were generated by Dr. Tanya Panchenko.
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the classification of bromodomains (Filippakopoulos et al., 2012), representative
members from seven major BrD sub-families were chosen for ITC titration assay.
While all the bromodomains tested here exhibited reported Kac binding activity
at their respective target sites, cognate Kcr binding was not detected for most
bromodomains (Figures 5.5A). Though the second bromodomain of TAF1
(abbreviated TAF1

BrD2

and in an analogous manner hereafter for other multi-

bromodomain proteins) displayed an H4K5crK8cr binding activity, its binding
affinity was three times weaker than the H4 acetylation counterpart (117 $M vs
52 $M, Figure 5.5A).
The Li group next synthesized a series of histone acylation peptides
bearing Kac, Kpr, Kbu, and Kcr marks (Figure 5.5B) at sites H4K8, H3K14, and
H3K18, and performed quantitative ITC titrations for BRD4 :H4K8ac/pr/bu/cr,
BrD1

BAZ2A-H3K14ac/pr/bu/cr, BRD3 -H3K18ac/pr/bu/cr, as well as AF9
BrD2

YEATS

-

H3K18ac/pr/bu/cr pairs. Interestingly, all bromodomains exhibited reduced
binding following chain extension from acetylation to crotonylation (Figure 5.5C),
suggesting that bromodomains are primarily evolved towards Kac readout with
restricted tolerance to Kpr, Kbu and Kcr. By contrast, AF9-YEATS exhibited
enhanced binding following chain extension with tightest binding for Kcr
(Figures 5.5C). The above observations on BrD acyl-lysine readout are in
agreement with a recent profiling study, in which 49 bromodomains tested
displayed compromised binding to non-acetyl acylations (Flynn et al., 2015).
Collectively, these data suggest that bromodomains do not exhibit YEATS-like
preference for non-acetyl acylation, especially crotonyl-lysine.
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Structural Basis for Differential Recognition of H3K18 Acylation by BRD3 and
AF9
The above data suggest that BRD3 and AF9 recognize H3K18 acetyl versus
crotonyl with distinct acylation type preference. To better explore the underlying
structural basis, the Li group determined the co-crystal structure of BRD3

BrD2

bound to H3 K18ac peptide at 2.6 Å resolution. In the complex structure, H3
10-24

“A15-P16-R17-K18ac-Q19-L20-A21-T22” could be modeled with K18ac inserted
into the well-established Kac reader pocket formed by loops L and L (Figures
ZA

BC

5.5D). Interaction analysis revealed that Kac is notably stabilized by hydrophobic
contacts and hydrogen bonding interactions involving an invariant asparagine
N391 as well as Y348 and P333 (mediated by water) (Figures 5.5D). Moreover,
H3K18ac flanking sequences contributed multiple hydrogen bonding and
hydrophobic contacts with BRD3 . Notably, histone H3R17 at -1 position formed
BrD2

a hydrogen-bond with D394 and histone H3L20 at +2 position is inserted into a
hydrophobic pocket formed by W332, P333, H395, V397 and M400, collectively
accounting for H3K18 site preference (Figures 5.5D).
It is interesting to note that both BRD3

BrD2

and AF9 adopt a similar strategy

to recognize a signature “R-K” motif around H3K18ac/cr, in which the “-1R” is
stabilized by an aspartate residue (D394 in BRD3 and D103 in AF9), while
K18ac/cr is inserted into an adjacent reader pocket (Figures 5.5E and 5.5G). The
Kac pocket of BRD3

BrD2

is formed at the center of the four-helical bundle of the

bromodomain (Figures 5.5D and 5.5E). This configuration, with its tight network
of hydrogen bond stabilized water molecules (Figure 5.5E, blue balls) is
perfectly suited for Kac binding, but would be restrictive to any further extension
of the hydrocarbon chain. Conceivably, in order to fit into the reader pocket,
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Figure 5.5: Bromodomains Do Not Exhibit Crotonyllysine Preference and
the Underlying Molecular Basis.
(A) Summary of Kcr- and Kac-binding affinities by select bromodomains
from seven phylogenetic families (Filippakopoulos et al., 2012). Cognate
modification sites are listed in the last column of the table. (B) Comparison
of chemical structures of lysine acetylation (Kac), propionylation (Kpr),
butyrylation (Kbu) and crotonylation (Kcr). The planar part due to %conjugation is box-shaded. (C) ITC fitting curves comparing Kac, Kpr, Kbu
and Kcr binding affinities of H4K8 readout by the first bromodomain of
BRD4 (BRD4 ), of H3K14 readout by BAZ2A bromodomain, of H3K18
BrD1

readout by the second bromodomain of BRD3 (BRD3 ) and AF9 YEATS. (D)
BrD2

Histone H3K18ac binding by BRD3 . BRD3
BrD2

BrD2

is presented as ribbon covered

by its half-transparent surface. H3K18ac peptide is shown as yellow sticks.
Water molecules are shown as cyan balls. (E) Recognition of H3 “R17-K18ac”
by BRD3 . BRD3
BrD2

BrD2

is shown as surface view. Note the spatial restraints

around the K18 acetylamide group caused by the side-open pocket. (F) Steric
clash between F334 of BRD3

BrD2

and a modeled K18cr. The experimental K18ac

group is shown in yellow and overlaid for reference. The extended
hydrocarbon group of crotonylation is colored green. Red disk indicates
steric clash. (G) Recognition of H3 “R17-K18cr” by AF9 YEATS. Note the
position of crotonylamide group in the extended and end-open pocket. The
data and analysis presented in Figure 5.5 were generated by the Li group.
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bulkier acylations such as propionylation and butyrylation have to adopt a bent
conformation at the cost of binding energy. This may account for about 4- and
38-fold reduced affinity for H3K18pr and H3K18bu readout by BRD3 ,
BrD2

respectively. Furthermore, given the planar feature of crotonylation, H3K18cr
may be too rigid and bulky to fit into the BRD3

BrD2

reader pocket, thus causing

total loss of binding. In support, the modeled Kcr hydrocarbon chain directly
clashes against the phenyl ring of F334, a residue highly conserved in
bromodomains (Figures 5.5F) (Filippakopoulos et al., 2012). In contrast, the
extended AF9 YEATS reader pocket is a flat and open ended, ideal dimension for
acyl chains bulkier than Kac, especially Kcr (Figure 5.5G).

Kcr and AF9 YEATS Co-Localize Genome-Wide
To assess the functional role of the AF9 YEATS-Kcr interaction I returned to the
lipopolysaccharide (LPS)-induced inflammatory response as a model of gene
activation. In Chapter 4, I describe a role for p300-catalyzed H3K18cr in
inflammatory gene activation by studying the macrophage-like cell line
RAW264.7 (Sabari et al., 2015). To assess the role of AF9 in LPS-driven gene
activation I first compared cells pre and post LPS stimulation by chromatin
immunoprecipitation followed by high throughput sequencing (ChIP-seq) for
AF9 and in parallel generated a RAW264.7 cell line expressing a FLAG-tagged
AF9 and performed FLAG ChIP-seq under the same conditions. Both ChIP-seq
data sets showed that AF9 is recruited to LPS-induced genes upon LPS
stimulation, demonstrating that AF9 is involved in the process of inflammatory
gene activation (Figures 5.6A and 5.6B). Both datasets showed that AF9 peaks 3’
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Figure 5.6: ChIP-Seq for AF9 and FLAG-AF9.
(A-B) AF9 is recruited to LPS stimulated genes. Average profile of (A) AF9
ChIP-seq

and (B) FLAG-AF9 ChIP-seq data from unstimulated or LPS-

stimulated RAW264.7 cells plotted

±5kb TSS of LPS-stimulated genes

(log (fold)>2; 890 genes). (C) Comparison of endogenous AF9 (grey) and
2

FLAG-AF9 (purple) ChIP-Seq from RAW264.7 cells at two genes with
endogenous AF9 peaks, Slfn2 and Ccl3. (D) The FLAG-AF9 transgene is
expressed at levels lower than endogenous AF9. Whole cell lysates from the
indicated RAW 264.7 cell lines were resolved by SDS-PAGE and subject to
immunoblot with an antibody against AF9. The FLAG tagged AF9 migrated
slower due to increased molecular weight. The asterisk denotes a non-specific
band.
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of the transcription start site (TSS) and exhibited a tail that stretches into the gene
body, as can be observed in average profiles of genes (Figures 5.6A and 5.6B) or
at specific loci (Figure 5.6C). While ChIP-seq for the endogenous AF9 exhibited
the same trends as the FLAG ChIP-seq, the endogenous AF9 data set suffered
from high levels of background signal. Furthermore, the FLAG-AF9 protein was
expressed at levels comparable to, if not lower than endogenous AF9 (Figure
5.6D), mitigating concerns about artifactual localization due to hyper overexpression. For these reasons the remainder of the analysis was performed with
the higher-quality FLAG-ChIP-seq data.
I next asked whether AF9 and H3K18cr co-localize across the genome.
Using ChIP-seq data for FLAG-AF9 from LPS-stimulated cells I generated a list
of 4735 genes with high confidence AF9 peaks ± 1kb from their TSS and plotted
FLAG-AF9 and H3K18cr (Sabari et al., 2015) at these genes around the TSS
(Figure 5.7A). From this global analysis, the 3’ peak of H3K18cr co-localized with
the peak of AF9. Additionally, 95% of AF9 bound genes were also marked by
H3K18cr (4511 out of 4735) (Figure 5.7B). The co-localization of AF9 and
H3K18cr can be further appreciated locally at representative genes Ccl3 and Slfn2
(Figures 5.7D). Having shown that H3K18cr co-localizes with AF9 across genes
marked by AF9, I next asked whether the levels of H3K18cr correlate with the
levels of AF9. To do this I ranked genes marked by H3K18cr by number of read
bases normalized to total reads (RPKM) ± 1kb TSS (8480 genes) and grouped
these genes into quintiles Q1-Q5, with Q1 genes exhibiting the most reads for
H3K18cr and Q5 the lowest (1696 genes per group). FLAG-AF9 data was then
plotted for these quintiles around TSS and the highest FLAG-AF9 signal was
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Figure 5.7: Genome-Wide Co-Localization of H3K18cr and AF9.
(A) H3K18cr and AF9 co-localize at genes marked by AF9. Average profile
of FLAG-AF9 and H3K18cr ChIP-seq data from LPS-stimulated cells plotted
+/- 5kb TSS of genes occupied by AF9 (4735 genes). (B) Venn diagram
showing the overlap of AF9 occupied (purple) and H3K18cr marked (blue)
genes. H3K18cr marks 95% of genes occupied by AF9. (C) Genome-browser
view of FLAG-AF9 (purple) and H3K18cr (blue) at three representative AF9occupied genes. (D) Venn diagram showing the overlap of FLAG-AF9
occupied (purple), H3K18cr marked (blue), and H3K18ac marked (red)
genes.
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found on genes with the highest H3K18cr and vice versa (Figure 5.7D). In a
similar analysis, RPKM values ± 1kb for genes in Q1-Q5 were counted for FLAGAF9 and then graphed in box and whisker plots (Figure 5.7E). Each successive
group of ranked genes exhibited significantly higher FLAG-AF9 reads
demonstrating the correlation between AF9 and H3K18Cr levels at active genes.
The same trend was observed by plotting and counting RPKM values for
H3K18cr for groups ranked by levels of FLAG-AF9 (Figures 5.7F and 5.7G).
These data demonstrate the co-localization of AF9 and H3K18Cr across the
genome and specifically 3’ of the TSS of active genes.

The AF9-Kcr Interaction Positively Regulates Gene Expression in a YEATSDependent Manner
Having shown that AF9 is recruited to LPS-stimulated genes and that AF9 colocalizes and correlates with H3K18cr genome-wide, I next asked whether this
co-localization is H3K18cr- and/or YEATS-dependent. I have previously
reported that by increasing the cellular concentration of crotonyl-CoA prior to
LPS stimulation I could directly increase the levels of H3K18cr thereby increasing
expression of a number of p300-targetted genes (Sabari et al., 2015) (see Chapter
4). Based on our findings that the YEATS domain exhibits preferential binding to
Kcr, I hypothesized that this interaction and subsequent recruitment of YEATScontaining complexes could be the molecular mechanism driving the enhanced
stimulation capacity of Kcr. To understand the impact of increasing H3K18cr on
AF9 recruitment I performed ChIP-seq for FLAG-AF9 from cells pre-treated with
crotonate (10mM) followed by LPS stimulation. Utilizing previously published
RNA-seq data sets (Sabari et al., 2015), I generated two groups of LPS-stimulated
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Figure 5.8: FLAG-AF9 ChIP-Seq.
(A) AF9 is further recruited to genes transcriptionally responsive to
increased crotonyl-CoA concentration by crotonate pre-treatment. FLAGAF9 ChIP-seq data from RAW264.7 cells unstimulated (green), LPSstimulated (orange), or pre-treated with 10mM sodium crotonate and then
LPS-stimulated (purple) ±5kb TSS of genes either responsive to crotonate
(log (fold-FPKM)>1.0; 52 genes) shown in left panel, or genes unresponsive
2

to crotonate (log (fold-FPKM)<0.01; 233 genes) shown in right panel.
2

Sequenced input from crotonate treated and LPS stimulated cells is plotted
in pink. (B) Box and whisker plot (10-90 percentile) of fold change due to
th

crotonate pre-treatment in FLAG-AF9 RPKM ±1kb TSS of crotonate
responsive and crotonate unresponsive genes. ****: t-test derived p-value <
0.0001. (C) Genome-browser view of FLAG-AF9 ChIP-seq (purple) and
RNA-seq (black) data from cells unstimulated, LPS-stimulated, or
crotonate pre-treated and LPS-stimulated for a representative responsive
gene (Rsad2) and representative unresponsive gene (Ccl3).
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genes (log (fold)>1.0; ± LPS), those that were crotonate responsive (log (fold)>1.0;
2

2

LPS ± crotonate) and those that were unresponsive to crotonate (log (fold)<0.01;
2

LPS ± crotonate). FLAG-AF9 ChIP-seq data from unstimulated, LPS-stimulated,
and LPS-stimulated plus crotonate pre-treatment conditions were plotted around
the TSS of these two sets of genes (Figure 5.8A). Consistent with a role for AF9 in
crotonate-responsiveness, FLAG-AF9 signal was higher with crotonate treatment
only at crotonate responsive genes. By comparing FLAG-AF9 RPKM ± 1kb TSS of
genes in each group and calculating the fold change induced by crotonate pretreatment for each gene, I observed a mean fold-change in AF9 of 1.58 for
responsive genes compared to 0.92 in unresponsive genes (Figure 5.8B). The
increase in AF9 localization due to increased Kcr by crotonate treatment can be
seen at Rsad2, a representative crotonate responsive gene, whereas at Ccl3, a
representative unresponsive gene, there was no change to AF9 localization
(Figure 5.8C). Together these data support a role for enhanced AF9 localization
at genes that have enhanced H3K18cr levels and expression.
To test whether the increase in AF9 upon increased Kcr is dependent upon
the YEATS-Kcr interaction Dr. Panchenko generated a RAW264.7 cell line
expressing FLAG-AF9(F59A), a point mutation which ablates H3K18cr binding
in vitro and in cells (Figures 5.3E and 5.4C), and I compared this line to FLAGAF9(WT) by FLAG-ChIP under pre-treatment of increasing concentrations of
sodium crotonate. The two transgenes were expressed at equivalent levels, as
demonstrated by immunoblot and qRT-PCR (Figures 5.9A and 5.9B). Using
primers designed at AF9 peaks, ChIP-qPCR analysis at a number of crotonateresponsive genes (Rsad2, Il6, Ifit1, Cmpk2, and Gbp2) showed that while AF9
signal increased with increasing concentrations of crotonate, the F59A mutant
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Figure 5.9: The Increased Recruitment of AF9 Due to Crotonate Pre-Treatment
is YEATS-Kcr Dependent.
(A) Immunoblot analysis for AF9 protein levels of whole cell lysates from the
indicated cell lines. Top band is the FLAG-tagged AF9, the middle band is
endogenous AF9, and the band marked by an asterisk is a non-specific protein.
(B) qRT-PCR analysis of FLAG-AF9 expression in the indicated cell lines. Data
is presented as mean relative expression with standard deviation. (C) FLAGChIP was performed from RAW264.7 cells expressing a wild type AF9 (FLAGAF9(WT)) construct or an AF9 construct with the YEATS-Kcr abrogating F59A
mutation (FLAG-AF9(F59A) under the conditions indicated followed by qPCR
analysis of ChIP product and appropriate inputs. Data are plotted as mean
percent input + standard deviation. ***: t-test derived p-value = 0.0001; ****:
<0.0001; ns >0.05.
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was unresponsive (Figure 5.9C). Together these data support the model that the
AF9-YEATS interaction with H3K18cr is capable of enhancing AF9 recruitment.
Interestingly, the F59A mutant was recruited to tested loci upon LPS
stimulation to comparable levels as the wild-type protein suggesting that it was
integrated into its associated complexes and recruited by YEATS-independent
means, yet it lost the capability to “read” H3K18cr and was not further recruited
upon crotonate treatment (Figure 5.9C).
The increase in H3K18cr by crotonate pre-treatment is associated with
increased gene expression. To test whether AF9 is responsible for crotonateenhanced expression, Dr. Panchenko engineered a RAW264.7 cell line with
genetic knockout of AF9 by CRISPR-Cas9 (Figure 5.10A) and I tested whether
previously described genes were still crotonate responsive in this genetic context.
By pre-treatment of parental cells with crotonate, the crotonate-responsive genes
tested (Rsad2, Il6, Ifit1, Cmpk2, and Gbp5) exhibited between a 3 to 4-fold increase
in gene expression over LPS-induction, while cells lacking AF9 demonstrated a
significantly reduced response, as measured by qRT-PCR (Figures 5.10C-5.10G).
Importantly, this reduction could be rescued by addback of wildtype AF9 but not
by AF9 (F59A), demonstrating the gene selectivity of the phenotype and the
functional importance of the YEATS-Kcr interaction in this process (Figures
5.10C - 5.10G). Ccl3, as a representative non-responsive gene, was unaffected by
crotonate pre-treatment (Figure 5.10H). Both the AF9 and AF9 (F59A) transgenes
were expressed at the same level (Figure 5.10B). Taken together these findings
establish a functional role for the YEATS-Kcr interaction in the positive
regulation of gene expression.
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Figure 5.10: The Transcriptional Response to Increased Crotonyl-CoA
is Dependent on AF9 and the YEATS-Kcr Interaction.
(A) Sequence verification of AF9 knockout by CRISPR-Cas9. The guide
RNA used to target AF9 is indicated. Nucleotide deletions leading to a
frameshift mutation are observed on both alleles at the predicted cut site.
(B) qRT-PCR analysis of FLAG-AF9 expression in the indicated cell lines.
Data is presented as mean relative expression with standard deviation.
(C-H) The fold change in mRNA abundance, as measured by qRT-PCR,
due to crotonate pre-treatment under 120’ LPS stimulation was compared
across four RAW264.7 cell lines: 1) wild type control (no guide), 2)
CRISPR-Cas9 mediated AF9 genetic knockout (AF9 KO), 3) AF9 KO
expressing a wild type construct of FLAG-AF9 (AF9KO + WT), and 4)
AF9 KO expressing a F59A mutant construct of FLAG-AF9 (AF9KO +
F59A). Data for five crotonate responsive genes (C-G) and one crotonate
unresponsive gene (H) are presented. Data are plotted as mean fold
change of two biological replicates + standard deviation. ****: t-test
derived p-value < 0.0001; ns: >0.05.
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DISCUSSION
Although a variety of histone lysine acylations have been identified, diverse in
both chemical structure and site of modification, it remains unclear how they are
functionally distinct from acetylation, the archetypal histone acylation. Focusing
on Kcr, we have previously reported the enzymatic and metabolic means by
which Kcr is regulated independently of Kac and the enhanced transcriptional
response when the balance is shifted towards Kcr (Sabari et al., 2015). Driven by
insights gleaned from the co-crystal structure of AF9 YEATS domain in complex
with H3K9ac (Li et al., 2014), we postulated that the YEATS binding pocket
would prefer Kcr. This hypothesis was confirmed by ITC with purified
components as well as by the “designer nucleosomes” pulldowns. The
underlying molecular basis for YEATS-Kcr recognition was further revealed by
co-crystal structural studies. In addition, utilizing a cell-based model of
transcriptional activation wherein histone crotonylation levels can be perturbed,
we showed that AF9 positively regulates gene expression in a YEATS-Kcr
dependent manner. Collectively, our work reported here establishes that the
YEATS domain, originally annotated as a novel family of Kac effector proteins,
exhibits an evolutionarily conserved preference for Kcr over Kac. This provides
the mechanism by which Kcr stimulates transcription, further highlighting the
functional distinction between Kcr and Kac.

YEATS Possesses a Unique Mechanism for Preferential Crotonyl-lysine
Readout
Crotonyl-lysine sets itself apart from other acylation marks by its %-electron
conjugation of its crotonylamide group, thus being rigid and planar in shape
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(Figure 5.3B). Structural analysis of AF9 YEATS domain bound to H3K9cr or
H3K18cr demonstrates the crotonylamide plane is sandwiched by aromatic
residues Y78 from the top and F59 from the bottom, and %-aromatic stacking and
hydrophobic contacts contribute to preferential crotonylation readout (Figure
5.3B).

Among them, Y78 is primarily responsible for the amide group

recognition, while F59 provides critical stacking contacts with the extended
crotonyl hydrocarbon chain. An aromatic feature at positions 59 and 78 is highly
conserved among YEATS domain proteins from yeast to human (F and Y at
position 59, or Y and W at position 78) (Figure 5.3F), accounting for the
conserved crotonyl-lysine reader activity among YEATS family members.
Following crotonyl-lysine insertion, AF9 F28 from the L1 loop displayed
adaptive side chain flip, suggesting a role of F28 in sensing the tip part of the
longer chain acylations. Thus, the occurrence of F28 may partly account for the
binding loss observed for the branched Khib and acidified Ksu marks.
Interestingly, residues at position 28 displayed large discrepancy across species,
ranging from small side chain residue serine in YEATS2 to basic residue arginine
in Sas5 (Figure 5.3F), which suggests that different YEATS domains may display
fine-tuned acylation type sensitivity in addition to the common Kcr preference.
Comparison between the co-crystal structures of BRD3-H3K18ac and AF9H3K18cr highlights the ways in which YEATS is distinct from bromodomains.
The reader pocket of bromodomain is generated at the center of a four-helical
bundle and side-open (Figure 5.5D). Acetyl-lysine is perpendicularly inserted
into the pocket positioned in such a way that any extension of the acylation chain
would be restricted by the pocket dimension (Figure 5.5E). As supported by
previous structural studies (Flynn et al., 2015; Vollmuth and Geyer, 2010), longer
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acylation chains such as propionylation and butyrylation, must be rotated to
protrude out of the pocket from the side opening, compromising affinity.
Crotonyl-lysine, due to its bulky and planar feature cannot be rotated and is
therefore occluded from binding most bromodomains. By contrast, the reader
pocket of YEATS is elongated and open ended, being ideal to positively sense a
large repertoire of acyl-lysine marks with extended acylation chains (Figure
5.5G).

AF9 YEATS Regulates the Response of Inflammatory Genes to Histone
Crotonylation
We demonstrate here that AF9 is recruited to activated genes in the LPS-induced
inflammatory response. AF9 is a member of two distinct transcription-associated
complexes, the Super Elongation Complex (SEC) and the Dot1L complex
(DOT1LC) (Lin et al., 2010; Yokoyama et al., 2010). While this is the first direct
demonstration that AF9 is recruited to LPS stimulated genes, it is not entirely
surprising given that the inflammatory response requires the recruitment and
activity of multiple remodeling and elongation complexes (Medzhitov and
Horng, 2009; Smale et al., 2014). Furthermore, it has been previously
demonstrated that components of the SEC (ELL2 and AFF4) are recruited to
regulatory elements of activated genes in the context of EGF-stimulation (Lai et
al., 2015). AF9 localization is enhanced beyond levels attained by signal-induced
recruitment

by

crotonate

pre-treatment.

This

crotonate

enhanced

AF9

localization is dose-dependent and occurs specifically at genes that have been
previously shown to exhibit dose-dependent increases in H3K18cr, decreases in
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H3K18ac, and increases in gene expression under the same crotonate pretreatment and stimulation conditions (Sabari et al., 2015). AF9 is recruited to sites
of gene activation in a YEATS-independent manner (Figure 5.9C, compare 0 mM
crotonate, ± LPS), likely driven there by its known interactions with multiple
components of the DOT1LC or SEC. The interaction of AF9 with its complex
members is known to be YEATS independent, with mapped interaction domains
in AF9’s C-terminus (Biswas et al., 2011; He et al., 2011; 2010; Li et al., 2014;
Yokoyama et al., 2010). These observations suggest that robust and coordinated
signal-induced recruitment can override the need for the YEATS-Kcr/Kac
interaction, yet still the YEATS domain allows AF9 to “read” the chromatin
landscape and respond to increases in histone crotonylation. (Figure 5.9C,
compare increasing crotonate treatment WT vs. F59A). Furthermore, the
enhanced expression observed with crotonate pre-treatment is dependent on
AF9 and a fully functional YEATS domain (Figure 5.10C - 5.10G).
Our data support a role for the AF9 YEATS-Kcr interaction in the positive
regulation of gene expression, but also suggest that Kcr exerts its function
through other pathways as well. CRISPR-mediated knockout of AF9 significantly
reduces the crotonate response in our model system, but does not abolish it
completely (Figure 5.10). This residual response could be due to another YEATS
domain protein (ENL, GAS41, or YEATS2) or another as of yet unidentified Kcr
reader domain (trans-effects). Histone Kcr could also cause changes to
nucleosome stability or inter-nucleosomal interactions, thereby promoting
transcription in a reader-independent manner (cis-effects). In support of
potential cis-effects, a recent study demonstrated that H3-H4 tetrasomes
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comprised of H3K122cr were less stable in solution than tetrasomes with
unmodified H3 (Suzuki et al., 2015). As such, we anticipate that future studies
will uncover other pathways mediated by Kcr.
In this Chapter, in close collaboration with the Drs. Haitao Li and
Yuanyuan Li from the Li group, and Dr. Tanya Panchenko, my colleague in the
Allis lab, I demonstrate that the YEATS domain has an expanded acyl-binding
repertoire with highest binding to Kcr. This Kcr preference prompted us to focus
on the functional role of the YEATS-Kcr interaction within the context of gene
activation. The enhanced affinity for Kpr or Kbu as compared to Kac for the
YEATS domain is likely functional and we anticipate that perturbations to these
histone modifications will impact YEATS domain localization proportional to the
measured binding affinities. The preferential binding of YEATS to Kcr as
compared to Kac, reported here, makes YEATS unique among acetyllysine
readers, so far tested, demonstrating that specific protein folds have evolved to
functionally exploit the diversity of lysine acylations. This work supports the
general view that the wide range of lysine acylations being uncovered in histone
proteins function to expand the cell’s repertoire of transcriptional responses
through the selective engagement of acyl-specific reader proteins.
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CHAPTER

6:

IDENTIFICATION

AND

CHARACTERIZATION

OF

DECROTONYLASE ACTIVITIES

INTRODUCTION
The steady-state balance of a PTM is regulated by the counteracting activities of
the catalytic addition and removal of the modification. For histone acetylation
this balance is regulated by the activities of the HATs and HDACs. For
mammals, four classes of HDACs have been described. Classes I, II, and IV
represent HDACs 1-11, which all share a similar Zn -dependent catalytic
2+

mechanism. These are considered the “classic” HDACs with homology to the
yeast Rpd3, the first characterized HDAC (Taunton et al., 1996). Class III HDACs
represent the sirtuin proteins (SIRT1-7), NAD dependent deacetylases with
+

catalytic domain homology to the yeast sir2, described as a deacetylase by
Guarente and colleagues (Imai et al., 2000). The sirtuin enzymes are catalytically
and structurally distinct from the classic HDAC enzymes and for the purposes of
this thesis we will consider the two major classes of HDACs as classic HDACs
and sirtuins.
The classic HDACs are the enzymes inhibited by butyrate and other
HDAC inhibitors that demonstrate intriguing cancer-specific toxicities. The
NAD dependency of the sirtuins has sparked interest in how these enzymes
+

could be used as sensors of the metabolic redox state of the cell. Many intriguing
observations have been made about the sirtuins role in DNA-damage, cancer,
and aging (Guarente, 2007). Given the interesting biology of both classes, these
proteins have been the subject of pharmacological interest for discovery of both
inhibitors and activators. A small molecule inhibitor of Class I and II HDACs,
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SAHA/Vorinostat was the first epigenetic therapy to be approved for clinical
trial and is currently used in the treatments of T cell lymphoma. Several other
HDAC inhibitors have been approved or are in clinical trial for the treatment of
various malignancies (Falkenberg and Johnstone, 2014). As the sirtuin proteins
have been implicated as anti-aging factors (Guarente, 2007; 2012) , efforts have
been focused on developing sirtuin activators for the treatment of aging and agerelated diseases (Sinclair and Guarente, 2014).
Several findings led me to focus on the sirtuin enzymes as potential
decrotonylases. SIRT1, 2, and 3 were shown to have depropionylase and
debutyrylase activities (Smith and Denu, 2007). SIRT5 was shown to have highly
specific de-succinylase and de-malonylase activity in vitro and in vivo (Du et al.,
2011). These studies suggested that the sirtuin family of enzymes might have
acyl-specific roles. During the time of my thesis work other papers were
published to further demonstrate the unique capacity of sirtuin enzymes to
remove various acylations. SIRT6 was shown to have activity for long-chain
acylations, specifically lysine palmitoylation (16 carbon) and myristoylation (14
carbon) (Jiang et al., 2013). SIRT5 was shown to have activity on glutarylation
(Tan et al., 2014b). While these studies focused on non-histone substrates, they
suggested a role for the sirtuin enzymes in removal of acylation more complex
than acetyl-lysine.
During the time of my thesis work two independent studies have shown
that sirtuins have decrotonylase activity. The first study from John Denu’s lab
carried out a systematic screen for the capacity of the sirtuin enzymes to remove
a large variety of lysine acylations from histone peptides (Feldman et al., 2013).
This study assayed all seven mammalian sirtuins against twelve different
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acylations from short-chain to long-chain at position H3K9, and included
crotonyl-lysine. This study provided quantitative rate measurements for all
reactions assayed. In relation to crotonyl-lysine, they showed that both SIRT1
and SIRT2 have broad deacylation activity, which includes decrotonylation. They
did not detect any decrotonylation activity from the other five sirtuins assayed
and they do not observe any activity from SIRT7 (Feldman et al., 2013). The
second study utilized a peptide crosslinking strategy to purify proteins
interacting with crotonyl-lysine and isolated SIRT1, SIRT2, and SIRT3 from
nuclear extracts. Although previous reports have demonstrated SIRT3’s
mitochondrial localization, they proceed to characterize SIRT3 as a nuclearlocalized decrotonylase (Bao et al., 2014). Intriguingly, they demonstrated that
knockdown of SIRT3 increased global and local levels of histone crotonylation,
while knockdown of SIRT1 and SIRT2 had no measurable effect.
Here, I present data demonstrating decrotonylase activities of SIRT1, 2, 6,
and 7. Intriguingly, SIRT6 and SIRT7 only exhibit substrate-specific activities, in
that they only have deacetylase or decrotonylase activity on nucleosomal
substrates. I also demonstrate that HDAC1 has decrotonylase activity. Unlike the
HATs, where most families tested could not catalyze crotonylation, making
p300/CBP unique, the HDAC families appear to be generally promiscuous to
decrotonylation. Further kinetic analysis is required to distinguish the rates of
deacetylation and decrotonylation for these described activities.
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Figure 6.1: Purification of Recombinant Sirtuins.
cDNA for SIRT1, SIRT2, SIRT6, and SIRT7 were FLAG-tagged and cloned
into pFastbac1. Baculovirus were generated through the bac-to-bac protocol
and viral particles were added to sf9 cultures in exponential growth. FLAGtagged protein was purified from nuclear extract by immuno-affinity
chromatography with M2 resin (Invitrogen).

Shown here are coomassie

stained SDS-PAGE gels of the serial elutions (e1-e4), the column flow
through (FT), the cytoplasm fraction from the nuclear preparation (cyto),
and the whole cell extract (WCE).
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RESULTS
Nuclear Localized Sirtuins Exhibit Substrate Dependent Decrotonylase
Activities
The seven mammalian sirtuin proteins have specific cellular localizations. SIRT1
and SIRT2 localize to the nucleus and the cytosol, SIRT3, 4, and 5 localize to the
mitochondria, and SIRT6 and SIRT7 localize to the nucleus and nucleolus
(Michishita et al., 2005). In my efforts to identify a histone decrotonylase activity
I focused my attention on the nuclear localized sirtuins, SIRT1, 2, 6, and 7. I first
generated recombinant protein via the sf9/baculovirus expression system.
Baculovirus were generated encoding FLAG-tagged cDNA for all four of these
sirtuins and full-length protein was purified from nuclear extracts of infected sf9
cells (Figure 6.1).
To test the decrotonylase activity of the nuclear-localized sirtuins, I
established a decrotonylase activity assay where the readout was reduction in
immunoblot signal from crotonyl-specific antibodies. As an initial test of the
decrotonylase activities, histones acid extracted from crotonate treated cells were
used as generically hyper-crotonylated substrate. Under identical reaction
conditions, with all reactions containing the necessary cofactor NAD , SIRT1 and
+

SIRT2 exhibited decrotonylase activity while SIRT6 and SIRT7 were inert (Figure
6.2). SIRT1 and SIRT2 reduced the amount of histone crotonylation to levels
below detection on all four core histones. I next sought to test whether these
sirtuins could specifically decrotonylate p300-catalyzed crotonylation or
acetylation.
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Figure 6.2: Sirtuin Activity Assay with Acid Extracted Histones as
Substrate.
Histones were acid extracted from crotonate treated HeLa cells (as in
Chapter 3) and used as substrate for the recombinant sirtuin enzymes. All
reactions contain NAD . Reaction products were immunoblotted with
+

panKCr antibody.
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I prepared both recombinant histone octamers and oligonucleosomes
purified by sucrose gradient from MNase digested nuclei. The oligonucleosomes
were previously used as substrate in the histone crotonyltransferase (HCT)
purification (Figure 2.1) and the octamers were used as substrate in the
validation of HCT activity (Figures 2.3 and 2.4). The oligonucleosomes contain a
wide range of nucleosome lengths from mononucleosomes to >12mers (Figure
6.3A). Because the oligonucleosomes are purified by sedimentation from
complex extract they do contain contaminating proteins (Figure 6.3B). The
octamers were assembled in vitro from recombinant histones purified under
stringent conditions from bacteria essentially as in (Dyer et al., 2004), with slight
modifications taken from (Ruthenburg et al., 2011). As such, these octamer
preparations did not contain unknown contaminating proteins. The only
contaminant was trace amounts of the rhinovirus 3C protease used during the
processing of recombinant histones, which co-elutes with histone octamers
(Figure 6.3C). Under the salt concentrations used in all reaction conditions, these
octamers were in fact tetramers of H3-H4 and dimers of H2A-H2B. Octamers
were used because several HATs, specifically GCN5, cannot modify nucleosomal
substrates unless they are within their respective multi-subunit complex
(Brownell et al., 1996; Grant et al., 1997). p300 can modify either substrate.
Octamer or oligonucleosomes were acetylated or crotonylated by p300
and then diluted and added as substrate to sirtuin reactions containing NAD

+

and SIRT1, SIRT2, SIRT6, or SIRT7. Deacylase activity was measured by
reduction in signal from immunoblot with antibodies against H3K18Cr and
H3K18Ac, the dominant p300-catalyzed acylation. The reactions with acylated
octamers looked very similar to the reactions with acid extracted histones, SIRT1
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Figure 6.3: Composition of Oligonucleosome and Octamer Substrates.
(A) The DNA purified from sucrose gradient fractions resolved over a 2%
agarose gel and stained with ethidium bromide. The fractions pooled as
oligonucleosomes are indicated. (B) Increasing volume of purified
oligonucleosomes resolved over SDS-PAGE and coomassie stained. High
molecular weight contaminants can be observed. (C) Increasing volume of
recombinant histone octamers assayed as in (B). The asterisk designates
trace amounts of rhinovirus 3C protease used in HIS-tag cleavage that coelutes with histone octamers.
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Figure 6.4: Sirtuin Activity Assay with p300-catalyzed Octamers or
Oligonucleosomes as Substrate.
(A-B) Histone octamers (A) or oligonucleosomes (B) are crotonylated by
p300 and then added as substrate to reactions with the designated
sirtuin. Unmodified substrate and modified substrate in the absence of a
sirtuin are included. Immunoblot of reaction products are shown here.
(C-D) same as (A-B) except substrate are acetylated by p300. (E) antiFLAG immunoblot of reactions with FLAG-tagged sirtuins.
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and SIRT2 exhibited decrotonylase and deacetylase activity (Figures 6.4A and
6.4C). Surprisingly, the activities of the sirtuins changed when nucleosomal
substrates were used. SIRT1 was substantially inhibited and SIRT6 and SIRT7
gained deacylase activity, all while SIRT2 remained the dominant deacylase
(Figures 6.4B and 6.4D). These experiments did not detect a dramatic difference
between

the

decrotonylase

and

deacetylase

activities.

More

thorough

investigation and development of quantitative activity assays will be required to
compare the rates of the two activities. An immunoblot with FLAG antibody
demonstrated the loading differences of the FLAG-tagged sirtuins (Figure 6.4E).

Overexpression of SIRT2, SIRT6, or SIRT7 Reduces Global Levels of H3K18Cr
To test whether these in vitro reactions were predictive of the sirtuins cellular
activity, I overexpressed SIRT2, SIRT6, and SIRT7 in 293T cells by transient
transfection. I also generated cDNA for catalytically dead SIRT2, SIRT6, and
SIRT7 by mutating the conserved histidine within the catalytic pocket to a
tyrosine (HY-mutants), and overexpressed these constructs in parallel along with
an empty vector control. Immunoblots of extracted histones demonstrated that
global levels of both H3K18Ac and H3K18Cr were reduced upon transfection of
SIRT2, SIRT6, and SIRT7, but not upon transfection of the respective HY-mutants
or empty vector (Figure 6.5). The reductions for SIRT2 and SIRT6 were more
pronounced than the slight reduction observed with SIRT7 overexpression, but
SIRT2 and SIRT6 were expressed at higher levels (Figure 6.5). SIRT1
overexpression did not lead to a marked reduction in global histone acylation,
but the protein was not effectively expressed upon transient transfection (data
not shown). The reductions in immunoblot signal from cells transfected with
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Figure 6.5: Overexpression of SIRT2, SIRT6, and SIRT7 in 293T
cells Reduces Global Levels of H3K18Cr and H3K18Ac.
293T cells were transfected with pCDNA3.1 containing FLAGtagged wildtype or HY-mutant SIRT2, SIRT6, or SIRT7, or an
empty vector. Histones were acid extracted and whole cell extracts
were prepared. Immunoblots with the indicated antibodies are
shown here.
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sirtuin cDNA mirrored the in vitro reactions with oligonucleosome substrates,
demonstrating that the nucleosome is most likely the physiological substrate for
these enzymes. The levels of both H3K18Ac and H3K18Cr showed the same
trend in response to sirtuin overexpression.

HDAC1 Exhibits Decrotonylase Activity
To test whether decrotonylase activity was unique to sirtuins, I purified
recombinant HDAC1, the best-studied member of the Class I HDACs, from
baculovirus infected sf9. I performed several in vitro reactions comparing
HDAC1 to SIRT2. First, I used histones acid extracted from crotonate treated cells
as a source of acetylated and hyper-crotonylated substrate and immunoblotted
the products with either acetyl-specific antibodies to detect deacetylation or
crotonyl-specific antibodies to detect decrotonylation. As expected, HDAC1 and
SIRT2 deacetylated acid extracted histones as measured by immunoblot with
panKAc and H3K18Ac antibodies (Figure 6.6A). HDAC1 also decrotonylated
this substrate and reduced immunoblot signal for both panKCr and H3K18Cr
antibodies to below detection levels, as did SIRT2 (Figure 6.6A). Next, p300acetylated or –crotonylated octamers were used as substrate and both SIRT2 and
HDAC1 were able to effectively decrotonylate and deacetylate these substrates,
as measured by reduction in H3K18Cr and H3K18Ac immunoblot signal (Figure
6.6B). To test whether HDAC1 exhibited decrotonylation activity in cells, I
overexpressed HDAC1 in 293T cells and, in parallel, transfected cells with SIRT2
and an empty vector control. Immunoblots of acid extracted histones
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Figure 6.6: HDAC1 has Decrotonylase Activity.
(A) Acid extracted histones from crotonate treated cells were used as substrate
in reactions with SIRT2 or HDAC1. Reaction products were immunoblotted
with the indicated antibodies. Reactions with SIRT2 contained NAD . (B)
+

p300-acetylated or –crotonylated histone octamers were used as substrate in
reactions with SIRT2 and HDAC1 as in (A). (C) 293T cells were transfected
with FLAG-tagged cDNA for SIRT2, HDAC1 or an empty vector.

Acid

extracted histones or whole cell extract were immunoblotted with the
indicated antibody.
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showed that overexpression of both SIRT2 and HDAC1 led to global reduction of
both H3K18Ac and H3K18Cr (Figure 6.6C). While quantitative kinetics of
HDAC1 or SIRT2 decrotonylation or deacetylation cannot be derived from these
qualitative immunoblot-based activity assays, these data clearly demonstrated
that decrotonylation is not a unique property of the sirtuin enzymes.

DISCUSSION
The physiological substrate for the sirtuin and HDAC enzymes is presumably
the nucleosome. Histone peptides, free histones, and histone octamers are all
used as convenient proxies for the nucleosome, yet the data presented in this
chapter suggest that the form of the substrate is critical for enzymatic activity.
This is not a new phenomenon for chromatin modifying enzymes, as enzymes
such as PRC2 and NSD2 have been shown to require the nucleosome structure
for activity (Cao et al., 2002; Li et al., 2009b). Yet for the sirtuin field, peptides
have been the dominant substrate since the discovery of sir2 deacetylase activity
(Imai et al., 2000). Peptides are very convenient substrates for HDAC activity
assays as they can be synthesized to carry any modification at any site at high
purity. A recent systematic survey of the sirtuin enzymes’ capacity to remove
various histone acylations missed the activity of SIRT6 and SIRT7 described here
presumably because peptides were used as substrates (Feldman et al., 2013).
The nucleosome dependency of SIRT6 deacetylation has been described
(Gil et al., 2013) and the nucleosome enhanced deacetylase activity of SIRT7 has
been implied without direct statement (Barber et al., 2012), neither group tested
whether the enzymes could decrotonylate. A recent publication demonstrated
that a measurable enhancement of SIRT2 deacetylates activity was observed with
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nucleosome over peptide substrates (Hsu et al., 2016). Although my assays were
not sensitive enough to observe a substrate effect for SIRT2, this study
corroborates my findings that the sirtuin enzymes have substrate-dependent
activities.
The results presented here are preliminary and many experiments should
be conducted to explore these observations further. For example, unknown
proteins and possibly chemical matter contaminate the oligonucleosomes I use in
my reactions. It is a formal possibility that the difference in SIRT6 and SIRT7
activity is due to an unknown contaminating activity. Of potential concern is the
observation made by Denu and colleagues that long-chain fatty acids activate
SIRT6 activity (Feldman et al., 2013). It is possible that long-chain fatty acids or
trace lipids contaminate my oligonucleosome preparation. Experiments
comparing recombinant octamers with recombinant nucleosomes could solve
this problem. Furthermore, experiments with recombinant nucleosomes
acetylated or crotonyl via amber suppression (as in Chapter 5) would facilitate
more quantitative assessment of rates for SIRT6‘s and SIRT7’s decrotonylation
and deacetylation reactions. A major limitation with the experiments presented
here is the source of modified substrate. Neither acid extracted histones nor
p300-modified octamers or oligonucleosomes begin with equivalent acetylation
and crotonylation; even more reason to use pre-acylated histones via amber
suppression.
The paper describing the discovery of histone crotonylation compared the
activities of HDACs 1-11 on acetylated or crotonylated peptide substrates by a
quantitative fluorometric assay (Tan et al., 2011). They did observe
decrotonylation activity for HDAC1, but it was just above background signal and
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~10x weaker than its deacetylation activity. As I do not measure rates of activity,
but only end-point analysis, it is possible that the HDAC1 activity I observe is
negligible compared to its deacetylase activity. It remains unclear whether a
particular enzyme or enzyme family is solely responsible for decrotonylation.
The data presented here point to broad promiscuity for HDACs and sirtuins in
relation to deacetylation and decrotonylation.
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CHAPTER 7: GENERAL DISCUSSION

The discovery of histone lysine crotonylation prompted interest in the regulation
and function of this novel histone PTM. In my thesis work I have identified and
characterized the writers, readers, and erasers of histone crotonylation. I have
demonstrated that the modification is regulated metabolically by the relative
concentration of crotonyl-CoA and acetyl-CoA and that shifts in acyl-CoA
metabolism are read out on the differential acylation state of chromatin.
Furthermore, this change in levels of histone crotonylation affects gene
activation, in part through the recruitment of YEATS domain containing
proteins, readers of crotonyl-lysine (Figure 7.1). These studies establish a
previously unrecognized link between acyl-CoA metabolism and potency of the
transcriptional response. Many questions still remain unresolved and new
questions are introduced by the results of these studies. In the general discussion
I will go through a few potential future directions and address open questions
that have not been sufficiently addressed in individual chapter discussions.

Histone Crotonyltransferase(s)
The initial purification of HCT activity from HeLa cells yielded p300 as a known
HAT with HCT activity. Other HATs tested did not exhibit HCT activity. While I
have been able to make fundamental observations about Kcr by studying p300’s
HCT activity in vitro and in cells, it is likely not the sole HCT activity in the cell
for the reasons described below. From MS/MS analysis of p300 reaction
products, there are specific lysine residues that p300 prefers to crotonylate, yet
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Figure 7.1: The Regulation and Function of Histone Crotonylation.
Schematic of the pathways involved in the regulation and function of
histone crotonylation. The model presented here is a summary of the
experiments described in the previous chapters of this thesis.
p300/CBP (writer) catalyze histone crotonylation (Chapter 2), which is
regulated by the relative concentration of acetyl-CoA and crotonyl-CoA
(acyl-CoA metabolism) (Chapter 3). Enhanced levels of histone
crotonylation lead to a boost in gene activation (Chapter 4), which is in
part mediated through the increased localization of AF9 (reader)
(Chapter 5). This process is reversible by the activity of decrotonylase
activities (erasers) (Chapter 6). This illustration was designed by Dr.
Tanya Panchenko.

136

this only explains a small percentage of the 37 known sites of crotonylation
(Huang et al., 2014). Furthermore, while knockdown of p300 in cells ablates
levels of the modifications identified as p300 targets (e.g. H3K18), it does not
remove all histone crotonylation, as measured by immunoblot with a pan-Kcr
antibody (Figure 7.2A). These observations suggest that there are other
unidentified HCTs. Indeed, in unpublished data from the purification of HCT
activity
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have

crotonyltransferase

observed
activities

“side

fractions”

(Figure

7.2B).

that

contain

Further

unassigned

purification

and

identification of these activities could yield other, as of yet unidentified, HCTs.
The field has not yet identified an enzyme that is solely a
crotonyltransferase without any acetyltransferase activity. It is possible that these
side fractions contain such an activity, but as HAT activity was also observed in
these side fractions (data not shown) the HCT activity is most likely due to
another HAT. It would be of interest to identify this HAT. If it were one of the
HATs that tested negatively for HCT activity in its recombinant form, then it
would be interesting to understand whether HCT activity was dependent upon
complex formation or upon being covalently modified. If it were one of the
HATs not tested, it would be interesting to compare the catalytic domain with
that of p300 and CBP to better understand the mechanisms of crotonyltransferase
activity.
During my thesis work, I explored the potential regulation of p300’s HAT
and HCT activities by PTM-induced conformational change, but with only
inconclusive results. The hypothesis was that only a fraction of the recombinant
p300 purified from sf9 cells was active as an HCT. If this were true it would most
likely be due to a covalent modification that may allow for separation of the
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Figure 7.2: Unidentified Histone Crotonyltransferase(s).
(A) While knockdown of p300/CBP ablates H3K18cr signal, panKcr signal persists. HeLa S3 cells were transfected with the
indicated siRNA. 72 hours post transfection lysates were
prepared and immunoblotted by the indicated antibodies. (B) At
least two side fractions of HCT activity of unknown identity
were observed through the partial purification of p300/CBP.
HCT activity assays of fractions from the three columnchromatography stages are shown here. Arrowed line designates
path of activities reported in Chapter 2, while the dashed line
highlights the unexplored side fractions.
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modified isoform by high-resolution ion-exchange chromatography. To this end,
I loaded FLAG-purified p300 onto a Mono S column (cation-exchange) and
eluted over a shallow KCl gradient collecting fractions along the broad peak of
p300 elution. HAT and HCT assays were performed on every other fraction in
order to detect whether any fraction contained more HAT or HCT activity than
the rest. After several attempts at this line of experimentation, the separation of
p300’s HAT and HCT activities was not observed (Figure 7.3). Yet, these results
do not conclusively show that there is no such isoform, but only that the
potential isoform was not separable by ion-exchange chromatography. It is also a
possibility that a modification occurring in the cell may not be recapitulated in
baculovirus infected sf9 cells.
Another line of experimentation that could yield an HCT specific enzyme
would be protein engineering of the p300 catalytic pocket, either by rationale
design or by screening of random mutagenesis. Generation of a p300 or CBP with
heightened preference or selectivity for acetylation or crotonylation would be an
invaluable experimental tool for studying differential acylation in cells and
potentially in vivo. It would also be interesting to explore how the cancerassociated mutations within the catalytic domain of p300/CBP affect the choice
between acetyl-CoA and crotonyl-CoA.
In vivo experimentation as to the function of histone crotonylation has
been hampered by the shared enzymology with histone acetylation. For example,
it is unclear whether the effects of knockout or knockdown of p300/CBP are due
in any part to the loss of histone crotonylation. ACSS2, while implicated in my
cell culture models in the generation of crotonyl-CoA is also known to be critical
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Figure 7.3: Ion-Exchange Chromatography of p300 Does Not Separate its
HCT and HAT Activities.
HAT and HCT activity assays were conducted with the indicated source of
enzyme and immunoblotted with the indicated antibodies. Reactions
blotted with H3K18cr contained only crotonyl-CoA, while reactions blotted
with H3K18ac contained only acetyl-CoA. L is the column input/load, FT
is the column flow through, and 1-12 are the eluted fractions. Equal
volumes of all fractions were assayed.
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for acetate derived acetyl-CoA for histone acetylation and fatty acid synthesis.
Therefore it will be difficult to determine whether effects of ACSS2 knockout or
overexpression are mediated in any part by histone crotonylation. The
identification of crotonyl-specific enzymes or the engineering of enzymes to
prefer or reject crotonylation is needed for the field to expand. To make specific
statement about histone crotonylation in the cell, my experiments have mainly
relied on the selective regulation of histone crotonylation by crotonyl-CoA. This
was mainly accomplished by the addition of supraphysiological concentrations
of crotonate, a convenient method for cell culture, but one a bit trickier for mouse
based models. Further development of tools for the selective perturbation of Kcr
is required.

Intracellular Concentrations of Crotonyl-CoA and other Acyl-CoAs
A major outstanding question remains whether the concentrations of crotonylCoA fluctuate in the cell or in tissues to a degree where differential acylation and
its influence on gene expression could be expected to impact physiological
processes. Quantitative measurements of acetyl-CoA, CoA-SH, and the various
acyl-CoAs have been hampered by the lability of these molecules in complex
extracts (Theodoulou et al., 2014). These molecules are heavily derivatized
during standard methanol extraction used in a majority of metabolomic studies.
Specific extraction protocols for the purification, isolation, and stabilization of
acyl-CoA species have been developed and used in combination with LC-MS to
measure whole cell concentrations of various acyl-CoAs (Tsuchiya et al., 2014)
and have been successfully utilized to study the levels of acyl-CoAs in cell
culture and their impact on histone modification (Lee et al., 2014; Sabari et al.,
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2015). Whole cell measurements include mitochondrial pools of acyl-CoA, which
are distinct from cyto/nuclear pools regulating the modification of histones, yet
subcellular measurements of small molecules are hampered by diffusion
between organelles upon cell lysis. Even so, whole cell measurements of the
various acyl-CoAs across tissue types would provide valuable information as to
the physiological dynamic range of the lesser-studied acyl-CoAs, including
crotonyl-CoA.
Measuring the concentrations of acyl-CoA pools and in parallel
characterizing histone acylation in tissues from mice following metabolic stress
such as starvation or variation in diet composition will be a major first step in
understanding the dynamic range possible for acyl-CoAs and their impact on
histone acylation. Low calorie, low carbohydrate, or ketogenic diets are known to
cause major rewiring on metabolic pathways in a number of organs. Verdin and
colleagues showed that the short chain fatty acid (SCFA) and product of
ketogenesis, 3-hydroxybutyric acid, has effects on chromatin leading to the
activation of FOXO3A and protection from oxidative stress (Shimazu et al., 2013).
3-hydroxybutyric acid was elevated in the serum of mice fasted or under caloric
restriction which correlated with increased histone acetylation in a number of
organs including kidney, brain, liver, and large intestine. The authors concluded
that the effects are due to 3-hydroxybutyrate’s activity as an HDAC inhibitor.
The results from my thesis work suggest that these effects could be due to
changes in acyl-CoA metabolism. While histone lysine 3-hydroxybutyrylation
has not yet been described in the literature, the effects observed by Verdin and
colleagues could be due to enhanced levels of 3-hydroxybutyryl-CoA or butyryl-
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CoA leading to increased levels of the respective acylation. The potential impact
of SCFAs is discussed in the next section.
Various differentiation pathways as well as the process of maintaining
pluripotency would be interesting conditions to profile. Histone crotonylation
has been implicated in spermatogenesis (Chapter 1) (Tan et al., 2011). It is of
interest to understand whether a unique metabolic state exists in the testis to
facilitate histone crotonylation. Studies with mouse embryonic stem cells have
observed that pluripotency is associated with a unique metabolic state (Wang et
al., 2009) with intriguing consequences for the chromatin landscape and its
regulation of transcriptional networks (Carey et al., 2014; Shyh-Chang et al.,
2013).
While unbiased profiling of primary tissue or cells under the discussed
conditions will likely yield useful associative data, a more rationale approach
would be to study acyl-CoA metabolism in established cell lines under genetic
depletion of various metabolic enzymes known to interact with either crotonylCoA or acetyl-CoA. For example, siRNA knockdown of enzymes known to be
involved in the metabolism and catabolism of acetyl-CoA (ACC1, ACAT, PDH,
ACLY) and crotonyl-CoA (ACSS2, GCDH, HADHA, ECHS1) followed by
immunoblot of cell lysates with acyl-specific antibodies and measurements of
acyl-CoAs by LC-MS would extend the observation made in Chapter 3 for
ACSS2. Acetyl-CoA metabolism was already discussed in Chapter 1 (Figure 1.4).
Crotonyl-CoA can be synthesized as an intermediate in both beta-oxidation and
lysine and tryptophan degradation (Lin et al., 2012). In beta-oxidation, acyl-CoA
dehydrogenase (ACAD) generates crotonyl-CoA from butyryl-CoA, which is
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Figure 7.4: Metabolic Enzymes Involved in Acetyl-CoA or Crotonyl-CoA
metabolism.
A simplified metabolic network of enzymes responsible for metabolism of
acetyl-CoA (AcCoA) and crotonyl-CoA (CrCoA) is presented here. The
enzymes listed followed by abbreviations in parentheses used are as follows:
acyl-CoA dehydrogenase (ACAD), glutaryl-CoA dehydrogenase (GCDH),
ATP-citrate lyase (ACLY), pyruvate dehydrogenase (PDH), hydroxylacylCoA dehydrogenase (HADHA), enoyl-CoA hydratase (ECHS1), acetyl-CoA
carboxylase (ACC1), and acetyl-CoA acetyltransferase (ACAT).
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followed by hydroxylation to form 3-hydroxy-butyryl-CoA catalyzed by either
hydroxyacyl-CoA dehydrogenase (HADHA) or enoyl-CoA hydratase (ECHS1).
Crotonyl-CoA can also be derived from glutaryl-CoA by glutaryl-CoA
dehydrogenase (GCDH) in the degradation of lysine and tryptophan. See Figure
7.4 for a simplified metabolic network, highlighting the roles of these candidate
enzymes. These experiments could lead to the discovery of other metabolic
enzymes critical to the production of crotonyl-CoA used for histone
crotonylation.
The Influence of Environmental Short Chain Fatty Acids
A major outstanding question from my thesis work is how crotonate is generated
in the cell. If in fact ACSS2 knockdown decreases histone crotonylation then the
assumed source of crotonyl-CoA will be from crotonate (Chapter 3). There are no
obvious enzymatic reactions that would generate crotonate in mammalian
metabolic pathways. Short chain fatty acids (SCFA) in general are thought of
more as products of microbial metabolism than mammalian. The majority of my
cellular studies rely on the addition of exogenous crotonate to cells, a potentially
physiological situation for luminal cells of the mammalian large intestine, which
are exposed to the diverse ecology of the microbiota and its secretions. The
microbes that reside in the large intestine secrete a large variety of SCFA, the
most abundant of which tend to be acetate (2-carbon), propionate (3-carbon),
butyrate (4-carbon), and valerate (5-carbon). While the luminal cells of the large
intestine are in direct contact with microbial-secreted SCFA, these compounds
are also found in hepatic, portal, and peripheral blood, suggesting they could
have influence outside of the gut (Besten et al., 2013; Cummings et al., 1987).
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Differences in the concentrations and makeup of SCFAs from environmental
sources have been implicated in a variety of physiological and disease states
ranging from gut microbiota dysbiosis leading to obesity, colitis, and cancer
predisposition to the regulation of immune cell development (Lee and Hase,
2014; Tan et al., 2014a). SCFAs have numerous roles outside of feeding acyl-CoA
pools used for histone modifications. SCFAs can also be utilized in host
metabolism, particularly in colonocytes where they are the cell’s major energy
source (Roediger, 1980). SCFAs can also influence host fatty acid, glucose, and
cholesterol metabolism (Besten et al., 2013). SCFA are also implicated in
signaling pathways as they have been described as ligand activators of the Gprotein coupled receptors GPR41 and GPR43 (Brown et al., 2003). Yet, whether
observed fluctuations in SCFA lead to an increase or decrease in their
corresponding histone acylation, as we have shown here with crotonate and
histone crotonylation remains largely untested.
One way to test this hypothesis would be to compare specific pathogen
free (SPF) mice from different vendors to germ free (GF) mice by both SCFA
composition in serum and feces as well as measurement of crotonylation and
acetylation in histone extracted from various tissues. SPF mice from different
vendors or breeding centers are known to exhibit variation in their gut
microbiota (Hufeldt et al., 2010) presumably with consequences on the SCFA
composition. GF mice will not have any microbial-derived SCFA and
comparisons with SPF mice as to the levels of histone acylations will reveal the
extent to which these modifications are derived from environmental SCFAs.
Tissue from various sections of the gut, including colon, cecum, small intestine
and stomach, as well as other tissues including thymus, liver, kidney, and
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pancreas could be collected and lysates generated for immunoblot detection
and/or mass spectrometry. If differences in histone crotonylation are observed
between SPF and GF mice, further experimentation could be carried out to
inoculate GF mice with specific bacteria in an effort to identify the strain
responsible for the effect. These types of gnotobiotic mouse models have been
successfully utilized to study the effects of butyrate secreting bacteria on the
activation of T 17 immune cells (Arpaia et al., 2013) and in the protection against
H

colorectal cancer under high-fiber diet (Donohoe et al., 2014), both studies
implicate the compounds HDAC inhibitor activity as the mechanism of action.
Conclusion
The regulation of histone crotonylation or the functional consequence of a
histone being acetylated versus crotonylated (differential acylation) has
remained unclear since the discovery of the modification was reported. During
my thesis work I have had the privilege of working with exceptional colleagues
and together we have shown that histone crotonylation is regulated both
enzymatically, by p300/CBP, and metabolically, by the relative concentration of
crotonyl-CoA and acetyl-CoA. We established a role for histone crotonylation in
transcription in both cell-free and cell-based models of transcriptional activation.
We demonstrated that part of this transcriptional response is mediated through
AF9 YEATS as a reader of crotonyl-lysine and characterized several
decrotonylase activities. In conclusion, we have demonstrated that the
differential acylation state of histones is an integration of environmental and
metabolic information, which serves a functional role in the regulation of gene
expression.
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CHAPTER 8: METHODS

HeLa S3 Nuclear Extract Preparation
For nuclear extract, HeLa S3 cells were grown in suspension culture in DMEM
supplemented with 10% FBS. Eight liters of HeLa S3 suspension culture
(~1x10^10 cells) were harvested by centrifugation and then washed in cold PBS.
The pellet was resuspended in hypotonic lysis buffer (20 mM HEPES pH 7.9, 10
mM KCl, 5 mM MgCl , 0.5 mM EGTA, 0.1 mM EDTA, 5 mM βME, 1 mM sodium
2

metabisulfite, 1 mM benzamidine, 0.8 mM PMSF) and dounced ten times with
pestle A and ten times with pestle B or until >90% of cells were determined lysed
by trypan blue staining. Lysed cells were centrifuged at 3000 rpm to pellet intact
nuclei. Nuclei were resuspended in a nuclear resuspension buffer (20 mM
HEPES pH 7.9, 110 mM KCl, 2 mM MgCl , 0.1 mM EDTA, 5 mM BME, 1x
2

complete protease inhibitor (Roche), 0.4 mM PMSF) and dounced ten times with
pestle A to homogenize the suspension. Solid ammonium sulfate was added to a
final concentration of 400 mM, samples were immediately mixed by inversion,
and left rotating at 4°C for 30 minutes. The samples were then clarified by
centrifugation at 35,000 rpm for 1 hour. The supernatant is the soluble nuclear
extract. The soluble nuclear extract was then subject to ammonium sulfate
precipitation/salting out to 60% saturation. The precipitate was collected and
gently resuspended in buffer D (20mM HEPES pH 7.9, 100 mM KCl, 1 mM
EDTA, 10% glycerol, 1 mM DTT, 1 mM PMSF) and dialyzed twice against 2 L of
Buffer D for 2 hours. The dialyzed extract is the crude nuclear extract that was
subject to further fractionation.
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Chromatographic Fractionation
Column chromatography was performed using the AKTA Purifier system with
the following columns: in-house packed POROS Heparin 50 uM (Invitrogen),
Mono Q 5/50 GL (GE Healthcare), and Mono S 5/50 GL (GE Healthcare).
Fractions were collected over a linear potassium chloride gradient from 0.15 M to
1 M.

Immunoblot Analysis
Histones were purified from cells using a standard acid extraction protocol
(Shechter et al., 2007). Whole cell lysates were prepared by boiling cell pellets in
2x Laemmli sample buffer for 5 minutes followed by brief vortexing. The
following antibodies were used in this study: Pan-KCr (PTM-Biolabs 501),
H3K18Cr (PTM-Biolabs 517), pan-KAc (PTM-Biolabs 105), H3K18Ac (Abcam
1191), H3K27Ac (Active Motif 39685), H3K56Ac (Abcam 76307), H3 (Abcam
1791), p300 (Santa Cruz 584), CBP (Santa Cruz 7300), ACSS2 (Cell Signaling
3658), alpha-actin (Sigma A2066), beta-actin (Abcam 8224), and lamin-A (Abcam
26300). The ACL antibody was a gift from the Thompson Lab.

Cell Culture and Transfections
HeLa S3, HEK 293T, and RAW 264.7 cells were cultured in DMEM,
supplemented with 10% FBS, and 1% GlutaMAX (Gibco) at 37°C under 5% CO .
2

Sodium crotonate was prepared by dissolving solid crotonic acid (MP 207938) in
water, followed by titration with sodium hydroxide to pH 7.4. Sodium acetate
was prepared similarly with acetic acid. siRNA transfections were performed
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using Dharmafect 1 (Dharmacon) as per manufacturer’s instruction. The
following siRNAs were used at the following concentrations: non-target control
(Dharmacon D-001810-10, 25nM), p300 (Dharmacon L-003486, 25nM), CBP
(Dharmacon L-003477, 25nM), ACSS2 #1 (Ambion s31745, 20nM), ACSS2 #2
(Ambion s31746, 20nM), ACSS2 #3 (Ambion s31747, 20nM), ACSS2 #4
(Dharmacon L-010396, 20nM), ACL #1 (Ambion s915, 10nM), ACL #2 (Ambion
s916, 10nM), ACL #3 (Ambion s917, 10nM), PDHE1α (Ambion s10245, 20nM),
mouse ACSS2 (Dharmacon L-065412, 25nM). DNA transfections were performed
using lipofectomine 2000 as per manufacturer’s instruction. For LPS stimulation,
RAW 264.7 cells were plated at ~25% density >24 hours prior to stimulation. LPS
from Salmonella typhosa (Sigma L2387) was added at 100 ng/mL and samples
were collected at indicated time points.

Recombinant Enzymes
Recombinant p300, MOF, Sirtuins and HDAC1 were expressed in Sf9 cells by
baculovirus infection and purified by FLAG immuno-precipitation (IP) of
nuclear extracts, described in next section. Recombinant p300 and p53 used in
transcription assays were purified by Dr. Zhanyun Tang as described previously
(Tang et al., 2013). SIRT1 (addgene #1791), SIRT2 (addgene #13813), SIRT6
(addgene #13817), SIRT7 (Open Biosystems MHS6278-202832829) cDNA were
cloned into pFastbac1 with C-terminal FLAG tags. MOF cDNA (MHS6278202808687) was cloned into pFastbac1 with an N-terminal FLAG tag. Baculovirus
was generated by the Bac-to-bac system per manufacturer’s instructions (Life).
Amplified baculovirus was used to transduce sf9 cells and protein was purified
by FLAG-IP, as described in the following section. The catalytic domains of
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GCN5 (residues 505-670) and TIP60 (residues 181-462) were cloned from HeLaS3
cDNA

libraries

into

pGEX6p1

to

generate

GST-fusion

proteins.

Rosseta2(DE3)pLysS were transformed, induced by IPTG, and soluble protein
was purified by standard glutathione-sepharose chromatography.

FLAG Purification from Baculovirus Infected Sf9 Cells
Baculovirus were generated by the Bac-to-Bac recombination strategy (Life).
Baculovirus were amplified by serial infection of sf9 cells. 20-30 mL of high-titer
baculovirus was added to 1 L of sf9 suspension culture in exponential growth
(~0.6x10

6

cells/ml). Three days post-infection, cells were harvested by

centrifugation and washed in cold PBS. The washed cell pellets were then
resuspended (~2x10 cells/ml) in hypotonic lysis buffer (20 mM HEPES, 10 mM
7

KCl, 5 mM MgCl , 0.1 mM EDTA, 1 mM DTT, 1x Complete Protease inhibitor
2

(Roche)) and dounced 10 times with pestle A and 10 times with pestle B, or until
>90% of cells were lysed as detected by trypan blue staining. Samples were
centrifuged at 3000 rpm to pellet intact nuclei. Pellets were resuspended (~4x10

7

cells/ml) in Buffer B (20 mM HEPES, 300 mM KCl, 1 mM EDTA, 0.1% TritonX100, 1 mM DTT, 0.4 mM PMSF) and dounced with pestle A to homogenize.
Samples were incubated rotating at 4°C for 30 minutes followed by
centrifugation at 35,000 rpm for 1 hour. The supernatant is the soluble nuclear
extract. Equilibrated Anti-FLAG M2 conjugated to agarose beads (Sigma A2220)
were added to soluble nuclear extract and incubated rotating at 4°C for 4 hours.
The FLAG M2 agarose beads were washed on column twice with ten times
column volume (CV) Buffer W (Buffer B/0.01% TritonX-100, 10% glycerol).
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Protein was eluted with four 0.5CV elutions of buffer E (Buffer W + 300 $g/mL
3X FLAG peptide). Peak fractions were pooled and dialyzed to buffer W.

In Vitro Assays
HAT/HCT assays were incubated at 30°C for 1 hour in Buffer A (50 mM Tris pH
8.0, 10% glycerol, 1 mM DTT, 0.2 mM PMSF). When extract was used as an
enzyme source 10mM Sodium Butyrate was included in Buffer A. 2-100 $M of
either crotonyl-CoA or acetyl-CoA (Sigma 28007 and A2181) was used as the
high-energy acyl donor. Unless otherwise noted, 100 $M was used in initial
purifications, 2 $M in subsequent HAT and HCT in vitro assays, and 50 uM in
the transcription assays. The oligonucleosome substrate was sucrose-gradient
purified from micrococcal nuclease-digested HeLaS3 nuclei, as previously
described (Fang et al., 2003). Recombinant chromatin used in p300 reactions and
transcription assays was prepared as described (Tang et al., 2013). Recombinant
histone proteins were purified and assembled into octamers as previously
described (Ruthenburg et al., 2011). Under reaction conditions the “octamers” are
most likely present as H3-H4 tetramers and H2A-H2B dimers, while
oligonucleosome and recombinant chromatin substrate will maintain their
structure. Sirtuin reactions were incubated at 30°C for 2 hours in Buffer S (10 mM
Tris-HCl, pH 8.0, 5 mM NAD , 150 mM NaCl, 0.2 mM DTT). Fluorescence-based
+

HDAC assays were performed using an HDAC Assay Kit (Active Motif 56200)
according to manufacturer’s instruction. p53-dependent in vitro transcription
assays were performed as previously described (Tang et al., 2013). Densitometry
of autoradiographs was performed with ImageJ.
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H3K18Ac and H3K18Cr ChIP
Cross-linking ChIP was performed with anti-H3K18Ac (Abcam 1191) and antiH3K18Cr (PTM-biolabs 517). RAW 264.7 cells were grown in full media,
pretreated with the indicated concentration of crotonate for six hours, and then
stimulated with 100 ng/mL of LPS for two hours. Chromatin from ~5x10 cells
7

was used per immuno-precipitation. Media was aspirated and cells washed with
PBS followed by addition of 1% formaldehyde (in PBS). Cells were cross-linked
directly on the plate for 10 minutes with gentle shaking. Glycine was added to a
final concentration of 125 mM to quench the crosslinking and allowed to
incubate for 5 minutes. Cells were scraped off the plates, pelleted, and washed in
PBS plus 1x Complete protease inhibitors (Roche), 10 mM Butyrate, and 10 mM
nicotinamide. Pellets were resuspended in 10mL LB1 (50 mM HEPES, 140 mM
NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP40, 1% TritonX-100, 1x Complete
protease inhibitor (Roche), 10 mM Butyrate, 10 mM nicotinamide) and incubated
rotating at 4°C for 20 minutes. Samples were centrifuged and pellets were
resuspended in 10 mL LB2 (10 mM Tris pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5
mM EGTA, 1x Complete protease inhibitors (Roche), 10 mM butyrate, 10 mM
nicotinamide). Samples were incubated rotating at 4°C for 10 minutes and then
centrifuged. Pellets were resuspended in 1.2 mL LB3 (10 mM Tris pH 8.0, 100
mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% sodium-deoxycholate, 0.5% sodium
lauroyl sarcosinate, 1% TritonX-100, 1x Complete protease inhibitors (Roche), 10
mM butyrate, 10 mM nicotinamide) and passed through a 27-gauge needle until
suspension was homogenized. The samples were then sonicated in a Bioruptor
cooled water bath sonicator (Diagenode) for 60 cycles of 30’ on 30’ off on high
intensity. Samples were clarified by centrifugation at 16,000 g for 15 minutes. The
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supernatant is the soluble chromatin extract. 5% of input volume was set aside.
7.5 $g of H3K18Cr or H3K18Ac antibody were conjugated to 75 $L protein A
Dynabeads (Novex) per immuno-precipitation. After unbound antibody was
washed away, the beads were added to the clarified soluble chromatin extract
and incubated rotating overnight at 4°C. A magnetic stand was used to separate
beads from the extract and beads were washed under the following conditions:
three times with 1 mL wash buffer 1 (50 mM HEPES, 100 mM LiCl, 1 mM EDTA,
1% NP-40, 0.7% sodium deoxycholate, 10 mM butyrate, 10 mM nicotinamide),
three times with 1mL wash buffer 2 (20mM Tris-HCl pH 8.0, 350mM NaCl, 1%
TritonX-100, 0.1% SDS, 2mM EDTA, 10 mM butyrate, 10 mM nicotinamide), and
once with 1 mL buffer TE plus 50 mM NaCl. The washed beads were
resuspended in 210 $L elution buffer (50 mM Tris pH 8.0, 10 mM EDTA, 1%
sodium dodecyl sulfate) and incubated at 65°C for 30 minutes while shaking to
prevent beads from settling. The eluate was transferred to a new tube, 5% inputs
were brought up to equal volume with elution buffer, and both were incubated
at 65°C overnight to reverse crosslinks. The samples were then treated with
RNase and Proteinase K. DNA was recovered using the Qiagen PCR purification
kit according to manufacturer’s instruction. A 1/100 dilution of each sample was
used for qPCR analysis as described in experimental procedures.

ChIP-qPCR
ChIP products and inputs were diluted 1/100 and then analyzed by qPCR using
Power SYBR Green (Life) and StepOnePlus Real-Time PCR system (Applied
Biosystems).
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The sequences of ChIP-qPCR primer pairs used for H3K18Ac and H3K18Cr ChIP
are:

Forward

Reverse

Il6

AATGTGGGATTTTCCCATGA

GCTCCAGAGCAGAATGAGCTA

Gbp2

GCCCAGGGCTAGGTGACA

TGTGAAGTCTTCTTTCCCAGAGTTT

Ifit1

GCCATCCTAAGACCCCCTAGTG

TCTGCAGTTCCTCCTTGGAAGT

Pim1

CTGGCCTCGGTGTGCAA

GGCGAAGGCTGTGCAAGA

Rsad2

CAATCCCAACTCCTTTCCCAACA

TCTGACCTCCATAACCAAATGAACT

Ccl3

ATCTCCAGCTCGAGCAATGG

AGTCACTTTGCGGCTGATGA

Ccl5

TGAGCCTTTGAGGAGGTTGG

CACTGCAAGTCACGGCCATA

The sequences of ChIP-qPCR primer pairs used for FLAG-AF9 ChIP are:

Forward

Reverse

Rsad2

GGTCCAGGAACTTACCAGCC

TCCACACAGCCAAGACATCC

Il6

CTGCTCACTTGCCGGTTTTC

AGCATCAGTCCCAAGAAGGC

Ifit1

CCTGAGGGTCCAGGGAGTTT

TCCAGCACCAGGCACACA

Cmpk2

TGTTAGACACGGATGCTGCC

GGTAGGTGTTGGATGCACGA

Gbp2

GCCCAGGGCTAGGTGACA

TGTGAAGTCTTCTTTCCCAGAGTTT

Melt-curve analysis along a dilution series was carried out to ensure unique
product amplification for all primer pairs. All statistical analysis was performed
using PRISM v6.0 (Graph Pad).
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RT-qPCR
RAW264.7 cells were plated at ~25% confluency >24 hours prior to harvest.
Sodium crotonate was added 12-16 hours prior to harvest. LPS was added to a
final concentration of 100ng/ml 2 hours prior to harvest. Total RNA was
extracted using the RNeasy Kit (Qiagen) and Dnase treated on column according
to manufacturer’s instructions (Qiagen). cDNA was prepared using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to
manufacturer’s instructions. cDNA fragments were analyzed by qPCR using
Power SYBR Green (Life) and StepOnePlus Real-Time PCR system (Applied
Biosystems). A standard curve for each primer pair was used to ensure linear
dilution and to quantitate cDNA abundance. Relative expression values were
derived by normalization to Gapdh quantity for each sample. The sequences of
RT-qPCR primer pairs with forward followed by reverse are:

Forward

Reverse

Il6

GTTCTCTGGGAAATCGTGGA

TTTCTGCAAGTGCATCATCG

Gbp2

CTCTACCGCACAGGCAAATC

GATGCCCTTGGTGTGAGACT

Ifit1

AGTGAGGTCAACCGGGAATCT

TCTAGGTGCTTTATGTAGGCCA

Pim1

TCAAGGACACAGTCTACACGG

AGCGATGGTAGCGAATCC

Rsad2

AACCCCCGTGAGTGTCAACTA

AACCAGCCTGTTTGAGCAGAA

Ccl3

TACAGCCGGAAGATTCCACG

TCAGGAAAATGACACCTGGCT

Ccl5

GTGCCCACGTCAAGGAGTAT

CCCACTTCTTCTCTGGGTTG

Cmpk2

GACCTAGTTGACCAGTGCCC

AGTGTGGTCTTACCAGTGGC

Cxcl10

ATGACGGGCCAGTGAGAATG

TCGTGGCAATGATCTCAACAC

Ifnb

TGGGAGATGTCCTCAACTGC

CCAGGCGTAGCTGTTGTACT

Gapdh

TGGTGAAGGTCGGTGTGAAC

CCATGTAGTTGAGGTCAATGAAGG
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Gbp5

CGGACCTCGTCTAGAAAGCC

CCGGGCCAAGGTTACTACTG

FLAG-

TGGACTACAAAGACCATGACGG

GGCACGTCGTAGGGGTATC

AF9

Melt-curve analysis along a dilution series was carried out to ensure unique
product amplification for all primer pairs. All statistical analysis was performed
using PRISM v6.0 (Graph Pad).

RNA-seq
RNA-seq libraries were prepared using the TruSeq RNA Sample Prep Kit
(Illumina) as per manufacturer’s instruction. The procedure includes purification
of poly-adenylated RNAs. Libraries were sequenced with 50bp single read
sequencing on the HiSeq2500 (Illumina). Sequencing data was processed and
analyzed as described in (Trapnell et al., 2012). RNA-seq data sets are available
through GEO under the accession number GSE63889.

ChIP-seq for H3K18Ac and H3K18Cr
ChIP-seq libraries were prepared using the TruSeq ChIP Sample Prep Kit
(Illumina) as per manufacturer’s instruction. Libraries were sequenced with 50bp
single read sequencing on the HiSeq2500 (Illumina). 50bp reads were aligned
using bowtie (v1.0.1) to the mouse mm9 reference assembly reporting only
unique reads in the best stratum, with up to 2 mismatches (bowtie -p 8 -S -q -v 2 m 1 -k 1 --best –strata). Samtools (v0.1.19) was then used to convert files to bam
format, sort, and remove PCR duplicates (Li et al., 2009a). For genome browser
representation, tdf files were generated by IGVtools (v2.3.7) and data were
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visualized using IGV (v2.1.28) (Thorvaldsdottir et al., 2013). Ngs.plot (v2.08) was
used to generate average profiles of ChIPseq reads (Shen et al., 2014). MACS
(v1.4.2) was used to call peaks (Zhang et al., 2008). BEDOPs (v2.4.1), bedmap -basses function, was used for read counting within specified genomic regions
(Neph et al., 2012). ChIP-Seq data sets (H3K18Ac, H3K18Cr, and inputs) are
available through GEO under the accession number GSE63889. The p300 ChIPseq data presented here were reanalyzed from publically available data available
through GEO at accession number GSE19553 (Ghisletti et al., 2010).

Immuno-detection of Secreted Inflammatory Mediators
Supernatants from RAW 264.7 cells under indicated conditions and for indicated
length of LPS stimulation were assayed by two distinct immuno-assays. A
standard immobilized ELISA for mouse Il6 (Life KMC0061) was used as per
manufacturer’s instruction. And a bead-based assay that uses the principles of
sandwich ELISA to quantify soluble analytes using a flow cytometer (Biolegend:
Legendplex assay) was used to quantify the concentration of a number of
secreted chemokines and cytokines, as per manufacturer’s instruction.
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Mass Spectrometry Analysis of p300 Reaction Products
[The methods described here were carried out by He Huang and members of the
Zhao group]
Recombinant chromatin was acetylated or crotonylated by p300 in the presence
of p53 and reaction products were resolved on an 8% Tris-Glycine SDS-PAGE
gel. The gel bands of core histone proteins were excised and subjected to in-gel
tryptic digestion. The tryptic digests were desalted with Ziptip C18 and loaded
onto a homemade capillary column (10 cm length with 75 um inner diameter)
packed with Jupiter C12 resin (4 µm particle size, 90 Å pore size, Phenomenex
Inc.) connected to a NanoLC-1D plus HPLC system (Eksigent Technologies LLC,
Dublin, CA). Peptides were eluted with a gradient of 5% to 90% HPLC buffer B
(0.1% formic acid in acetonitrile, v/v) in buffer A (0.1% formic acid in water,
v/v) at a flow rate of 300 nL/min over 76 min. The eluted peptides were ionized
and introduced into a LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher
Scientific Inc., Waltham, MA) using a nanospray source. Full MS scans were
acquired in the Orbitrap mass analyzer over the range m/z 300-1800 with a mass
resolution of 60000 at m/z 400. Twenty of the most intense ions were isolated for
MS/MS analysis. Database searching was performed against the NCBI protein
sequence database, using Mascot. The database searching parameters included:
lysine acetylation, protein N-terminal acetylation, lysine crotonylation, lysine
trimethylation,

lysine/arginine

di-methylation,

lysine/arginine

mono-

methylation, and methionine oxidation as variable modifications. All the
identified peptides were manually verified.
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Mass Spectrometry Analysis of Mono S Fractions
[The methods described here were carried out by Dr. Henrik Molina]
50 $L of each fraction was precipitated overnight using 500 $L ice cold acetone.
Same process was followed for the ‘input’ sample with the exception that sample
volume was 100 $L and 1000 $L ice cold acetone was used for precipitation.
Acetone was carefully removed, first by suction, then by evaporation.
Precipitates

was

dissolved

in

30

$L

8M

Urea/0.1M

ammonium

bicarbonate/10mM Dithiothreitol and vortexed at room temperature for 45
minutes. Reduced proteins was alkylated in the dark by adding 7 $L 100mM
iodoacetaminde to each vial. Samples was then diluted 2-fold with 0.1M
ammonium bicarbonate and 1ug Endopeptidase Lys-C (Wako Chemicals USA,
Inc, Richmond, VA) in 10 $L in 0.1M ammonium bicarbonate was added to each
vial. Digestion was allowed to proceed for 6h. Samples were further diluted by
adding 80 $L 0.1M ammonium bicarbonate prior to the addition of 1ug trypsin
(Promega, Madison, WI, USA) dissolved in 20 $L 0.1M ammonium bicarbonate.
Trypsination of the samples was allowed to proceed overnight, and the digestion
was halted by adding 2 $L trifluroacetic acid. Half of each sample was desalted
using in-house SPE columns made with Empore C (Rappsilber et al., 2003).
18

Generated peptides were measured by nano LC-MS/MS using a Q-Exactive
mass spectrometer (Thermo, Bremen, Germany) coupled to a Dionex NCP3200RS
HPLC setups (Thermo, Sunnyvale, CA, USA). Samples were desalted and
concentrated on a trap column prior to separation on a packed-in-emitter C

18

column (75 $m by 12 cm, 3 $m particles - Nikkyo Technos Co., Ltd. Japan). The
analytical gradient was generated at 300 nL/min increasing from 10% Buffer B
(0.1% formic acid in acetonitrile) / 90% Buffer A (0.1% formic acid) to 45% Buffer
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B / 55% Buffer A in 137 minutes, followed by a wash step with 90% Buffer B /
10% Buffer A for 16 minutes and conditioning for 10 minutes with 1% Buffer B /
99% Buffer A Buffer B. Data Dependent Acquisition experiment: MS survey
scans was scanned from m/z 300 to m/z 1400 at resolution of 70,000@200 Th
(AGC: 5e5 and maximum IT: 100 ms). Up to the 20 most abundant ions were
subjected to MS/MS and measured at a resolution of 17,500 (AGC: 5e5 and
maximum IT: 60 ms) with m/z 100 as lowest mass. Precursor ions were isolated
at 2.0 Th. Lock mass of m/z 371.10123 was used for all measurements. All
samples were analyzed in technical duplicates. Data were searched and
quantified using MaxQuant 1.5.30 (Cox et al., 2014). Technical replicates were
merged for the analysis. The Uniprot Complete Proteome human protein
database (July 2014) was queried. Match between runs was utilized. Combining
all samples approximately 3,700 proteins were matched at 1% protein and
peptide False Discovery Rate. For the comparison of the data set intensity Based
Absolute Quantitation (iBAQ) (Schwanhäusser et al., 2011) was used. MaxQuant
‘proteinGroups.txt’ output is available in Table S1.

Mass Spectrometry Analysis of Acetyl-CoA and Crotonyl-CoA
[The methods described here were carried out by Drs. Justin Cross and Vladimir
Yong-Gonzalez]
HeLa S3 and RAW 264.7 cells were maintained in DMEM medium
supplemented with 10% FBS, 2 mM of L-glutamine, 100 units/mL penicillin and
100 $g/mL streptomycin at 37°C under an atmosphere of 5% of CO . The acyl2

CoA extraction procedure was based upon the method previously described by
(Basu and Blair, 2011), with minor modifications. Cultured cells were washed
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once with cold deionized water and metabolites extracted by the addition of 1
mL of ice cold 10% trichloroacetic acid (TCA). Following 15 seconds incubation
on ice, cells were collected by scrapping and transferred to a 1.5 mL Eppendorf
tube. Cell extracts were sonicated for 3 x 30 seconds (Bioruptor, Diagenode) and
then centrifuged at 14,000 rpm for 5 minutes at 4°C to remove protein. AcylCoAs were further purified using a HLB 96-well plate solid phase extraction
plate (30 mg) and vacuum manifold (Waters Corporation). SPE wells were
conditioned with 1 mL of methanol, and equilibrated with 1 mL of water.
Supernatants were applied and then SPE wells were washed with 1 mL of water;
acyl-CoAs were eluted using three successive applications of 0.5 mL of methanol
containing 25 mM ammonium acetate. Eluted acyl-CoAs were dried for 5 hours
in a bench top solvent evaporator (Genevac EZ-2 Elite). Dried samples were
stored at -80°C and re-suspended in 100 µL of 5% 5-sulfosalicylic acid (SSA)
immediately prior to analysis by liquid chromatography/mass spectrometry
(LC/MS).
Acyl-CoA were separated using a Phenomenex Luna C18 column (2.0 mm
x 50 mm, 5 µm) using 10 mM ammonium acetate in water, pH 8 as the aqueous
mobile phase and 90% acetonitrile, 10% water with 10 mM ammonium acetate,
pH 8 as the organic phase. The injection volume was 15 µl (Accela Open
Autosampler, Thermo Fisher Scientific) and a constant column temperature was
maintained at 30°C using a thermostatically controlled column oven (MayLab).
LC-20A pumps (Shimadzu) were used for the primary LC gradient: 0 min, 3% B;
1 min, 3% B; 6 min, 40% B; 7 min, 40% B; with an additional 6 min allowed for
column re-equilibration between injections. A constant flow rate of 0.2 mL/min
was maintained, with an additional 0.1 mL/min of 90% acetone, 10% dimethyl
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sulfoxide added post-column by means of an Accela 1250 pump (Thermo Fisher
Scientific) and PEEK tee, to increase the sensitivity of acyl-CoAs detection.
Acyl-CoAs were detected using a TSQ Vantage triple quadrupole mass
spectrometer (Thermo Fisher Scientific) equipped with H-ESI II probe, operating
in positive ionization mode. MS parameters were: spray voltage, 3000 V; sheath
gas pressure, 35 psi; auxiliary gas pressure, 30 psi; capillary temperature, 270°C;
and vaporizer temperature, 250°C. Data acquisition was performed in single
reaction monitoring (SRM) mode using S-lens of 200 V, collision energy of 26 eV,
50 millisecond scan time and compound specific parameters: Acetyl-CoA 810.1
! 303.1 m/z, Crotonyl-CoA 836.1 ! 329.1 m/z. Data was acquired and analyzed
using TraceFinder 3.1 software (Thermo Fisher Scientific).

Crystallization, Data Collection, and Structure Determination
[The methods described here were carried out by members of The Li group]
Crystallization was performed via the sitting or hanging drop vapor diffusion
method under 18°C or 4°C by mixing equal volumes (0.2-1.0 $l) of AF9 YEATSH3K9cr/18cr (1:2 molar ratio, 6–8 mg/ml) or BRD3 -H3K18ac (1:10 molar ratio,
BrD2

6–8 mg/ml) and reservoir solutions: 20% (w/v) polyethylene glycol 4000, 0.2 M
ammonium

sulfate,

and

0.1

M

sodium

citrate

tribasic dihydrate, pH 5.6, supplemented with 3% MPD (AF9-H3K9cr) or with
0.1 M copper chloride dihydrate (AF9-H3K18cr); 30% (w/v) polyethylene glycol
methyl ether 5000, 0.2 M ammonium sulfate, 0.1 M MES, pH 6.5, plus 0.1 M
guanidine hydrochloride (BRD3-H3K18ac).The complex crystals were briefly
soaked in cryoprotectant containing the reservoir solution supplemented with
20% glycerol and then flash frozen in liquid nitrogen for data collection. The
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diffraction data set was collected at the beamline BL17U or BL19U of the
Shanghai Synchrotron Radiation Facility at 0.9791 Å. All diffraction images were
indexed, integrated, and merged using HKL2000 (Otwinowski and Minor, 1997).
The structure was determined by molecular replacement using MOLREP (Vagin
and Teplyakov, 2010) with the AF9-H3K9ac structure (PDB ID: 4TMP) as the
search model. Structural refinement was carried out using PHENIX (Adams et
al., 2010), and iterative model building was performed with COOT (Emsley and
Cowtan, 2004). Detailed data collection and refinement statistics are summarized
in

Table

S1.

Structural

figures

were

created

using

the

PYMOL

(http://www.pymol.org/) program.

FLAG-ChIP
RAW264.7 cells were plated at ~25% confluence >24 hours prior to harvest.
Sodium crotonate was added 12-16 hours prior to harvest. LPS was added to a
final concentration of 100ng/ml 2 hours prior to harvest. Cells were fixed on
plate with 1% PFA in PBS for 10 minutes. Glycine was added to a final
concentration of 125mM. Cells were scraped off the plates, pelleted, and washed
in PBS plus 1x Complete protease inhibitors (Roche), 10 mM Butyrate, and 10
mM nicotinamide. Pellets were resuspended to 1x10^7cells/mL LB1 (50 mM
HEPES, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP40, 1% TritonX-100,
1x Complete protease inhibitor (Roche), 10 mM Butyrate, 10 mM nicotinamide)
and incubated rotating at 4°C for 20 minutes. Samples were centrifuged and
pellets were resuspended to 1x10^7cells/mL LB2 (10 mM Tris pH 8.0, 200 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA, 1x Complete protease inhibitors (Roche), 10
mM butyrate, 10 mM nicotinamide). Samples were incubated rotating at 4°C for
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10 minutes and then centrifuged. Pellets were resuspended to 6x10^7 cells/mL
LB3 (10 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1%
sodium-deoxycholate, 0.5% sodium lauroyl sarcosinate, 1% TritonX-100, 1x
Complete protease inhibitors (Roche), 10 mM butyrate, 10 mM nicotinamide) and
passed through a 27-gauge needle until suspension was homogenized. Samples
were then sonicated using Covaris ultrasonicator model S220 for 20 minutes with
the following settings: 140W peak power, 5% duty, 200 cycles per burst. Samples
were clarified by centrifugation at 16,000 g for 15 minutes. The supernatant is the
soluble chromatin extract. 400ug of soluble chromatin was used per ChIP. For
FLAG ChIP, soluble chromatin extract was mixed 1:1 with LB4 (10mM Tris pH
8.0, 100mM NaCl, 1mM EDTA, 0.5mM EGTA, 0.1% NP40, 1% TritonX-100, 1x
Complete protease inhibitors (Roche), 10mM butyrate, and 10mM nicotinamide)
to dilute FLAG-incompatible buffer components. FLAG-M2 (SIGMA F1804) was
conjugated to Protein G Dynabeads (Novex) at 7.5ug antibody to 75ul bead
slurry per IP. M2-beads were added to diluted extract and incubated rotating
overnight at 4°C. A magnetic stand was used to separate beads from the extract
and beads were washed six times with FLAG-ChIP wash buffer (50mM Hepes,
500mM NaCl, 1% TritonX-100, 0.1% NP40, 1x Complete protease inhibitor
cocktail, 10mM butyrate, and 10mM nicotinamide) and then once with 1 mL
buffer TE plus 50 mM NaCl. The washed beads were resuspended in 210 $L
elution buffer (50 mM Tris pH 8.0, 10 mM EDTA, 1% sodium dodecyl sulfate)
and incubated at 65°C for 30 minutes while shaking to prevent beads from
settling. The eluate was transferred to a new tube, inputs were brought up to
equal volume with elution buffer, and both were incubated at 65°C overnight to
reverse crosslinks. The samples were then treated with RNase and Proteinase K.
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DNA was recovered using the Qiagen PCR purification kit according to
manufacturer’s instruction.

ChIP-Seq Analysis for FLAG-AF9
ChIP-seq libraries were prepared using the TruSeq ChIP Sample Prep Kit
(Illumina) as per manufacturer’s instruction. Libraries were sequenced with 75bp
single read sequencing on the NextSeq 500 (Illumina) for FLAG-AF9 or 50bp
single read sequencing on the TruSeq 2500 for endogenous AF9. Reads were
aligned using bowtie (v1.0.1) to the mouse mm9 reference assembly reporting
only unique reads in the best stratum, with up to 2 mismatches (bowtie -p 8 -S -q
-v 2 -m 1 -k 1 --best –strata). Samtools (v0.1.19) was then used to convert files to
bam format and sort (Li et al., 2009). For genome browser representation, tdf files
were generated by IGVtools (v2.3.7) and data were visualized using IGV
(v2.1.28) (Thorvaldsdottir et al., 2013). Ngs.plot (v2.08) was used to generate
average profiles of ChIPseq reads (Shen et al., 2014). BEDOPs (v2.4.1), bedmap -basses function, was used for read base counting within specified genomic
regions (Neph et al., 2012). RPKM values were derived as follows: [(readbases)/(region-length in kb)]/(total mapped reads in Mb). FLAG-AF9 marked
genes were defined by RPKM value +/- 1kb TSS >70. H3K18cr and H3K18ac
marked genes were defined by RPKM value +/- 1kb TSS >50. Different cutoffs
were used due to the different levels of background noise between FLAG-AF9
and H3K18ac/cr ChIP-Seq. Publically available H3K18cr ChIP-Seq, H3K18ac
ChIP-Seq, and RNA-seq data used in this study can be accessed through GEO
accession number GSE63889.
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Protein Production Related to Chapter 5
[The methods described here were carried out by members of The Li group]
Recombinant wild type and mutant AF9 YEATS (residues 1-138) was produced
as previously described (Li et al., 2014). Briefly, AF9 YEATS was expressed in E.
coli strain BL21 (DE3) (Novagen) with 0.4 mM IPTG induction at 16°C. After cell
lysis by an Emulsiflex C3 (Avestin) high-pressure homogenizer thrombin and
centrifugation, the supernatant was kept and applied to a HisTrap (GE
Healthcare) nickel column and the protein was eluted with a linear imidazole
gradient from 20 mM to 500 mM. After thrombin (Sigma) digestion overnight for
His-tag removal, AF9 YEATS was further purified by a HiTrap SP (GE
Healthcare) cation-exchange column and a HiLoad 16/60 Superdex 75 (GE
Healthcare) gel filtration column using AKTA Purifier 10 systems (GE
Healthcare). AF9 YEATS proteins were stored in 500 mM NaCl, 25 mM Tris, pH
7.5, and 2 mM b-ME at ~ 10 mg/ml in an -80°C freezer. All chromatographic
steps were performed using AKTA Purifier 10 systems (GE Healthcare).
Recombinant YEATS domains of human ENL (1-138), and yeast Yaf9 (1-171),
Taf14 (1-136) were constructed based on the pET28b vector. All above proteins
were expressed and purified essentially the same as WT AF9 YEATS.
Recombinant

bromodomains

were

constructed

into

pET28b

vector,

expressed with N-terminal 6xHis tag, and purified as previously described
(Filippakopoulos et al., 2012; Li et al., 2014). After removal of the N-terminal His
tag, purified Bromodomains were stored in buffer containing 150 mM NaCl, 25
mM HEPES, pH 7.5 for future use, except that the second bromodomain of TAF1
was stored in buffer containing 150 mM NaCl, 25 mM HEPES, pH 7.0).
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Isothermal Titration Calorimetry (ITC)
[The methods described here were carried out by members of The Li group]
ITC measurement was performed as previously described (Li et al., 2014).
Briefly, synthetic pre-modified histone H3 peptides (SciLight Biotechnology,
LLC) and the recombinant YEATS and Bromodomain proteins were extensively
dialyzed against ITC buffer: 500 mM NaCl, 25 mM Tris, pH 7.5, and 2 mM β-ME
for YEATS proteins; 150 mM NaCl and 25 mM HEPES, pH 7.5 for Bromodomain
proteins (except that 150mM NaCl and 25 mM HEPES, pH 7.0 used for TAF1 ).
BrD2

The concentrations of peptides and proteins were measured using A205nm and
A280nm, respectively. The titration was performed using MicroCal iTC200
system (GE Healthcare) at 15°C for YEATS proteins and 25°C for Bromodomain
proteins. Each ITC titration consisted of 17 successive injections with 0.4 $l for
the first and 2.41 $l for the rest. Usually, H3 peptides at 1.0-1.2 mM were titrated
into YEATS or Bromodomain proteins at 0.07-0.1 mM. The resultant ITC curves
were processed using the Origin 7.0 software (OriginLab) according to the “One
Set of Sites” fitting model.

MNase Digestion and FLAG AF9 IP
[The methods described here were carried out by Dr. Tanya Panchenko]
The micrococcal nuclease (MNase) IP was performed essentially as described
(Bailey et al., 2013). Briefly, approximately 5 × 10 HeLa cells stably expressing
7

FLAG tagged AF9 (Li et al., 2014) were harvested and resuspended in hypotonic
lysis buffer (3.75 mM Tris at pH 7.5, 20 mM KCl, 0.5 mM EDTA, 0.5 mM DTT,
0.05 mM spermidine, 0.125 mM spermine, 1 mM PMSF, and 0.1% digitonin). All
buffers contained 20 mM nicotinamine, 10 mM sodium butyrate, cOmplete,
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EDTA-free protease inhibitor and phosSTOP phosphatase inhibitor cocktails
(Roche). Cells were homogenized to release the nuclei and then pelleted at 300 g.
The pellets containing the nuclei were resuspended in Wash Buffer A (20 mM
HEPES at pH 7.5, 20 mM KCl, 0.5 mM EDTA, 0.5 mM DTT and 1 mM PMSF ,
pelleted and resuspended in Wash Buffer B (Wash Buffer A supplemented with
300 mM NaCl). Nuclei were resuspended in Wash Buffer B supplemented with 3
mM CaCl . Chromatin was digested for 5 minutes at 37 C using 2000 units of
o

2

MNase (Worthington). The MNase digestion was stopped by adding 5 mM
EGTA and 0.05% TritonX and pelleted at 10,000 g for 15 min at 4°C. The
supernatant contained predominantly mono-nucleosomes as confirmed by
agarose gel electrophoresis was used for FLAG IP. FLAG M2 agarose (Sigma)
was used to bind the mononucleosome containing nuclear extract overnight at
4 C. Beads were washed 3 times using Wash Buffer B and boiled in SDS loading
o

buffer for western blot analysis. The following antibodies were used for analysis
of the IP: anti- H3K9cr and H3K18cr (PTM Biolabs PTM-516 and PTM-517), antiELL2 (Bethyl A302-505A), anti-AFF4 (ab103586), anti-FLAG (Sigma A8592).

Generation of Pre-modified Histones by Amber Suppression
[The methods described here were carried out by Dr. Tanya Panchenko]
All histones not containing site specifically modified lysines were expressed and
purified as previously described by A. J. Ruthenburg (Ruthenburg et al., 2011).
For site specific incorporation of crotonylated lysine, amber suppression system
developed by Peter Schultz’s lab was used (Kim et al., 2012). Briefly, an
orthogonal Methanosarcina barkeri tRNA/pyrrolysyl-tRNA synthetase (MbPylRS) pair was used where Mb-PylRS was mutated to accept crotonylated
169

lysine (Kim et al., 2012). The crotonylated lysine was synthesized as described by
Gattner M. J. (Gattner et al., 2013) as was used to supplement bacterial culture at
5 mM in the presence of 20mM nictonamide expressing H3 from a plasmid
containing an amber stop codon “TAG” at either lysine 9 or lysine 18. Similarly,
an amber suppression system developed by the Chason Chin lab was used in
order to generate site specifically acetylated histones. Here an Mb-PylRS was
mutated to accept acetylated lysine (Neumann et al., 2009). N-e-Acetylated lysine
was purchased from Sigma and was used to supplement bacterial culture at 5
mM in the presence of 20 mM nictonamide expressing H3 from a plasmid
containing an amber stop codon “TAG” at either lysine 9 or lysine 18.

Nucleosome Assembly
Octamers were reconstituted as described (Ruthenburg et al., 2011). The 601
nucleosome positioning sequence was used for nucleosome reconstitution
(Lowary and Widom, 1998). The DNA was amplified by PCR using primers
containing a biotin tag on the 5’ end to produce 189 bp linear DNA and purified
using QIAEXII kit (Qiagen). Nucleosomes were assembled using the standard
step-wise dialysis method (Dyer et al., 2004).

Generation of AF9 Transgenic and Mutant Cell Lines
[The methods described here were carried out by Dr. Tanya Panchenko]
For overexpression and rescue studies, PCDH plasmids containing 3xFLAG
tagged AF9 or AF9 F59A were used (Li et al., 2014). All lentivirus construct
plasmids were packaged into virus using HEK293-T cells as packaging cell lines
together with helper plasmids VSV-G (envelope) and psPAX2 (packaging, gag170

pol) following standard protocols. Primary cells were spin infected with
concentrated virus-containing media supplemented with 8 $g/mL Polybrene for
1.5 hours at 2500 rpm at 37°C and then selected with 5 $g /ml blasticidin. For
knockout of AF9 in RAW264.7 mouse macrophage cells, several CRISPR guides
were designed using the CRISPR design tool (http://crispr.mit.edu/) and cloned
into the pSpCas9(BB)-2A-GFP (PX458) plasmid (Ran et al., 2013). Plasmids were
transfected into RAW264.7 cells using LipofectamineLTX (ThermoFisher) and
FACS sorted 24 hours after transfection. Single clones were selected and tested
for AF9 expression using anti-AF9 specific antibody (Bethyl A300-595A) and
genotyped for the deletion (Figure S7D). The guide RNA sequence used in this
study targeted the 3 exon of AF9 which corresponds to the YEATS domain. The
rd

guide RNA sequence is GTAGAAGAGTCCGGGTACGC. The sequencing
primers to test the AF9 deletion were: TGAGCTACACTCCACTCAGA (forward)
and TTCAGAATGGCAATCACTCTTCA (reverse).
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